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Abstract
Cardiac disease is the most common cause of death among the adult
population worldwide and atrial fibrillation (AF) is the most common
cardiac arrhythmia. The state of the art in AF treatment involves cre-
ating lesions of heart tissue through radiofrequency ablation. In this
thesis, mathematical modelling techniques are developed to design de-
cision support tools that could help a cardiologist determine the best
location to ablate in clinic. Firstly, parameter optimisation methods
are explored to adapt a model designed for the ventricles to the atria,
and a novel technique is introduced to characterise pathways through
parameter space from a healthy state to a diseased state using a multi-
objective genetic algorithm. Next, I reproduce clinical signals recorded
during AF ablation through the use of a phenomenological model of the
cardiac action potential on a cylinder and show how this model can en-
able us to recover information lost in clinic to improve clinical decision.
This is followed by introducing a more simplistic approach to the same
problem, by characterising the electrical activity on the recording by
a sine wave. Finally, the effectiveness of these two approaches is com-
pared in the clinical setting by testing both as decision support tools.
The emphasis of the approaches throughout the thesis is on develop-
ing techniques with clinical applicability. We demonstrate that lost
information in clinic can affect the decision made by an experienced
clinician, and that the mathematical modelling approaches developed
in the thesis can significantly reduce the impact that this information
loss can have on clinical decision making.
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Chapter 1
Introduction
1.1 Thesis Aims
In this thesis I focus on the development and application of mathematical modelling
techniques towards real-time decision support tools for guiding cardiologists treating car-
diac conditions. This chapter introduces the basic theory of how the cardiac conduction
system functions in health and disease, then briefly addresses why mathematical models
can be useful in the study of heart disease and development of associated tools. The
literature review in chapter 2 will expand on this background theory in more detail. The
chapter concludes with an outline of the thesis.
1.2 Introduction to Theory of Cardiac Conduction
and Modelling
1.2.1 Electrical Conduction in Normal Heart Rhythm
The human heart consists of four chambers: the atria, responsible for collecting blood
from the lungs (left atrium) and rest of the body (right atrium), and the ventricles, re-
sponsible for pumping blood to the lungs (right ventricle) and the rest of the body (left
ventricle). This pumping action is performed by a sharp but coordinated contraction of
the cardiac muscle cells. A weak or uncoordinated contraction pattern in the heart mus-
cle will cause a reduced cardiac output. The coordination and power of the contraction
is regulated by an electrical signal in the form of a travelling electrical pulse called an
action potential (AP).
The electrocardiogram (ECG) is an aggregation of activity of single cells, used in
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clinic to record the electrical activity of the heart. The ECG can be recorded from the
skin (body surface ECG), which will record activity across entire heart, primarily used
for diagnosis and monitoring of overall heart rate. Intracardiac ECGs are recorded from
inside the heart, and record activity across a small patch of heart tissue, used for deter-
mination of the optimal location to apply treatment.
In terms of electrophysiology, cardiac cells can largely be categorised into two groups:
cardiac pacemaker cells and cardiomyocytes (non-pacemaker cells). Healthy pacemaker
cells are able to fire action potentials autonomously at a regular rate, although this
rate can be driven by the intracellular Voltage fluctuations of neighbouring cells. Non-
pacemaker cells will maintain a constant resting potential until neighbouring cells fire
an AP. The electrical conductivity of the cardiac tissue allows this action potential to
propagate from one non-pacemaker cell to the next.
The main electrical conductance pathway in the heart begins in a node of pacemaker
cells called the sinoatrial node (SAN), located high in the right atrium. The SAN is the
most important part of the heart for maintaining a regular heartbeat at between 60 and
100 beats per minute (BPM), although this can be influenced by external factors such as
the need for quicker blood flow during exercise, and internal factors such as disease.
The AP from the SAN spreads out over the tissue of the atrial myocardium, causing
it to contract. This process generates the P Wave on the body surface ECG (see Fig-
ure 1.1). The myocardial tissue is made up of non-pacemaker cells, and under normal
circumstances will not contract without a signal from the SAN. The atrial contraction
passes collected blood from the atria into the ventricles. The right atrium will pump
deoxygenated blood, collected from across the body, into the right ventricle, while the
left atrium pumps oxygenated blood from the lungs, collected through the pulmonary
veins, into the left ventricle. Blood flow is illustrated in panel a of Figure 1.2.
The travelling excitation wave then passes through the second node of pacemaker cells,
the atrioventricular node (AVN). The AVN will naturally pulse at a frequency of 40 BPM
but will phase lock to the rate of the atria under normal conditions [1, 2]. The purpose
of the AVN is to delay the propagation of the action potential, allowing the ventricles to
fill up with blood from the atria, and to regulate electrical signal down towards them,
as in a healthy, anatomically normal heart, the AVN is the only electrically conductive
pathway from the atria to the ventricles. Electrical flow is illustrated in panel b of Figure
1.2.
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Figure 1.1: Typical ECG Morphology of AF Patient. A body surface ECG recording
from an Atrial Fibrillation patient at Bristol Heart Institute with annotations showing
the P wave (contraction of the atrium) QRS complex (contraction of the ventricles) and
T wave (recovery of ventricles). The main difference between this morphology and that
of a healthy patient is the lack of a well-defined P wave.
From the AVN, the wave travels along fibres called the His bundle that eventually split
into the left and right bundle branches. From there, the wave spreads across the surface
of the ventricles via the Purkinje fibres. The contraction of the ventricles is stronger than
that of the atria, and this process causes the highest amplitude spike on a typical ECG
signal (the QRS complex). The contraction of the left ventricle pumps the deoxygenated
blood to the lungs for reoxygenation, while the right ventricle pumps oxygenated blood
around the body. The recovery of the ventricles causes the T wave. The recovery of the
atria is not visible on the ECG as it is obscured by the larger amplitude QRS complex.
Figure 1.1 displays an ECG recording from a patient with the PQRST morphologies
annotated. The signal is filtered with a wavelet denoising algorithm to filter out the
residual noise in the signal.
1.2.2 Electrophysiology of Cardiomyocytes
The AP that propagates across the atrial and ventricular tissue is a short (roughly 200-
300ms [3]) travelling pulse, generated by ion channels maintaining a current by the reg-
ulation of the flow of calcium (Ca), potassium (K) and sodium (Na) in and out of the
cell [4]. The cardiac AP is commonly defined in 5 key phases [5], beginning with phase 4.
These are typically defined with phase 4 first, as phase 4 both begins and ends the AP,
as shown on in Figure 1.3.
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(a) Blood Flow in the Heart (b) Electrical Flow on the Heart
Figure 1.2: Blood and Electrical Flow in the Heart. (a) Diagram showing blood
flow through the four heart chambers. Arrows represent direction of flow. Blue regions
contain de-oxygenated blood, which flows in through the vena cava and out through the
pulmonary artery to the lungs and red regions contain oxygenated blood, which flow in
from the lungs via the pulmonary veins and out through the aorta. (b) Diagram showing
electrical flow along the cardiac muscle fibres. The electrical signal travels from the
Sinoatrial Node (SAN) across the atria, causing a contraction, pumping blood into the
ventricles. The signal is delayed as it travels through the Atrioventricular Node (AVN)
before propagating on to the ventricles, pumping blood to the lungs and rest of the body.
Phase 4 is the resting potential, typically between -80 and -90 mV for both atrial and
ventricular cardiomyocytes [6], caused by the ionic concentration differential across the
membrane, mostly inwards flowing K+ ions via the IK1 channel. Once the cell is given an
electrical stimulus, either externally during experiment, directly from the SAN, or from
a neighbouring cardiomyocyte, phase 0 is activated: a sharp depolarisation during which
the intracellular potential rapidly increases to between 20 and 50 mV (depending on cell
type and location) by the activation of a rapid inwards Na+ current (INa). The maximum
gradient reached during phase 0 is called the upstroke velocity. However, if the stimulus
does not bring the membrane Voltage above a firing threshold, the cell will not fire an AP.
Following the peak, the Voltage slightly declines in phase 1, before the longest active
phase of the AP, the plateau phase (phase 2), where a high Voltage is maintained by a
balance of inwards flowing Ca2+ (ICa−L) and outwards flowing K+ (IKS) currents. Phase
3 slowly causes the ICa−L to close and an additional outwards K+ channel (IKR) to open,
causing a repolarisation of the cell and a return to the resting potential (phase 4). All 5
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Figure 1.3: Simulated Healthy Action Potential. A healthy atrial action potential
showing the four main phases into which the action potential is typically characterised.
Action potential is simulated from the Courtemanche model, a biologically detailed math-
ematical model [4].
phases of a healthy human atrial AP, simulated by a mathematical model, are shown in
Figure 1.3.
Following an action potential, the cell is in a diastolic interval (DI) or recovery phase.
During this phase, the ionic concentrations are restored by the rectifier channels while the
Voltage remains at the resting potential. The first part of the DI is a refractory period,
during which the cell cannot fire an action potential regardless of the stimulus strength.
Following the refractory period, the subsequent AP will have a much shorter plateau and
a shorter Action Potential Duration (APD) in general. The typical measure for this is
the APD 90, defined as the period of time for which the action potential is above 90%
repolarisation.
This definition is equivalent to the duration at which the voltage is above 0.1 if the
AP voltage is scaled to be from 0 to 1. The APD is an important aspect of cardiac
electrophysiology, as this has profound implications on the time at which the cell will be
able to fire again, influencing all subsequent APs that pass through the cell.
APD properties can be investigated in both experimentation and model simulation
by an S1-S2 protocol, in which the cell is given two stimuli at a certain time period apart
(this time period is known as the basic cycle length (BCL)). At a long enough BCL for
the cell to completely recover, APD1 will equal APD2. For shorter BCL, the second APD
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will be shorter. This is known as restitution.
The APD restitution curve is a curve that shows how the APD of a single cell (typ-
ically the APD90) varies under S1 - S2 stimulation with different BCLs. The steepness
of the APD restitution curve is often a predictor of how susceptible the heart is to an
arrhythmia. On the x axis is either the basic cycle length (time between stimuli) or the
diastolic interval (BCL-APD1), while on the y axis is typically APD2. As the period
between stimuli decreases, the recovery time, and thus the next APD, are shorter.
Eventually, for a short enough BCL, S2 will fail to fire an AP, and the curve ends.
When investigating these regions of the APD restitution curve, it is common to run
multiple stimuli to either detect 2:1 firing behaviour (where one AP is fired for every
2 stimuli) or alternans [7]. Alternans (2:2) behaviour can occur close to the threshold
BCL value between 2:1 and 1:1 firing behaviour, and occurs when a short DI triggers a
short APD, which in turn triggers a long DI, and a long APD. The cycle can continue
indefinitely, producing alternately long and short APDs (stable alternans) or can be
unstable and tend towards 1:1 firing [8].
1.2.3 Cardiac Wave Propagation and Arrhythmia
The transfer of the AP from one cell to the next across an excitable medium is termed
propagation. The propagation pattern (a travelling front that moves across the heart)
is responsible for maintaining a regular contraction pattern from the SAN to the ven-
tricles. Physiologically, this AP transfer is facilitated by gap junctions which allow ions
to transfer between cells [9], but the purposes of this thesis, detailed descriptions of the
underlying biophysics of this process are not relevant.
Propagation is simplest in a one-dimensional string or cable of heart tissue. In the
human heart, this type of propagation is seen in the His-Purkinje complex. Under normal
circumstances a stimulus given to one end of the cable will cause the first cell to fire an
AP that will propagate to the other end, however, there are a number of factors that
can disrupt this propagation. The speed of this propagation is the Conduction Velocity
(CV). If the cell is forced too quickly (short BCL), the shorter recovery period leads to
a reduced CV. At an even shorter BCL, either A) the stimulus may fail to exceed the
firing threshold or B) the AP generated is too weak to exceed the firing threshold for all
future cells, causing propagation to fail.
In two-dimensional tissue, a greater range of propagation patterns can be seen. Given
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a rectangular sheet of heart tissue, a stimulus applied in the middle will create a circular
or elliptical front that spreads out from the focus (target wave). AP propagation in a
real heart is often anisotropic, i.e. the CV has a prominent direction, causing an ellip-
tical shape in the emerging activation front. Many modelling works ignore this, and so
simulated target waves are often circular. If one side of the sheet is stimulated at the
same time, the resulting propagation front is a straight line (plane wave). Temporarily
assuming that the heart tissue has no depth, the front created by the SAN is a target
wave, and propagation patterns in the atria in a regular, healthy heart are target and
plane waves.
Many types of arrhythmia can be explained by considering the two-dimensional prop-
agation case. Propagation fronts can be disrupted by either an anatomical obstacle
(e.g. physical scar tissue blocking the AP) or a functional obstacle (e.g the collision of
wavefronts from two separate sources). Under these circumstances, it is possible for an
activation front to travel in a circular pattern and return back to where it came from.
This phenomenon is called a re-entrant wave, or spiral wave after the spiralling wavefronts
created. During a spiral wave, the overall frequency of the heart rate is determined by
how quickly the spiral can cycle (determined itself by the CV and restitution properties),
rather than the BCL of the pacemaker. This often causes a heart rate that is regular but
much quicker than sinus rhythm. Stable spiral waves are associated with atrial or ventric-
ular tachycardia. The most dangerous cardiac arrhythmias occur when these spiral waves
break up into smaller spirals, causing spatiotemporal chaos. In this state, seen during
atrial or ventricular fibrillation, there is no order or coordination to the wavefronts at all.
For this reason, atrial and ventricular fibrillation are a serious and immediate medical
concern.
Cardiac arrhythmias are often diagnosed by the examination of the body surface ECG.
For example, if there is no clearly defined P wave and a wavering baseline, the clinical
cardiologist can infer that there is something wrong with the atria. A large delay between
the P and the R wave can imply a blockage in the SAN. However, the body surface ECG
is often insufficient to determine any information on a smaller scale.
In the case of atrial fibrillation, spiral waves are often caused by an ectopic (un-
wanted) wavefront originating from the Pulmonary Veins (PVs) instead of from the SAN
(see Figure 1.2). Various clinical techniques have been developed that either target the
elimination of the spiral wave itself through anti-arrhythmic drugs or block the origin
of the ectopic signal by formation of lesions around the source. These lesions are most
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commonly created by ablating tissue by application of radiofrequency energy, guided by
intracardiac ECGs recorded around the vein ostium to monitor activity around the PV. A
combination of the body surface ECG and intracardiac ECGs can help determine the ac-
tivation time of localised regions in comparison to the rest of the heart. The primary goal
of this thesis is to develop decision support tools that could help a cardiologist identify
the optimal ablation location using intracardiac ECGs .
1.2.4 Modelling
Since cardiologists are using variation in the electrical signals recorded from the heart
over time to make decisions about regions of the heart to ablate, mathematical modelling
is a potentially suitable tool to provide additional relevant information.
We do this by studying the cardiac conduction system from a mathematical modelling
perspective. Mathematical models are useful for both their explanatory and predictive
power. Exploring how the parameters of a realistic mathematical model influence the
solution can provide hypotheses for experimental testing and is easier than running ex-
periments on physical cells. Investigation of a model also allows the varying of parameters
that are impossible to control in reality, and ethical limitations are not a factor, allowing
for a greater range of investigations into a beating heart.
Mathematical models also have the potential to be used to make predictions about
the electrophysiology of the heart, which has obvious applications in deciding on the best
methods of treatment [10], effects of drugs [11], and also in predicting heart attacks to
guide an artificial pacemaker [12]. Inverse problems (working from the output back to the
underlying input parameters) can also be used in diagnosis at no distress to the patient.
One of the most simple methods for this is the clustering of ECGs into categories by
fitting Hermite polynomials [13].
The most commonly investigated mathematical models of non-pacemaker cells are
reaction-diffusion equations where the reaction term focuses on modelling the ionic cur-
rents behind the generation of the AP, and the diffusion term approximates the effect of
gap junctions, allowing the simulated AP to spread across a series of coupled cells. The
complexity of such models ranges from the simple two dimensional FitzHugh-Nagumo
model [14] to much larger and more detailed more complex biophysical models, of which
there are numerous reviews [15]. Models are typically solved either on a flat sheet of
tissue using finite difference methods or on an anatomically accurate mesh using finite
element methods.
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In addition to reaction-diffusion equations of cardiomyocytes, models exist for the
pacemaker nodes (SAN and AVN), typically taking the form of oscillators that resem-
ble the van der Pol oscillator [16], i.e. capable of self-oscillating, and will phase lock to
the rate of the fastest oscillator when coupled. Models for the body surface ECG signal
range from phenomenological models whose solutions resemble the correct form [17] to
biophysical models that model the conductance of both the heart and the entire torso,
most importantly the ribs [18].
In this thesis, the main aim of the study is to develop techniques using mathematical
modelling approaches that have the potential to be used clinically in the operating theatre
during the treatment of Atrial Fibrillation (AF). For this reason, I am most concerned
with phenomenological reaction-diffusion models of non-pacemaker cells which can model
the atrial AP and related signal phenomenology in close to real time on a sufficiently
realistic domain.
1.3 Thesis Outline
In chapter two, I review the relevant literature, starting with a review of recent AF
research, covering prevalence and prognosis, what we believe today about the mech-
anisms behind the generation and sustenance of AF, and the efficacy of the current
state-of-the-art in medical treatment, including clinical intervention (notably pulmonary
vein isolation) and pharmacological treatments. We then review the advances in cardiac
mathematical modelling, first covering initial attempts to model the heart and their mod-
ern day relevance, then the benefits and limitations of the hugely complex and detailed
biophysical models prominent in the literature today. Finally, I introduce the key alter-
native phenomenological approaches to modelling of the cardiac AP that were developed
to mimic the key properties of the biophysical models. Throughout the literature review,
I present simulations showing the key properties and solutions of the models I discuss
through the simulation of APs, restitution curves and two-dimensional simulations of
heart tissue demonstrating the behaviour of cardiac rhythms in health and disease.
The third chapter discusses methods to optimise the parameters of a cardiac model.
We discuss the classic hill-climbing methods often used as a first approach, and then
contrast these with a genetic algorithm based method. Multi-objective parameter fits are
explored as I characterise the pathways through parameter space from health to disease,
and attempt to optimise multiple features of the cardiac model simultaneously.
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Chapter four presents research on the development and use of phenomenological mod-
els in the use of a theoretical therapeutic decision support system to direct the application
of radiofrequency ablation during pulmonary vein isolation. We first build a mathemati-
cal model of a clinical signal frequently recorded during this procedure, a model of which
has not been produced before, using the parameters obtained for the cardiac model in
chapter three. We use this to explore the potential of using the model to enhance the
reliability of electrocardiogram recording in the operating theatre when some signals are
not properly recorded. The model and associated decision support algorithms are vali-
dated using clinical data collected from Bristol Heart Institute.
Chapter five explores a different approach to the same problem: can the key features
of the clinical signals of relevance to atrial fibrillation be accurately modelled without re-
course to simulation of the underlying electrophysiology? A method is presented in which
the activation pattern on the relevant catheter is accurately reproduced using an analytic
function rather than a differential equation, validated with the same data as chapter four.
We follow on from this work in chapter six by testing the capacities of the method-
ologies presented in chapters four and five in a clinical setting. Signals recorded from
patients undergoing AF ablation are modified to simulate information loss commonly oc-
curring in clinic. This lost information is then reconstructed by the techniques presented
in chapters 4 and 5. The validity of these techniques is compared in the context of guiding
clinical decision-making by presenting a cardiologist experienced in atrial ablation with
the original, modified and reconstructed signals. The cardiologist’s choice of ablation
target can then be compared to assess which of these two methods are most effective to
minimise the impact of the information loss on clinical decision-making.
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Chapter 2
Literature Review
2.1 Introduction
In this chapter I review the relevant background research to the thesis. In section 2, the
biomedical background is discussed, beginning with a brief review of the classic and mod-
ern research on the underlying mechanisms of the generation and sustenance of AF. The
biological section concludes with a review of clinical techniques, including pharmacological
agents but focusing on radiofrequency ablation techniques to isolate the pulmonary veins.
The remainder of the review focuses on mathematical modelling techniques, beginning
with a section presenting the numerical methods used to simulate cardiac arrhythmia.
Secondly, the first attempts to model the cardiac action potential with a differential equa-
tion are discussed. These classical models have been superseded by modern models which
provide more realistic description of the physiology, but provide useful historical context
with which to place modern approaches. Next I focus on biophysical models, aiming to
capture as much detail of the underlying physiology as possible. This invariably leads to
large systems of differential equations and a long simulation time. We discuss the most
prominent examples in the modern literature. Finally, modern phenomenological models
are discussed. This type of model aims to reproduce the general behaviour of either the
more complex biophysical models or data, but with much less biological and mathemati-
cal detail (such models are useful for situations in which simulations must be performed
quickly). We explore three prominent examples (Fenton-Karma, Mitchell-Schaeffer and
Bueno-Orovio Cherry Fenton) and present 2D simulations of cardiac arrhythmia using
these models. For visualisation of travelling waves on a 2D domain, links are provided to
video files.
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2.2 Atrial Fibrillation and Radiofrequency Ablation
Therapy
2.2.1 Prevalence and Prognosis
The heart is prone to a wide variety of pathological conditions, most commonly arising
from wave propagation disruption as a result of functional or anatomical disturbances, or
from pacemaker node dysfunction. Cardiac disease is the most common cause of death
globally, especially among the adult population in the developed world [19]. Arrhythmias
are cardiac conditions involving an irregular or otherwise abnormal heart rhythm. The
most common serious cardiac arrhythmia is atrial fibrillation (AF) [20], a condition in
which the wave propagation in the atria is disordered, which may be represented mathe-
matically by a state called spatiotemporal chaos [21].
AF can have severely negative consequences on the quality of life of the patient. AF
is the most serious cardiac risk factor for stroke, with stroke risk increasing by 480% in
AF sufferers, as well as a threefold increased risk of congestive heart failure [22]. An
estimated 15 - 20% of all strokes are a result of AF [23, 24]. Furthermore, other cardiac
arrhythmias can be triggered by AF resulting from the lack of coordination between the
atria and the ventricles, or the strain on the AVN [25, 26]. In general, AF carries a 1.5 -
1.9 fold mortality increase [27].
In addition to the severe consequences of AF, the high prevalence leads to a signif-
icant burden on public health. Adults aged 40 and above have a one in four chance to
develop AF at some point in their lifetime, with 9% of over 80s currently living with the
disease [20, 28]. In the UK, the cost of treating cases of AF and its consequences are
estimated at £2 billion [29]. These statistics are only set to increase, partly as a result of
greater longevity, more accurate diagnosis, and improved cardiac medical care meaning
people can live with AF for longer, increasing prevalence [30]. In the USA, AF rates are
projected to increase by more than double (to 5.6 million) by 2050 [31].
Furthermore, AF can often occur with no visible symptoms, and is frequently parox-
ysmal, which makes accurate diagnosis difficult and the true number of AF sufferers is
likely to be higher than estimated [32, 33]. It is expected that a third to a quarter of all
AF sufferers have not yet been diagnosed. The average delay between onset of symptoms
and diagnosis of AF has been reported to be as high as 2.6 years [34].
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2.2.2 Mechanisms of Atrial Fibrillation
AF is characterised by the disorder of the electrical activity in the atria, which domi-
nates the pacemaking signal fired by the SAN. The contracting of the atrial myocytes
is therefore uncoordinated, resulting in reduced cardiac output. While the firing rate of
the SAN is roughly 60 to 100 BPM (sinus rhythm rate), during AF the firing rate of the
atria can reach rates of 400 BPM [35, 36]. This is most dangerous when the AVN can
no longer regulate the extremely high-frequency signals through to the ventricles. While
not all atrial beats follow through to the ventricles, those that do result in an increased
ventricular rate [35] and can lead to Ventricular Tachycardia (VT). This poses an imme-
diate threat to the life of the patient.
Figure 2.1: Sketch of the Left Atrium. Sketch of the left atrium including the pul-
monary veins (PVs) (left superior (LS), right superior (RS), left inferior (LI) and right
inferior (RI)). The posterior wall faces the chest.
AF is typically diagnosed from the body surface ECG by a fractionation of the P
wave. In the typical PQRST complex of a normal ECG, the P wave is a consequence
of atrial contractions, so with no coordination in the atrium, there is no well-defined P
wave [37]. This is often one of the first clear clinical markers of AF. The AVN’s inability
to properly regulate these signals through to the ventricles can also sometimes result in
irregular R-R intervals [38].
The main causes of AF are ectopic signals (am unwanted source of electrical activity
separate from the nodes of pacemaker cells) and re-entrant circuits in the left atria [36, 39].
Ectopic beats are defined as spontaneous activation of cardiac myocytes independent of
the SAN. These ectopic beats often fire much faster and dominate the SAN. The most
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common ectopic focus location is in a small section of the left atrial myocardium that
extends over the base of the pulmonary veins (PVs) (94% from Haissaguerre [40], and
88% from Chen [41]). A sketch of the left atrium, including the pulmonary veins, is given
in Figure 2.1.
Although spontaneous activity of the PVs has been observed since the 1800s, there
has been significant progress in recent years in understanding the mechanisms linking
the PVs to AF [42]. AF can begin as atrial tachycardia (AT) from the rapid heart rate
caused by the ectopic beats in the pulmonary veins dominates the firing rate of the tissue
across the atria. The locations of the pulmonary veins can be important in the genesis
and sustenance of AF.
Re-entrant circuits in this context are a functional or anatomical irregularity that
allows an electrical impulse to travel back to where it started, causing a self-sustained
‘rotor’ (termed spiral wave mathematically). The atria are firing rapidly, but still in a
roughly regular manner, a state classified as AT. Due to the spiralling pattern of recover-
ing tissue, one directional blocks can occur, causing re-entrant circuits, spiral waves, and
disordered dynamics [43]. This can lead to paroxysmal or persistent AF.
AT alters the physiological characteristics of the cells in a process known as remod-
elling. The two main effects relevant to electrophysiology are a reshaping of the atria
(structural remodelling) and a change in the firing properties of the individual cells (elec-
trical remodelling). Electrical remodelling alters the shape and properties of the AP by
the modification of ion channel function. Remodelling can drastically decrease the size
of the dome, APD and recovery time, lowering the APD restitution curve [11]. These
changes largely occur as a result of increased activation of repolarising K+ current [44].
Remodelling is the driving force behind the progressive nature of AF, as the pro-
gression from sinus rhythm to AT to AF is supported by the structural and electrical
changes in the atria, increasing susceptibility to arrhythmia [45, 46]. As a result of re-
modelling, certain regions of tissue can fire much faster than they should normally, which
supports the rapid nature of AF. Electrical remodelling has the end result of increasing
the maximum firing rate of the cells during AF, leading to the abnormally high firing
rates reaching 400 BPM. The shorter APD increases the likelihood of spiral waves to
break up, causing AF.
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2.2.3 Clinical Procedures
There exist a number of different clinical approaches for dealing with AF. Antiarrhythmic
drugs remain a common treatment method today, over 100 years since their introduc-
tion to the medical community [47]. The majority of antiarrhythmic drugs focus on the
inhibition of the K+ current to increase the APD and reverse the effects of electrical
remodelling. Alternatively, Na blockers reduce cardiac excitability, reducing the chance
of arrhythmia occurring, however as all antiarrhythmic agents affect more than one chan-
nel, in practice categorisation, is difficult. K+ is usually targeted, as this current is not
so prevalent in the ventricles, in theory allowing for atrial-targeted ion channel control
[48, 49]. However, it is impossible to effectively target specific channels in isolation, for
example, amiodarone, presently the most commonly prescribed drug, inhibits the IKr,
INa, IKur, Ito, ICa,L, and IK,ACh channels [50].
Unfortunately, pharmacological agents for the treatment of AF are associated with
only moderate success rates, high recurrence rates, and dangerous side effects [51]. As
it is impossible to target only the atria, drug treatment for AF can also affect the ven-
tricles, resulting in an increased risk of ventricular arrhythmias, which are often more
dangerous than their atrial counterparts. It has been well known for quite some time
that antiarrhythmic drugs can have proarrhythmic effects [51]. A large scale 2011 study
on the efficacy of antiarrhythmic drugs identified amiodarone as the most effective drug
for terminating AF, but also had the highest rate of an adverse effect occurring, and an
overall increased mortality. Dronedarone, a popular alternative, has been found to have
a higher recurrence rate of AF, but fewer proarrhythmic events [52]. There is no evidence
for a reliably effective and safe antiarrhythmic drug in the treatment of AF.
As an alternative, radiofrequency ablation (RFA) is a minimally invasive surgical
technique that has emerged in the last couple of decades as the leading technique for the
treatment of paroxysmal AF. RFA uses a catheter (called the ablator) to deliver pulses
of radiofrequency energy to burn lesions into the heart tissue with target temperatures
of 50 - 55 ◦C [53, 54]. The lesions formed block the conduction of the AP.
Recently, many creative alternative techniques have been developed for ablation. One
such alternative to RFA is cryoballoon ablation, which works by freezing cells instead of
burning them, although the two techniques have similar levels of success [55, 56]. Laser
Balloon Ablation, in which the veins are ablated by a continuous laser beam [57], is an-
other alternative. As balloon catheters have not yet been widely adopted by the clinical
community, it is difficult to make any comparisons between technologies. A 2016 review
26
stated ‘it is important to note that the investigators did not have prior experience with
using the investigational catheters’ when comparing effectiveness of cryo and laser bal-
loon catheters with the traditional RFA approach [58]. In this thesis, we focus on RFA,
as it is by far the most commonly used technology in the present day, and used by our
collaborators in both Bristol and Bordeaux, where data was collected.
The origin of the ectopic beats causing the arrhythmia is often within the PVs. To
treat AF, RFA is applied around the PV ostium to block any ectopic signal escaping.
This technique, called pulmonary vein isolation (PVI), was first developed by Professor
Michel Ha¨ıssaguerre and documented in 1998 [40]. After successful PVI, a continuous
circular lesion is formed around the PV. This isolates the PV from the rest of the atrium
so that the ectopic signals can no longer propagate outwards.
Figure 2.2: Ablation Strategies for Pulmonary Vein Isolation. Sketch of the
left atrium including dashed lines representing lesions resulting from pulmonary vein
isolation by radiofrequency ablation. CPVI lesions encircle the base of the veins, L1
indicates roofline ablation and L2 is the second linear lesion. Together, these form a
CVPI+L1+L2 strategy.
There are three different strategies for radiofrequency ablation. Circumferential pul-
monary vein isolation (CPVI) describes the circular lesions surrounding and isolating the
pulmonary vein. Linear ablation consists of straight lines of ablated tissue, typically from
one part of the heart to another. Roofline ablation is a common linear ablation technique
which consists of a continuous line joining the superior pulmonary veins (L1), which in
combination with CPVI, has been shown to increase effectiveness with few complications
[59]. Secondly, it is common to join the inferior pulmonary veins across the posterior wall
by another linear lesion (L2). The third ablation strategy, complex fractionated atrial
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electrogram (CFAE) ablation, consists of targeting specific points on the atrium with un-
usual electrophysiological properties, such as a very short cycle length out of synchrony
with the rest of the atrial firing rate [60], resulting in nonconductive cells spread across
the atrium, which causes spiral waves to break up and dissipate as seen in model stud-
ies [61]. These general ablation strategies are consistent across the various technologies
available to ablate the veins.
Meta-analyses that perform comparisons of ablation strategies have found mixed re-
sults [62]. This is most likely as it is difficult to isolate strategy as the only variable,
therefore when comparing outcomes of two trials using different strategies, skill level and
technological availability to the clinician also skew results. However, trials involving mul-
tiple ablation strategies tend to lean towards a hybrid approach, such as CPVI + CFAE,
being the most effective at restoring sinus rhythm [63, 64]. From the available clinical
trial data, we conclude that CPVI is necessary but not always sufficient for effective AF
treatment. A recent modelling study predicted that CPVI with both linear ablation lines
will have the highest antiarrhythmic effect [10]. Figure 2.2 shows a CPVI + L1 + L2
ablation strategy.
In my experience in clinic, CPVI is often the first approach to AF ablation, followed
by linear ablation lines if CPVI fails to isolate the veins. However, cardiologists of a simi-
lar level of experience at the same institute will often have differing opinions on what the
next move should be during a case, to the extreme case of disagreeing on what side of the
heart the arrhythmia is coming from when presented the same information. In general,
the exact choice of ablation strategy appears to depend on the personal preference and
intuition of the clinician.
Perfect isolation is a difficult task, as the movement of the ablator can often leave
small conduction gaps in the lesion [65, 66]. This is problematic for two reasons: a con-
duction gap allows electrical impulses to escape the vein, compromising the effectiveness
of the procedure, and secondly, lesions that do not successfully isolate the target area
simply create more anatomical obstacles, which can be pro-arrhythmic. Work undertaken
in this thesis provides no insight into which ablation strategy is the most effective, but
is focused on ensuring that a circular line of lesions is successfully formed in the first place.
Whilst the initial success rate of pulmonary vein isolation is approximately 85% [67],
recurrence rates 5 months after ablation therapy can be as high as 30% in paroxysmal AF
patients or 78% in permanent AF patients [53]. One popular clinical hypothesis for the
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Figure 2.3: Clinical Pulmonary Vein Recording. The PV recording of a patient with
AF during PV isolation therapy. Bipolar recordings were obtained from a deflectable,
circular, 10-pole Lasso catheter (Biosense Webster Ltd).
processes underlying recurrence is tissue regeneration within the ablated lesion, leading
to new conduction gaps that undo the effect of the surgery [66].
There are several ablation devices available to isolate the veins (e.g. nMARQ, Biosense
Webster) [68]. During the isolation procedure, small conduction gaps in the lesion, which
may be caused by poor depth penetration of the lesion, incomplete ablation, or tissue
healing over time, must be ablated. Bipolar recordings of electrical activity around the
pulmonary vein are taken using a lasso catheter typically consisting of 10 or 20 elec-
trodes. Figure 2.3 shows an exemplary time-trace recorded at the University Hospital
of Bordeaux from a deflectable, circular, 10-pole Lasso catheter (Biosense Webster Ltd)
during sinus rhythm. The activation pattern of the recorded electrical activity on the
lasso catheter is used as a guide towards where to ablate. Further application of ablation
is performed at the site or sites at which the first spikes are observed [40, 69].
However, it is common for some electrodes to make poor contact with the tissue,
and not display a useful recording. If these missing channels correspond to the region of
first activation, this information loss could potentially lead to ablation of the wrong re-
gion. Such issues continue to inhibit further development of techniques involving bipolar
lasso catheters. In 2011 a method was proposed to infer a PV activation map by gentle
movement of the catheter [70], however, the authors raised concerns that this approach
resulted in unreliable signals, due to some electrodes touching the endocardium whilst
others were not. Further, electrodes located symmetrically with regard to a conduction
gap will record a zero signal despite a wavefront passing, this is a known weakness of
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bipolar recordings and can cause additional signal loss even at sites with proper contact
of the electrodes with tissue.
Ablation of the pulmonary veins carries a risk of pulmonary vein stenosis [71] and
if complete electrical isolation is not achieved, the lesions can become pro-arrhythmic
through the creation of conduction obstacles that facilitate the initiation of reentrant
waves. Consequently, it is desirable to minimise both the time taken to perform the pro-
cedure as well as the amount of scar tissue formed through ablation by more accurately
determining the optimal ablation location. Information loss that increases the difficulty
of this task is potentially dangerous as well as increasing the duration of the procedure.
The remainder of this review focuses on mathematical models of the cardiac AP, begin-
ning with a section on general numerical methods used in modelling of cardiac arrhythmia.
2.3 Numerical Methods for Cardiac Modelling
2.3.1 Coupling of Cardiac Cells
In cardiac tissue, cells are electrically coupled via gap junctions, which allow the prop-
agation of an AP. This transfer is facilitated by the transfer of ions (primarily sodium,
calcium and potassium) across the gap junction. When one cell is excited, this transfer of
ions raises the voltage of its neighbours, and should this excitation be sufficiently strong,
the cell will fire an AP which will propagate further. Numerically, this is approximated by
nearest-neighbour diffusive coupling using a term ∇(D∇u). This diffusion term, plus the
reaction term from the models previously described, creates a reaction-diffusion equation
capable of modelling many cardiac conditions.
Numerically, we typically solve these equations using the finite difference method.
The more complex finite element method is used when solving cardiac models on more
complex domains, such as an anatomically accurate mesh, but these are not necessary
for our goals. Numerical simulations require discretisation of the domain into a finitely
sized grid or mesh that represents a region of cardiac tissue. For isotropic 2D simulations,
we use a simple five point stencil and the central difference method to approximate the
spatial derivative, as shown in Figure 2.4. In this chapter Neumann Boundary Conditions
are used on all boundaries, implemented by a 3 point stencil on the edges and 2 on the
corners, effectively allowing the travelling wave to propagate out of the domain.
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Figure 2.4: Five Point Stencil for the Finite Difference Method. A schematic of
the approximation method used for the diffusion term (∇ · (D˜∇u)) for isotropic simula-
tions performed on a two dimensional uniform grid (rectangular, cylindrical or toroidal).
Time derivatives are approximated by the forward Euler method.
2.3.2 Anisotropy
In the five point stencil displayed in Figure 2.4 diffusion is isotropic, i.e. diffusion is con-
stant in every direction. However, in cardiac tissue, the AP primarily propagates along
fibres. The CV in the direction parallel to the fibres is therefore much faster than the
velocity in the perpendicular directions.
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Figure 2.5: Nine Point Stencil for the Asymmetric Finite Difference Method. A
schematic of the approximation method used for the diffusion term (∇· (D˜∇u)) when we
consider anisotropy (different diffusion speeds in different directions). For the asymmetric
scheme used, D is defined on the half indices (black circles).
Anisotropy has been well studied in both ventricular and atrial tissue. In ventricular
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muscle, a ratio of 3:1 has been observed between conduction velocities in the directions
longitudinal and transverse to the fibres (the degree of anisotropy) [72], which has been
known in animal hearts since at least 1959 [73]. Recent research using high-resolution
optical mapping in the canine atria has indicated that the degree of anisotropy increases
with age, from 4.5 in the infant group up to 10 in the old group [74].
However, in a study of 12 patients undergoing open heart surgery in the right atrium
[75], found that the ratio of the velocities of the fastest to the slowest conduction direc-
tions ranged only between 1.15 and 1.8, and that CV was not dependent on propagation
direction. This degree of anisotropy is similar to values used in [76], driven by the clinical
data collected from patients undergoing PVI [77]. Due to these discrepancies in experi-
mental and clinical studies, when considering anisotropy in fits to clinical data, we allow
the dominant angle and anisotropy degree (the eigenvectors of the diffusion tensor) to
vary.
In three dimensional tissue, a further factor affecting diffusion patterns is the twist-
ing dominant fibre direction throughout the tissue. This twist can affect the dominant
propagation direction from the epicardium to the endocardium by between 120 and 180
degrees. An excellent description of ‘rotational anisotropy’ and its effects on excitation
spread in the Fenton-Karma model can be found in [78] (this is also the paper that first
introduced said model). More recently, it has been claimed that the effect of this can be
approximated by using only two layers representing the epicardium and the endocardium
[79, 80]. Detailed consideration of this effect, however, is outside the scope of this thesis
as we deal only with two-dimensional domains.
As we only consider two-dimensional homogeneous domains when dealing with reac-
tion diffusion equations in this thesis, finite difference methods are sufficient for dealing
with all diffusion terms. However, using the 5 point stencil as shown in Figure 2.4, we are
limited to the longitudinal and transverse diffusion directions being parallel to the x and
y axis. To solve this issue and handle anisotropic diffusion with longitudinal diffusion
coefficient D‖ in the angle α and D⊥ in the transverse direction, we use a 9 point stencil,
and use the asymmetric finite difference method as shown in [81]. As a result, we use a
diffusion tensor
D =
(
D‖b21 +D⊥b
2
2 (D‖ −D⊥)b1b2
(D‖ −D⊥)b1b2 D⊥b21 +D‖b22
)
, (2.1)
defined on the half indices as shown in Figure 2.5. The method is known as an asymmetric
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method due to calculating diffusion on the half-indices requiring different treatment in
the x and y axes. If the tensor D is constant, the calculations reduce to
∇(D∇ui,j) ≈
−
(
D(1, 1)(ui+1,j + ui−1,j − 2ui,j)
∆x
+
D(1, 2)(ui+1,j+1 + ui−1,j−1 − (ui−1,j+1 + ui+1,j−1))
4∆y
)
/∆x
−
(
D(2, 1)(ui+1,j+1 + ui−1,j−1 − (ui−1,j+1 + ui+1,j−1))
4∆x
+
D(2, 2)(ui,j+1 + ui,j−1 − 2ui,j))
∆y
)
/∆y,
(2.2)
a full derivation of which is contained in Appendix B. If diffusion is isotropic such that
D = DI, Equation (2.2) reduces to the five point stencil in Figure 2.4.
2.3.3 Modelling of Cardiac Arrhythmia
The most simple domain capable of representing the propagation of the cardiac AP is a
one-dimensional chain of cells. The ‘cable’ can be used to model cardiac conduction in
the His-Purkinje fibres, where conduction mostly occurs along fibres. In terms of simu-
lation, a one-dimensional domain allows for much quicker simulation than two or three
dimensions, and so is useful for quantifying features such as speed of the travelling wave,
or AP features in the travelling wave solution, which often differ to the model being run
at a single point.
This can extended to a two-dimensional domain, representing a sheet of cardiac tis-
sue. In a two dimensional sheet, depending on the location and spatial shape of the
stimulus, plane waves (from stimulating one edge of the domain) and target waves (from
stimulation at a single point) can be generated. We present target and spiral waves from
a variety of models and for both isotropic and anisotropic diffusion in section 2.5 when
we discuss phenomenological models.
In the simplified case of a two-dimensional sheet of tissue, it is possible to induce spiral
waves representative of tachycardia, and breakup leading to spatiotemporal chaos, mod-
elling fibrillation. While it is possible to perform these simulations on an anatomically
realistic mesh, we present results in a two-dimensional flat slice of tissue to provide an
overview of spiral wave dynamics in cardiac models with minimal computational intensity.
Spiral waves can be initiated by perturbing a travelling plane wave in three different
ways. Firstly, we can initiate a collision of wavefronts by ‘cross-field stimulation’, de-
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scribed in detail in [82] and [83]. The S1 stimulus creates a plane wave that travels from
left to right across the plane. When the wavefront has propagated half-way across the
sheet, the S2 stimulus is applied to the bottom boundary, creating a wavefront collision
that breaks the S2 wavefront in half, resulting in a spiral wave.
Secondly, an ectopic stimulus applied to the waveback of a travelling plane wave. The
second stimulus cannot propagate in the same direction as the first, as this tissue is still
recovering. The only available pathway is back towards the source of the S1 stimulus,
causing re-entry. This stimulation protocol can result in a ‘double spiral wave, which
then breaks down into several independent sources’ [84] page 251. This is consistent with
results of our simulations using this procedure with the Fenton-Karma model, available
at https://www.youtube.com/watch?v=IKybSM8gD8s. However, the timing required for
this is very precise and difficult to reliably reproduce. If the second stimulus is applied to
early, there will be no propagation in either direction and if too late, will simply produce
a second plane or target wave.
Finally, we can reset the top half of the plane to the resting potential over a single
time step, as described by [85], The Virtual Heart’s Java Applets, and many others. The
half plane reset is less sensitive to timing and so easier to simulate, but less physiologically
plausible as an initiation mechanism.
2.4 Early Mathematical Models
2.4.1 Van der Pol
In this section we describe the earliest models in the literature, designed when little was
known about the intracellular dynamics.
Model 2.1 Van der Pol Oscillator
v¨ − µ(1− v2)v˙ + ω2v = 0 (2.3)
The Van der Pol Oscillator is a classic dynamical system prominent in many areas of
applied science, and a staple of many undergraduate mathematics courses in nonlinear
dynamics. Proposed initially in the 1920s, the Van der Pol Oscillator is a second order
differential equation capable of exhibiting ‘relaxation oscillations’, which are stable limit
cycle attractors with a non-sinusoidal solution [16]. With µ = 0 the equation reduces
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to v¨ + ω2v = 0, which has trivial sinusoidal solutions of period ω. Increasing the pa-
rameter µ causes the oscillations to become increasingly ‘sharp’ as seen in Figure 2.6.
Frequently for use in applications, the Van der Pol Oscillator is either forced or coupled
together in a network of oscillators representing a node of coupled pacemaker cells [86, 87].
Forcing of the Van der Pol Oscillator was an early example of deterministic chaos.
When forced with a function A sinωt, and in certain regions of the parameter space
spanned by µ, A, and ω, the solutions of the oscillator tend towards a stable chaotic
attractor with positive maximal Lyapunov Exponent [88, 89]. The seemingly random
fluctuations recorded at certain frequencies in experiment in the late 1920s were initially
dismissed as noise, but are now believed to have been recordings of deterministic chaos
[90] long before the work of Lorenz [91].
Shortly after the development of the oscillator, Van der Pol and Van der Mark explored
the potential for its use as a cardiac model [87]. Their model, the first mathematical ap-
proach to modelling the human heartbeat, consisted of three oscillators representing the
sinoatrial node, the atria, and the ventricles. Some 50 years later, the qualitative features
(notably the phase locking behaviour) of this model were verified experimentally [92]. In
the electrical conduction system of the heart, the overall frequency of the heartbeat is
most commonly regulated by the frequency of the fastest element. Systems of coupled
Van der Pol oscillators are useful for modelling the cardiac conduction system as this
property is conserved - a network of coupled Van der Pol oscillators will phase lock to
the frequency of the fastest oscillator, without affecting the amplitude [2, 93]. Further-
more, period doubling bifurcations, the route to chaos exhibited by a forced Van der Pol
oscillator, have been observed experimentally in cardiac pacemaker cells [94].
The use of Van der Pol oscillators in cardiac modelling remains useful in the present
day, even after the advent of the powerful biophysical reaction diffusion equations that
now dominate much of the literature on the subject. A modified version of Van der Pol,
from Grudzinski [2], is a popular phenomenological model for the self-excitatory cardiac
pacemaker cells of the sinoatrial and atrioventricular nodes and will be discussed later in
the chapter. As the Van der Pol oscillator is self-oscillating, it cannot be used to model
the behaviour of atrial or ventricular myocytes. Figure 2.6 shows the solution of Van
der Pol oscillator resembling the SAN AP. Later in the review, an extended Van der Pol
model is fit to a more realistic model to demonstrate how realistic these APs are.
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Figure 2.6: Solution of van Der Pol Oscillator. The solution of the van der Pol Oscil-
lator resembles the APs generated by the SAN, and was one of the earliest mathematical
models used in cardiac modelling.
While the solution of the Van der Pol oscillator does roughly match a real cardiac
pacemaker’s AP, the lack of biological detail included limits its usefulness in clinical re-
search. As previously discussed the cardiac AP is generated by underlying ionic currents.
However, the Van der Pol oscillator pre-dates the mathematical equations for describing
these processes, the Hodgkin-Huxley equations, which were not developed until 1952 [95].
As such the biological processes behind the AP generation are not described by the Van
der Pol oscillator, and the equation itself has no biological significance. Accordingly, it is
impossible to realistically simulate the effect of any pathological conditions at the cellular
level, since the parameters µ and ω have no physical meaning. The model has since been
modified by numerous authors to add greater detail and/or realism, and modern efforts
are described in section 2.4.3.
2.4.2 FitzHugh-Nagumo
Model 2.2 FitzHugh-Nagumo Model for Neuronal Action Potential
v˙ = α
(
v − v
3
3
− w
)
+ Iext
u˙ = µ(v + β − γw)
(2.4)
The FitzHugh-Nagumo model is a reduction of the Hodgkin-Huxley model [14] that
is effectively a modification of the Van der Pol Oscillator. The Hodgkin-Huxley model is
a Nobel Prize-winning model described in 1952, developed to simulate the AP propaga-
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tion in the squid giant axon by a system of four nonlinear ODEs that approximated the
underlying ionic mechanisms [95]. Although containing only the potassium, sodium and
leak currents, the Hodgkin-Huxley model was the first electrophysiological model based
on the underlying biological mechanisms (a biophysical model). Almost every success-
ful mathematical model of electrophysiology since has its roots in the Hodgkin-Huxley
model, whether it be a biophysical 40+ dimensional cardiac myocyte model or a phe-
nomenological reduction. A more detailed review of the Hodgkin Huxley equations with
respect to the Cardiac Physiome Project can be found in [96]. The Hodgkin-Huxley
model is a reaction-diffusion equation. The system of ODEs make up the reaction term,
and a diffusion term allows the pulse to propagate through a medium (e.g. cardiac tissue
or a neuronal axon).
The equations of FitzHugh-Nagumo were designed to reproduce the basic qualitative
behaviour of the Hodgkin-Huxley model, with neuronal AP propagation in mind [14],
although like the VdP Oscillator the parameters are purely phenomenological and have
no direct biophysical analogue. In the context of electrophysiology, v is the voltage term
which produces a spike or AP, and w is a recovery variable which inhibits v for a duration
after the AP. Iext is an external stimulus being applied to the model. While Iext = 0,
solutions tend to a stable equilibrium. If provided a strong enough stimulus, the solutions
will take an excursion in phase space along the v˙ = 0 nullcline before returning to the
equilibrium point.
Due to the model’s genericity and simplicity, it is a popular example of a travelling
wave model, as it is easy to study analytically as well as very fast to simulate. If multiple
FitzHugh-Nagumo type ‘cells’ are coupled together with a diffusion term (typically such
that Iext = ∇(D∇u)), the result is a travelling pulse solution. In this PDE formulation,
the FitzHugh-Nagumo model is a generic reaction-diffusion equation, with applications in
ecology, physics, and chemistry, among numerous other areas of applied science in which
the study of wave dynamics is relevant.
Within cardiology, the FitzHugh-Nagumo model is the simplest model used for the
propagation of the AP of atrial or ventricular myocytes. FitzHugh-Nagumo based models
have been described as ‘good for a first qualitative study, but, of course, are not adequate
for a detailed quantitative description’ [97]. This may be more applicable to modelling
a problem if the use of a biophysical model is too difficult or time-consuming, as the
FitzHugh-Nagumo model can be run on a large domain in a matter of seconds, unlike
some biophysical models which will be discussed later. While the model is quantitatively
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inaccurate for the vast majority of cardiac applications, it is still able to qualitatively
reproduce the most common wavefront patterns frequently seen in cardiac cells, such as
target, plane, spiral and scroll waves.
Figure 2.7: Action Potentials from the Fitz-Hugh Nagumo Model. Action po-
tentials generated by forcing the FitzHugh Nagumo model with small spike waves with
a period of 200 to produce an action potential. The red region of the action potential
(below the baseline) is a hyperpolarisation, which is unrealistic in cardiac cells.
If stimulated at a point in the centre of a two-dimensional sheet of synthetic tissue,
circular ‘target waves’ will propagate outwards from the point of stimulation. If stim-
ulated along one edge of the domain, a plane wave will propagate from one side of the
sheet to the other. Thirdly, and of most critical importance to simulations of cardiac
electrophysiology, FitzHugh-Nagumo travelling waves can be disrupted by either func-
tional disturbances (alterations to v, such as an ectopic stimulus), or by an anatomical
disturbance (such as a physical block or slow conduction path) to create spiral waves
[86, 98, 99]. Spiralling of cardiac excitation waves are the underlying phenomena of the
vast majority of dangerous cardiac arrhythmias, such as AT, AF and VF. In a three
dimensional domain, scroll waves are formed [97].
There are also functional limitations of the FitzHugh-Nagumo model. The breakup of
spiral waves that describes the transition from stable spirals (tachycardia) to spatiotem-
poral chaos (fibrillation) is difficult to reproduce with the FitzHugh-Nagumo equations,
even qualitatively, mostly due to the unrealistic restitution behaviour primarily caused
by the hyperpolarisations (red part of Figure 2.7) that occur after an AP. These are not
present in cardiac myocytes. While hyperpolarisations have been addressed by certain
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modifications, such as the Ailev Panfilov model [100], which will be discussed in more
detail in the following section, the model is generally not a good representation of cardiac
tissue, and wave propagation in FitzHugh-Nagumo type cells can be very different from
in tissue [101]. In modern cardiac literature, results obtained from the FitzHugh-Nagumo
model are often validated by a more realistic model, as described in [98]. Validation of
a simple model by a complex one allows the use of the simple model for the speed of
computation.
2.4.3 Recent Adaptations of Historical Models
With the benefit of additional experimental data and mathematical techniques available,
authors have subsequently modified the van der Pol oscillator and FitzHugh-Nagumo
equations to better represent reality while maintaining a similar complexity. In 2004,
Grudzinski and Zebrowski replaced the harmonic ω2v term in Equation (2.3) with a
cubic term from the Duffing equation [102] (v(v + d)(v + d)), creating a combination of
the Duffing and Van der Pol oscillators, originally proposed in [2]. Later this was modified
to vf(v+ d)(v+ e) [103], where d, e and f are additional parameters. The model is then
given by:
Model 2.3 Modified van der Pol Oscillator
v¨ + α(v2 − µ)v˙ + vf(v + d)(v + e) = 0. (2.5)
This modification adds two additional fixed points to the phase portrait of the van der
Pol oscillator. In addition to the unstable spiral (which tends to the stable limit cycle),
the modified oscillator contains a stable node at v = −e and a saddle at v = −d, the
stable manifolds of which are separatrices which divide the phase plane into two basins of
attraction. The second modification (as seen in Equation (2.5)) allows independent con-
trol of the locations of the stable node and saddle point. Sufficiently high initial voltage
will cause the cell to enter the stable oscillation regime, while on the stable focus side of
the separatrix, solutions will tend towards the focus. However, while a pacemaker cell can
flat-line, and can produce stable oscillations, the conditions are far more complex than
initial voltage. A large enough external stimulus can push the cell from its stable equi-
librium point v = −e over the separatrix to produce oscillations. However, the authors
state in their original paper [2] that: The justification in making this improvement is that
the phase space of Equation (2.5) resembles the phase spaces [104] of the Morris–Lecar
model of the neuron membrane [105]. Evidence that this resembles the phase spaces of
cardiac oscillators, however, is not given, and it is a curious decision to base the dynamics
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Figure 2.8: Modified Van der Pol Oscillator vs Sarai Model. Graph showing three
action potentials of the optimal fit of the Modified Van der Pol oscillator to the Sarai
model. Fit was performed using the Nelder-Mead Simplex Search.
of a cardiac pacemaker node model on a neuronal AP model when biophysical dynamic
models for the cardiac pacemaker AP existed at that time, such as the Kurata model [106].
Nonetheless, the model does reproduce cardiac dynamics relatively well and shows
good accordance with recorded AP data. Figure 2.8 shows how close the solutions of
Equation (2.3) match the detailed 2003 biophysical model from Sarai et. al. [107], which
consists of 41 variables, 99 constants and 146 functional parameters used in computation,
used as a proxy for real data. We calibrated parameters by using the Nelder-Mead Sim-
plex Search (NMSS) method to minimise the root mean squared (RMS) error through the
entire time trace. Furthermore, it is a simple task to adapt the frequency or amplitude of
the AP independently by variation of a single parameter, giving easy control of the model
solutions. The oscillator can equally accurately model either the SAN or the slower AVN
by variation of the parameter e. When two of these oscillators are coupled, the slower
one will phase lock to the frequency of the faster one, much the way the AVN naturally
oscillates at a slower frequency to the SAN but will lock to the same frequency during
normal cardiac propagation.
Figure 2.9 shows a simulation of this behaviour using two cells modelled with the
modified Van der Pol oscillator. The red curve represents the SAN, with e = 12, and
the blue curve represents the AVN, with e = 7 [2]. All other parameters are identical,
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and without coupling, the AVN oscillates slower than the SAN. The AVN is coupled to
the SAN with one directional diffusive coupling, which is turned on at t = 25 in the
simulation, resulting in the AVN being locked to the rate of the SAN.
By coupling this oscillator with FitzHugh-Nagumo cells, very simplified models of the
atria have been developed, using the Modified van der Pol to model cells in the SAN
and AVN, and FitzHugh-Nagumo cells for the atrial myocardium between them. This
allows realistic simulation of conduction block caused by a propagation delay across the
junction between node and myocardium [103], however, this simulation was performed
only in a one-dimensional cable.
Figure 2.9: Phase Locking in the Modified Van der Pol Oscillator. Plots of the
SAN and the AVN modelled by the Modified Van der Pol Oscillator. Phase locking
behaviour is shown when the AVN is coupled to the SAN from t = 25.
Work regarding the coupling of Van der Pol pacemaker models and the FitzHugh-
Nagumo model continues to add biological feasibility. In 2013, a one-dimensional cable
of SAN cells modelled by the modified van der Pol Oscillator which divides into two
separate cables of FitzHugh-Nagumo cells (representing the left and right atria) which
then combine into another one-dimensional cable of modified van der Pol Oscillators
(representing the AVN) was used to model the entire cardiac conduction system from the
SAN to the AVN [86]. A slow pathway or delay along one path can cause a functional
conduction block, which in turn creates re-entrant waves originating from the AVN and
propagating back towards the SAN, a pathological condition known as Atrioventricular
Nodal Reentrant Tachycardia (AVNRT). However, the rapid heartbeat symptomatic of
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AVNRT is not reproduced. The diffusely coupled grid from [98] provides a more physio-
logically accurate description of cardiac tissue during AVNRT using the same model on
a 100 x 100 grid of FitzHugh-Nagumo oscillators to represent the atrial tissue, with 10 x
10 squares of Modified Van der Pol oscillators in opposite corners representing the SAN
and AVN. Slow and fast pathways around an obstacle created AVNRT and alternans
dynamics. This is among the most computationally light methods in the literature to
describe the atrium in as much depth as two-dimensional wave propagation fronts, and
results were also repeated with the more accurate Fenton-Karma model [78], which will
be discussed in more detail in section 2.4.
The Aliev-Panfilov model is a 1996 development of the FitzHugh-Nagumo model to
address the issues of hyperpolarisation and APD restitution [100], although the indepen-
dent variable is still dimensionless and the parameters are not physiological.
Model 2.4 Aliev-Panfilov Model for Cardiac Excitation
u˙ = ku(1− u)(u− a)− uv
v˙ = (u)(ku− v)
(2.6)
where (u) is a step function: (u < a) = 1 and (u > a) = 0.1
In this model, a is the threshold for excitation and the parameter k controls the mag-
nitude of the transmembrane current. Parameters we obtained for the model by fitting
the APD restitution curve to experimental data. The model is capable of producing spiral
waves (2D) and scroll waves (3D) and is ideal for rapid computation of cardiac excitation
on a detailed mesh, while retaining a computation time similar to the FitzHugh-Nagumo
model. It is unclear why the Ailev-Panfilov model was not used by the groups studying
the modified van der Pol, as this would have eliminated any possibility of the dynamics on
the atrium and AVN junction being an artefact of FitzHugh-Nagumo hyperpolarisation.
The Aliev-Panfilov model is widely used in rapid simulation of cardiac dynamics,
as the propagation patterns are much the same as the more complex biophysical mod-
els discussed in the next section. A quick time scale becomes especially important if
multiple simulations are required for a range of parameters, making the Ailev-Panfilov
model ideal for such investigations [108]. [109] study their dependence on parameter set-
tings and thickness of the medium, finding that as the thickness of the medium increases,
so does the complexity of the wave tip meander and the length of the scroll wave filament.
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The Aliev-Panfilov model has featured prominently in many investigations into break-
ing up spiral waves with an external stimulus. The defibrillator most commonly used to
eliminate fibrillation uses a very strong single electric shock, however, the levels of current
can be damaging to cardiac tissue and are extremely painful [110], so it is desirable to
reduce the necessary strength of current. Sakaguchi and Fujimoto find that a periodic
force to the Aliev-Panfilov model with uniform frequency roughly equal to the frequency
of the breathing [111], while Panfilov found that by using a feedback algorithm to drive
a multiple shock protocol, only 20% of the current was needed to eliminate spatiotem-
poral chaos compared to using a single shock, although this number was higher (50%)
for more realistic models [110]. Panfilov later studied the mechanisms by which a spi-
ral wave breaks up into chaos, finding that a decreasing intercellular conductance can
prevent breakup [112], a simulation result in accordance with common knowledge. Ran-
domly distributed non-excitable cells are also inhibitive to the breakup of spiral waves in
the Aliev-Panfilov model [61], which is consistent with the principles of CFAE described
earlier, in which patches of tissue are ablated across the atria to prevent formation of
spiral waves.
The main disadvantages of the Aliev-Panfilov model are also present in FitzHugh-
Nagumo: the dimensionless time scale and the morphology of travelling waves. A dimen-
sionless time scale makes it difficult to infer relevant temporal information, such as CV
and firing rate, from the result. Furthermore, while the morphology of an AP is realistic,
the morphology of the travelling wave in the spatial axis is not. Waves generated by the
Aliev-Panfilov model are typically much thinner than those of a more realistic model, and
generated spiral waves are much more robust: i.e. spiral wave breakup (tachycardia to
fibrillation) is much more difficult to simulate in the Aliev-Panfilov model, and as spiral
waves are formed by the interaction of two wavefronts, the wave morphology is critical
to accurate simulation of this behaviour.
The work following the development of the Ailev-Panfilov model typically involves
multiple simulations wave propagation on a biophysically accurate grid with a high spatial
resolution, which is impossible to perform with a more detailed model. In contrast, the
work following Grudzinski’s modified van der Pol performs simulations in a context that
would not be too difficult with a biophysical model and does not play to the strengths of
such a phenomenological model.
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2.5 Biophysical Cardiac Models
2.5.1 Key Examples
Biophysical models are the type of models inspired by the Noble model’s approach [113]
to developing a model of a cardiac cell by including all known biological components.
This often leads to a large system of equations with a rich level of biological detail, in
principle appropriate for simulation of the effects of various cardiac pathologies, pharma-
cological agents and invasive surgical procedures. These models are largely based on the
ventricular AP, there are significantly fewer models for the sinoatrial, atrial and atrioven-
tricular APs, as shown in Table 2.1.
Biophysical models aim to describe the mechanisms behind the generation of the
cardiac AP in as much detail as possible. As more is learned about the heart through
experimental investigation, biophysical cardiac models have become progressively more
complex, and computationally intensive. Biophysical models are typically built by ap-
plying the Hodgkin-Huxley formalism to known ionic currents in the cell, and then the
parameters approximated by fitting the resulting solution, or the time trace of functional
parameters, to experimental data [96]. The voltage change over time is given by
dV/dt = 1/Cm(Iion + Istim), (2.7)
where Cm is the membrane capacitance, Iion is the sum of ionic currents, and Istim
are the external influences, either from neighbouring cells or an artificial stimulus. The
dynamic Luo-Rudy model for the ventricular myocyte from 1994 [114] was a significant
step forward for the biophysical modelling community and the first example resembling
models in use today. The same equation is used to describe the rate of change of each
ionic concentration, for any given ion B:
dB
dt
= − (IB · Acap)
VC · ZB · F , (2.8)
where all undefined parameters are constants except IB, which is the sum of all ionic
currents carrying ion B. IB is then given by the Hodgkin-Huxley equations for gated ion
channels.
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The Luo-Rudy model featured twelve ion channels in a system of fifteen ordinary dif-
ferential equations with a large number of parameters. The model has been modified to
fit various other cardiac cell types, and expanded for extra detail, but remains a popular
biophysical model in its original form. [96] cites sixteen different ‘extension’ models that
have been developed using Luo-Rudy as a base. The model accurately reproduces the
APD restitution curve of a cardiac myocyte, and as such has been responsible for various
insights into how restitution affects cardiac electrophysiology and the mechanisms behind
spiral wave generation [132].
The detail behind the Luo-Rudy model opened up many lines of theoretical investi-
gation by varying the parameters in such a way that would require considerable time and
effort to accomplish experimentally [133]. One example is the effect of heat on various
cardiac diseases, as demonstrated by [134], who discovered that the ionic mechanisms of
Brugada syndrome are a result of cell temperature.
The ten Tusscher-Noble-Noble-Panfilov (TNNP) model was a logical development
from Luo-Rudy with insights from modern experimental evidence [135]. The model and
its derivatives [125] are currently the most prominent cardiac models in the literature, and
are capable of modelling epicardial, endocardial, and mid-myocardial cells by a change
of parameter values.
Of most relevance to this thesis are biophysical models for the human atrial AP. The
two most widely adopted by the present literature are both from 1998 and contain 12
ion channels: the 21 variable Courtemanche model [4] and the 29 variable Nygren model
[130]. For work in future chapters, we use the Courtemanche model as a proxy for real
data (much the way the Ten Tusscher model has been used in the past in the context of
the ventricular AP [119]).
Model 2.5 Courtemanche for Cardiac Excitation
The Courtemanche model is given by Equation (2.7) where
Iion =INa + IK1 + Ito + IKur + IKr + IKs + ICa,L+
Ip,Ca + INaK + INaCa + Ib,Na + Ib,Ca
(2.9)
The full model equations are given in Appendix A. The Courtemanche model has
been responsible for the proposal of a theoretical anti-arrhythmic drug for the treatment
of atrial fibrillation [11]. This 1999 study proposed a new set of parameters to model the
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(a) Courtemanche Action Potentials (b) Courtemanche Restitution Curves
Figure 2.10: Single Cell Courtemanche Model. (a)Action Potentials of a single atrial
cell, simulated by the Coutemanche model with a time step of 0.1 ms. Action potentials
shown are a healthy atrial cell (blue) and the action potential of an atrial cell following
AF-induced electrical remodelling. (b) The APD90 restitution curves of the cells in a,
calculated at BCL lengths from 300 ms to 1 second in steps of 50 ms.
electrical remodelling process by reducing the currents Ito, IKur and ICa,L by 50%, 50%
and 70% respectively. These currents were thus cited as targets for a theoretical drug,
an observation which matches subsequent experimental and clinical data [44, 48, 49].
Most relevant to our purposes (to study the applications of mathematical models with
a view to therapeutic decision support during ablation therapy) the Courtemanche model
has previously been used to simulate the effect of ablated lesions on the heart [10]. In this
study, ablated lesions were set to points of zero conductance, and various ablation strate-
gies were modelled in an attempt to make a comparison in effectiveness. However, during
simulations, it was assumed that all lesions were completed successfully. Furthermore,
spiral waves were initiated in the atrium using the Courtemanche 1998 model, which has
not been adjusted to account for the effects of electrical remodelling. This has a huge
impact on the morphology of the AP and APD restitution, as seen in Figure 2.10, which
significantly affects the interactions of wavefronts occurring during a spiral wave.
In Figure 2.10 we show the AP and the APD90 restitution curve from the Courte-
manche model with the 1998 original parameters and the 1999 fit for electrically re-
modelled cells. When electrical remodelling is considered, the dome following the spike
disappears due to the reduction in the Ito, IKur and ICa,L channels. When modelling heart
tissue during AF treatment, during which fibrillation has already taken place, changes in
morphology are liable to affect any simulated recordings, and changes in restitution are
likely to affect spiral wave dynamics.
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2.5.2 Limitations of Complex Models
While biophysical models are the most detailed and becoming more detailed all the time
through adaptation to modern experimental data, they may not be the most suitable
approach to address clinical challenges, where speed may be of the essence. Additional
equations, especially additional dynamic variables, will inevitably cause an increase in
computation time. Functional parameters (those that depend on the dynamic variables)
will also add to the computation time, especially as the mathematical formulation of the
functions becomes progressively more complex. Even with modern numerical techniques
in place and today’s level of computing power, simulating biophysical cardiac models on
a biophysically relevant domain can take a huge amount of time. Modern research on
biophysical models aims to speed up computation times by using state-of-the-art GPU
parallelisation methods.
In 2011, using 16,384 cores in parallel, computation time on a realistic mesh took 240
times real time [136] using the TNNP model on a mesh, and a 2012 study from Nimma-
gadda reported speeds of 664 times real time to solve the model on a 256 x 256 x 256 grid
[137]. Such figures are of course a ballpark estimate and depend on numerous factors:
programming efficiency, language, numerical methods, and hardware. However, if the
objective is for the model to be used as part of a therapeutic decision support system
which can be simulated in real time alongside surgical treatment, computation must be
feasible on a standard hospital computer. The same study from Nimmagadda reported
453 hours to simulate one second of data with the same protocol on a realistic mesh
(1,630,800 times real time) on a high-end general purpose processor, and although this
figure varies widely depending on the simulation protocol and domain (Okada et. al. re-
ported 6 hours per cardiac cycle on a realistic mesh [138]), we are some way off being able
to solve biophysical models on a meaningful domain in real time using standard hardware.
In Table 2.1 details are given for a range of cardiac models, with the type of cardiac
cell that they model, and whether they are biophysical or phenomenological. ‘Pacemaker’
includes models of the atrioventricular and the sinoatrial nodes. Details of biophysical
models were obtained from the exported Matlab code from CellML models in the CellML
Repository [131] and may vary depending on the formulation, as algebraic parameters
(those that depend on the state variables) can typically move inside the differential equa-
tions in which they are used. This is not an exhaustive list, but we believe it provides a
good overview of electrophysiological models prevalent in the cardiac literature.
A further challenge lies in the number of model parameters. In the most detailed
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models, the fast sodium current alone can be described by 9 state variables and 171 pa-
rameters [139, 140]. Eventually, a systematic exploration of the parameter space becomes
impossible, and the results can become impossible to interpret. If a new set of parameters
are obtained by a black box type fitting method (as is often the way these models are
calibrated in the first place), how do we know these parameters are biologically relevant?
In the words of John von Neumann, ‘with four parameters I can fit an elephant, and
with five I can make him wiggle his trunk ’ [141, 142]. If one investigates how a specific
parameter changes the solution, all we see is a cross section of a high dimensional pa-
rameter space. Another issue is the methodology behind the determination of the default
parameter set; in some biophysical models, parameters have been fit to data collected
many years prior [143], or by reusing model components, which may result in parameters
for the same model being based on different cell types or even across different species [140].
Furthermore, biophysical models are difficult to study analytically. In Appendix A
are the full model equations for the Courtemanche model. As it is impossible to change
any of the parameters without in some way, directly or indirectly via the transmembrane
voltage, without affecting every variable in the system, traditional analysis techniques
(such as bifurcation theory) is ineffective. Even in the spaced clamped system, without
diffusion, for which the system is a non-autonomous ODE, it is impossible to build an
intuitive understanding of how the model behaves in its entirety. When diffusion is con-
sidered, the result is a PDE with many variables, and is even more difficult to approach
analytically.
As the focus of this work is to develop tools that could be used in the operating
theatre mid-surgery, biophysical models, especially of the modern level of complexity, are
not appropriate. Instead, we consider the potential of phenomenological models, using
the Courtemanche model as a proxy for real cellular AP.
2.6 Phenomenological Models
2.6.1 Fenton-Karma
The Fenton-Karma model dates back to 1998 and is the first phenomenological model of
the cardiac AP that is at least based on the ion channels underlying the electrophysio-
logical behaviour, and accurately reproduces a wide range of cardiac dynamics [78]. The
Fenton-Karma model was built to provide a balance between detail and computational
efficiency, ideal for studying cardiac wavefront propagation. The main advantages over
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FitzHugh-Nagumo type models are that the wavefront propagation patterns more accu-
rately reflect the behaviour of biophysical models, and the restitution properties when
the model is forced at different BCLs. The model has been further reduced and extended
by various authors, two prominent examples of which are described later in this section.
Model 2.6 Fenton-Karma Model for Ventricular Myocytes
u˙ = ∇ · (D˜∇u)− (Jfi + Jso + Jsi)
v˙ = H(uc − u)(1− v)/τ−v −H(u− uc)v/τ+v
w˙ = H(uc − u)(1− w)/τ−w −H(u− uc)w/τ+w
(2.10)
where the phenomenological ionic currents are given by
Jfi =
v
τd
H(u− uc)(1− u)(u− uc)
Jso =
u
τo
H(uc − u) + 1
τr
H(u− uc)
Jsi =
w
2τsi
(1 + tanh [k(u− usic )])
(2.11)
Without diffusion, the model is a three variable ODE with 12 parameters. The three
variables consist of the transmembrane voltage u, and two gating variables, v and w.
The ion channel modelling is simplified by considering categories of channels, rather than
the individual channels themselves. Based on simplifying the models of Luo-Rudy [114]
and Beeler-Reuter [120], the Fenton-Karma model contains three ion channels, Jfi (fast
inwards), Jso (slow outwards), and Jsi (slow inwards) currents. Jfi is a single current de-
pendant on the gating variable v approximates the net contribution of sodium channels
to the AP, although the actual underlying biophysics are significantly more complex than
this in reality. In the same manner, Jso represents the potassium currents and depends
only on voltage, while Jsi models the calcium currents, gated by w. A fourth current, Jext
(or sometimes Jstim) is an external or stimulus current needed to force the cell to spike. In
experimentation, Jstim can be a square wave used to push the voltage above a threshold
and fire an AP. In a healthy mammalian heart, the stimulus is the AP propagating from
the previous cell.
In the spatially extended model, much like the biophysical models, the Fenton-Karma
model is a reaction-diffusion equation where Iext = ∇ · (D∇u). The resulting travelling
wave behaves a lot more similarly to the biophysical models than it does FitzHugh-
Nagumo, and can produce a broader range of dynamics, notably the spiral wave breakup
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to spatiotemporal chaos.
Figure 2.11: Action Potentials of Fenton-Karma Model. A plot of the action
potential from the Fenton-Karma model, with parameters in [78]. The action potential
is from a point model, paced at 600 ms.
It was demonstrated in the original paper that the model can be fit to a few different
biophysical models, not only in terms of the AP morphology but also in terms of spiral
wave generation, breakup, and wavetip meander. In the original paper, parameter sets
were given for the model to reproduce the Beeler-Reuter, modified Beeler-Reuter, and a
modified version of the Luo-Rudy model. Many more parameter sets have been derived in
later papers, including parameter sets to distinguish the APs of epi/endo/mid-myocardial
cells, as well as pathological conditions [144].
The decreased complexity of a phenomenological model allows for much quicker sim-
ulations. Because of this, a greater range of questions can be answered in a feasible time
frame regarding the propagation of wavefronts through synthetic tissue. The Fenton-
Karma model was responsible for demonstrating the effect that fibre rotation had on
spiral wave generation in a three-dimensional parallelepipedal slab of tissue [78], a simu-
lation that would have taken many weeks to compute with a biophysical model. Shortly
after the proposal of the model, it was used to demonstrate various different mecha-
nisms by which spiral waves in tissue can break up and cause fibrillation [144], and
methods by which spiral wave break up could be controlled by a theoretical pacemaking
device [145]. We present video simulations of the Fenton-Karma model displaying the
break-up of spiral waves and persistent spatiotemporal chaos behaviour by a half-plane
reset in https://www.youtube.com/watch?v=87rYBkRJwl8 and by ectopic stimulation
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in https://www.youtube.com/watch?v=IKybSM8gD8s (linked previously).
2.6.2 Mitchell-Schaeffer
The Mitchell-Schaeffer model is a 2003 reduction of the Fenton-Karma model, with the in-
tention of creating a new cardiac model that was 1) similar to FitzHugh-Nagumo in terms
of complexity and computation time, 2) understandable analytically without numerical
methods, and 3) have an analytically calculable APD restitution curve as a function of the
parameters [8]. The model, therefore, contains less biological detail than Fenton-Karma
but is quicker to simulate (especially important for three-dimensional simulations) and
analytical approaches are more insightful.
Model 2.7 Mitchell-Schaeffer Model for Ventricular Myocytes
v˙ = Jin + Jout + Jstim
h˙ =
 1−hτopen if v < vgate−h
τclose
if v > vgate
(2.12)
where the ionic currents are given by
Jin =
hv2(1− v)
τin
Jout = − v
τout
(2.13)
The Mitchell-Schaeffer model is the simplest model in the literature that provides
a quantitatively accurate description of cardiac tissue, complete with a realistic APD
restitution curve and travelling wave morphology facilitating realistic simulations of ar-
rhythmic spiral waves on a reasonable timescale.
The reaction equations are handled by only two currents, an inwards and an out-
wards current, in addition to the stimulus. The inwards current is regulated by the
gating variable h, and the outwards current is only affected by membrane potential v.
This resembles the Fenton-Karma model with both inwards currents combined into one
with a single gating variable. The model has only five parameters, a firing threshold vgate,
and four time constants; τopen and τclose regulate the opening and closing of the gate h,
while τin and τout are time constants dictating the speed of the respective channels.
As the point model’s solutions exist in a two-dimensional phase space, a nullcline
analysis can provide a good graphical understanding of the solution. Rather than using
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Figure 2.12: Action Potentials from the Mitchell-Schaeffer Model. Simulated
action potentials obtained from solving the Mitchell-Schaeffer model with the parameter
set from [8] and a basic cycle length of 600 ms.
the APD90, approximating the APD as the time until h reaches its minimum value
provides an easy way of estimating the APD restitution analytically. This happens when
v = vgate, so rather than being above a 10% maximum depolarisation, the APD is defined
as the fraction of the time v is above the firing threshold. As the equation for h(t) can
easily be solved analytically while v > vgate, the maximum APD (assuming h starts from
its maximum value of 1) is APDmax = τclose ln(1/hmin), where hmin can be calculated from
the v˙ = 0 nullcline as hmin = 4
τin
τclose
. From there, knowing the basic cycle length BCL, it
can easily be estimated how much h will grow during the diastolic interval DI the time
the next stimulus hits by using the analytical solution for h(t) while v < vgate. Repeating
the procedure for finding the APD gives the APD as a function f of the diastolic interval:
APD2 ≈ f(DI) = τclose ln
(
1− (1− hmin)e
DI
τopen
hmin
)
(2.14)
which very closely predicts the APD restitution curve of numerical simulations. This pro-
vides a direct link between the parameters and the electrophysiology without even having
to solve the model. Other quantities that can be calculated analytically are DImin, the
minimum required value of DI for which the call can fire an AP, and an error parameter
 = τout/τclose that estimates the accuracy of the above calculations.
As each APD can be calculated in terms of the previous one, if one is only concerned
with APD restitution, the ODE model can be reduced to a one dimensional map:
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APDn+1 ≈ τclose ln
(
1− (1− hmin)e
BCL−APDn
τopen
hmin
)
. (2.15)
Figure 2.13: Spiral Waves in the Mitchell-Schaeffer Model. 4 heat maps of a) a
plane travelling wave, b) immediately after the half plane reset c) as the spiral begins to
form and d) a fully formed spiral wave. Red corresponds to regions of high Voltage, blue
to low Voltage.
This map can be analysed further with classic bifurcation theory. It is possible to
divide the parameter space into regions of differing qualitative behaviour based on how
the 1:1 solution loses stability upon reduction of BCL. For some region of the parameter
space, the map can, via a pitchfork bifurcation, exhibit stable alternans behaviour, an
alternation between APs of long and short APD.
In comparison with Aliev-Panfilov, the Mitchell-Schaeffer model is more accurate and
adjusting specific parameters allows greater control of the result, but does require a step
size 10 times as small to maintain stability [146]. In practice, the Mitchell-Schaeffer model
is most commonly used where a model of the body surface ECG based on cardiac wave
propagation is the desired result [18, 147], as solving electrical conduction on the torso
can be very complex, a simpler cardiac model is preferred. The Mitchell-Schaeffer model
provides a way to model realistic activation patterns but without microscopic detail un-
necessary for this purpose.
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(a) Anisotropic Stable Spiral Wave (b) Anisotropic Stable Spiral Wave Breakup
Figure 2.14: Anisotropic Spiral Waves and Breakup. a) A stable spiral wave with
a ratio of anisotropy of 4:1, with dominant angle pi/6 off the horizontal. b) A spiral wave
with the same diffusion properties, but parameters on the intracellular dynamics that
results in spiral wave breakup (fibrillation). Red corresponds to regions of high Voltage.
Simulations of spiral waves in the Mitchell-Schaeffer model are given in Figure 2.13,
performed on a 256 x 256 grid, with stimulation across the bottom edge of the do-
main. A wavebreak is initiated by a half-plane reset, which causes propagation in the
retrograde direction down the left-hand side. This results in re-entry, as this wave-
front returns to a place it has already been. This behaviour continues, forming a sta-
ble spiral wave. With a change of parameters, this wave can be caused to break up
into spatiotemporal chaos. The effect of raising τclose, lengthening the AP, is shown in
https://www.youtube.com/watch?v=JOJ3ryFtMBw.
In Figure 2.14 we show a simulation using anisotropic diffusion. In this simulation,
I chose diffusion coefficients at D‖ = 3, D⊥ = 0.75, α = pi/6 to demonstrate anisotropy.
Applying Equation (2.1), this gives us a diffusion tensor of
D =
(
1.3125 −0.9743
−0.9743 2.4375
)
.
The spiral waves in these plots are strongly elliptical rather than circular as in previous
simulations. In a real heart, the dominant conduction direction corresponds to the fibre
orientation in the heart muscle. A video of the entire simulation, in which a plane wave
is broken by a half plane reset to create an anisotropic spiral wave, which breaks up into
smaller spirals before eventually terminating, can be found in https://www.youtube.
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com/watch?v=Hplmg-rP-qo. The spiral waves destroy themselves when all cores veer
too close to the boundaries. In a human heart, fibrillation can be permanent, in which
the fibrillatory dynamics are stable or paroxysmal, in which episodes of fibrillation self-
terminate, however the mechanisms behind this distinction remain a mystery.
2.6.3 Bueno-Orovio Cherry Fenton
The Bueno-Orovio Cherry Fenton model (BOCF) is a 2008 extension of the Fenton Karma
model [119]. The BOCF model adds an extra variable to Fenton Karma that aims to
provide an accurate and complete description of the cardiac AP with the smallest amount
of complexity. In comparison to the Fenton-Karma model, the BOCF model is more de-
tailed with a longer computation time (although not orders of magnitude higher). The
extra detail allows greater control of the AP morphology, most notably the spike and
dome morphology, not possible with the Fenton-Karma model, although the lack of real
ionic currents means the model is still unsuitable for applications such as drug study [148].
Model 2.8 Bueno-Orovio Cherry Fenton Model for Ventricular Myocytes
u˙ = ∇ · (D˜∇u)− (Jfi + Jso + Jsi)
v˙ = [1−H(u− θv)](v∞ − v)/τ−v −H(u− θv)v/τv
w˙ = [1−H(u− θw)](w∞ − w)/τ−w −H(u− θw)w/τw
s˙ = ((1 + tanh[ks(u− us)])/2− s)/τs
(2.16)
where the ionic currents are given by
Jfi = −vH(u− θv)(u− θv)(uu − u)
Jso = (u− uo)(1−H(u− θw))/τo +H(u− θw)/τso
Jsi = −H(u− θw)ws/τsi
(2.17)
and other functional parameters can be found in [119].
Here u represents the transmembrane voltage, Jfi, Jso and Jsi are phenomenological
summations of the fast inward, slow outward, and slow inward currents respectively. Jfi
is effectively gated by the gating variable v, Jso is voltage gated, and Jsi is effectively
gated by the product of the gating variables w and s. DBOCF is either a spatially de-
pendant diffusion constant (under the assumption of isotropic diffusion), or a diffusion
tensor (under the assumption of anisotropic diffusion). We always take initial conditions
at the resting state, where [u(0), v(0), w(0), s(0)] = [0, 1, 1, 0]. A full description of this
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model can be found in [119].
Figure 2.15: Action Potentials from the BOCF Model. Action Potentials simulated
using two separate parameter sets. In blue is the parameter set from [119], optimised for
the ventricular action potential. In red is a parameter fit to [11] for AF remodelled atrial
cells. The fit is explained in detail in chapter 3.
The model has been validated by comprehensive fitting to both experimental data
and biophysical ventricular models, most notably the TNNP model [135], and the models
of Priebe Beuckelmann [149] and Iyer Mazhari Winslow [150] for both the point and the
spatially extended form of the model. A list of references for the experimental data used
in the development of the Bueno-Orovio Cherry Fenton model can be found in section
2.1 of [119]. The parameters were fit to ensure resting membrane potential, threshold
for excitation, upstroke, AP morphology, APD and CV rate dependence all matched the
relevant experimental data, for which 5 different parameter sets are given in the paper,
for epi/endo/midmyocardial cells, and to fit to the TNNP, Priebe-Beuckelmann, and
Iyer-Mazhari-Winslow models. The ratio in computational timescales between BOCF,
Priebe-Beuckelmann, TNNP and Iyer-Mazhari-Winslow is 1:31:50:8084 respectively, and
a 512x512 grid can take as little as 2 to 5 times real time to compute using a GPU based
implementation [151].
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(a) Plane Wave from BOCF Model (b) Spiral Wave from BOCF Model
Figure 2.16: Spiral Waves in the BOCF Model. (a) A plane travelling wave initiated
from stimulating the bottom edge of the domain (b) 5 seconds after initiating a wavebreak,
the solution stabilises to a spiral wave. As before, red indicates high voltage. Compared
to the wavefronts in the Mitchell-Schaeffer model, the BOCF contains a band of yellow
shortly after the wavefront due to the spike and dome morphology.
The Bueno-Orovio Cherry Fenton model reproduces key characteristics of biophysical
models in tissue simulation as well as a point model, even when spiral waves are gen-
erated [152]. The Bueno-Orovio Cherry Fenton model provides us with a good balance
of realism, reproducing key features quantitatively, and not having a computation time
inhibitive to running multiple simulations. For this reason, it should be ideal for studying
the effects of conduction blocks, such as those caused by radiofrequency ablation, and
the greater control of AP morphology over the Fenton-Karma model increases likelihood
of being able to successfully adapt the model to reproduce the effects of atrial electrical
remodelling.
We present a simulation of this in Figure 2.15, which shows simulations using the
default parameter set (in blue), which models a healthy ventricular cell and a parame-
ter fit to the AP of an atrial cell following electrical remodelling as a result of AF by
using the Courtemanche model with the 1999 parameter set [11] to generate synthetic
data (in red). We explain this parameter fit in much more detail in the following chap-
ter, it is shown here for descriptive purposes only. In Figure 2.16 we show the model
in a two-dimensional sheet of tissue, in both a plane travelling wave and a spiral wave
after initiating a wavebreak. A video of the spiral wave simulation can be found at
https://www.youtube.com/watch?v=-XAt4QgQWug.
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In the following chapter, we investigate the parameter space of the BOCF model
in more detail using single and multi-objective optimisation techniques to determine
parameter sets corresponding to health and disease, and also to investigate the important
parameters along this transition.
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Chapter 3
Parameter Optimisation in Cardiac
Wave Propagation
3.1 Introduction
3.1.1 Background to Problem
In this thesis I am interested in the applications of mathematical modelling in terms of
AF and associated clinical practice, however, the phenomenological models introduced
in chapter 2 are all designed to model the ventricles. This is done primarily by fitting
parameters to match the solutions of the more complex biophysical ventricular models
described in chapter 2, or by fitting to real data. In this chapter, we optimise the param-
eters of the Bueno-Orovio Cherry Fenton (BOCF) [119] model to produce relevant APs
for a model of the atrial tissue in relation to both healthy and diseased states. Secondly,
we use multi-objective optimisation techniques to find the key parameters underlying this
transformation.
To maximise relevance to AF, we wish to model the atrial AP following AF-induced
electrical remodelling. Electrical remodelling, as described in chapter 2.2, is an elec-
trophysiological change at the cellular level that facilitates the sustenance of functional
re-entrant waves in the atria through a shortening of the APD. The shorter AP allows
for a larger number of excitation fronts to coexist, causing episodes of AF to last for longer.
Although there is a lack of phenomenological models available for the atrial AP, there
do exist biophysical models such as the Nygren model [130] and the Courtemanche model
[4] discussed in the literature review and given in Appendix A. The Courtemanche model
is particularly useful for providing a proxy for real data as it has already been optimised
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to model the electrical remodelling process by mimicking the experimentally measured
reductions in the ionic currents Ito, IKur and ICa,L by 50%, 50% and 70% respectively [11].
Although the modification was performed in 1999, predictions made were subsequently
verified by experimental data in 2012 [48, 49] and 2015 [44].
3.1.2 Motivation
Many techniques exist for fitting a model solution, x(t) to data, y(t). These methods
typically involve formulating the problem as an optimisation function to minimise. The
most intuitive optimisation function is the root of the mean of the squared errors at each
time point t in the simulation (the Root-Mean-Squared error, or RMS). There are numer-
ous methods available for solving the problem of finding the minimum of a function of
n parameters, including the Nelder-Mead Simplex Search (NMSS), Genetic Algorithms
(GAs), and Particle Swarm Optimisation (PSO).
These methods are often sufficient for fitting a model to data (either synthetic or
experimental) for a single cell model. However, as we are performing this fit with a view
to using the resulting calibrated parameters to model travelling waves on the pulmonary
vein, we require a fit to the propagating AP. This increases the complexity of the problem
as we now require both the speed and the morphology of the emerging AP to match the
data. While for all other parameters held constant, CV is proportional to the diffusion
constant D, effective CV is also influenced by the AP morphology, most importantly
the upstroke velocity. A sharp upstroke velocity causes the difference in the intracellular
voltage between neighbouring cells to grow faster. This increases the value of the diffu-
sion term and causes the next cell to spike faster, thus a smaller value of the diffusion
constant is required to maintain the same CV. In short, any derived diffusion constant
D is only valid for a specific set of parameters. Further, including diffusion multiplies
the computation time of each iteration by the number of nodes used in the simulation,
increasing the requirement for fast convergence.
For this problem, a potential difficulty arises in fitting the AP by minimisation of the
RMS error E = Σ((x(t)− y(t))2)/N due to the temporal translation induced by varying
D. Formally, we define the objective function ERMS(p) for the RMS error between an
AP xi(p) from the BOCF model generated by a parameter set p and a target action
potential yi, each consisting of N time points i, to be:
ERMS(p) =
√∑N
i=1(xi(p)− yi)2
N
(3.1)
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As the wave speed varies depending on all 21 parameters, it is possible, in theory, for a
set of parameter values for the cell model that generates an AP with perfect morphology
to spike at a different time to the data. For such a case, the objective function ERMS(p)
would return a large error. The sharp upstroke exacerbates this problem, as even a small
difference in spike time will result in values of t such that x(t) = 0 and y(t) = 1.
Firstly, this chapter investigates methods by which we can improve the fit by find-
ing a more suitable combination of objective function and fitting method than ERMS(p)
minimised by NMSS. We investigate whether we can obtain a better fit (or the same fit
with fewer function evaluations) over the RMS error by using the cross-correlation as an
objective function, a method which focuses purely on the morphology and is independent
of spike time.
To ensure that the results obtained are not simply an artefact of the NMSS, we verify
results by using a single objective GA. This also allows us to be able to compare the
efficiency of these two different parameter optimisation methods. All optimisations using
both the cross-correlation and the mean squared error will be performed using the NMSS
and a genetic algorithm.
These fitting methods optimise only the AP morphology to a single target AP. The
second purpose of this chapter is to investigate the use of multi-objective optimisation
algorithms to fit not only to the electrically remodelled AP but also map the pathway
through parameter space between the two. This could help to obtain more information
about the transition between health and disease.
The two questions we aim to answer in this chapter are as follows:
1. Does maximising the cross-correlation provide a better fit for the AP morphology
than minimising the root mean squared error?
2. Can multi-objective optimisation algorithms help us to better understand the key
parameter changes that model the transition between health and disease?
3.2 Methods
3.2.1 Data Generation and Numerical Algorithms
Synthetic data were generated from simulating the Courtemanche model using a spatial
resolution ∆x = 0.2 mm and a temporal resolution of ∆t = 0.01 ms on a one-dimensional
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cable of length 2 cm (100 nodes) with a BCL of 600 ms. We simulate two APs by an
S1-S2 stimulation protocol in all cases and use only the second one for error calculation
to account for restitution properties at this BCL. 600 ms was chosen as the BCL to match
the pacing used clinically at the Bristol Heart Institute.
To estimate the value of D for the Courtemanche model, we fit the model to match
the clinically observed CV (48 cm/s [153]). To do this we calculated the time elapsed
between the 20th and 80th APs in the model (to avoid influence from the stimulus and
boundary conditions) using the beginning of the upstroke as a reference point which can
be easily and reliably identified, and ensured this corresponded to a CV of 48 cm/s. As
the wave speed depends monotonically on D while all other parameters are held constant,
optimisation of D can be performed using any basic root finding method. We found a
value of D = 2.615 calculated through simple interval bisection. At the opposite end
to the stimulus, we use Neumann boundary conditions, minimising the effect that the
boundaries have on nearby nodes. The red line of Figure 3.1 shows the target AP.
3.2.2 Parameter Fitting Methods for Uniobjective Optimisa-
tion Problems
We consider the initial parameter set from the sample fitting code provided in appendix
3 of [119] to be our nominal parameters (the initial parameter set) and denote this p0.
However, this code fits to the point model, and as such only contains the 20 parameters
for the AP morphology and does not contain a value of D. To estimate a nominal param-
eter value for D, we used the same technique used to optimise D for the Courtemanche
model. The AP generated by p0 is shown by the blue curve in Figure 3.1.
NMSS [154] is a simple search algorithm for a problem of n continuous inputs, which
given an initial point p0, first creates an initial simplex of n + 1 points. We create the
initial simplex from p0 by creating an additional point by a 5% increase along each of the
21 dimensions of the parameter space. To edge towards the minimum, most iterations of
NMSS perform a reflection, in which the point on the simplex with the highest function is
translated through the centre of the simplex. If this new point is better than the original,
we continue reflection, if not, the simplex contracts on to the local minimum. NMSS will
stop if a local minimum is detected, therefore if the function has many local minima,
the result will be highly dependent on the initial point and unlikely to find the global
minimum. To perform this computation, Matlab’s ‘fminsearch’ function was used.
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Figure 3.1: Propagating Action Potentials from Courtemanche and BOCF. The
Courtemanche model factoring in atrial remodelling (red) is the target data. The blue
curve is the default parameter set for the BOCF model with only the diffusion constant
calibrated so the AP morphologies can be better compared. Simulations were performed
on a string of 100 cells stimulated at one end, with the AP displayed on the 80th cell.
The APs have an RMS error of 0.2494 and a Cross-correlation Error of 0.1119.
Rather than using one initial point, the GA starts from a population of initial points
in parameter space. For each parameter, we use an initial range one order of magnitude
either side of p0. The members of the population with the best fitness value are selected
as parents for the next generation. From these, three types of children are created. The
best of the parents survive to the next generation as elite children. Crossover children
are created by combining parameters of two parents. Finally, mutation children are a
random perturbation to a single parent. For single objective optimisation, each gener-
ation consists of 200 members, of which 10 are elite, 160 crossovers and the remaining
30 are mutation children. The evolution terminates (indicating convergence) when the
relative change in the best member of the population over a number of generations falls
below a tolerance. For single objective optimisation, we use 50 generations and a function
tolerance of 10−6, meaning the algorithm will continue until the optimal fit across the 50
previous generations has varied below 10−6. Matlab’s ‘ga’ function was used for all of
our genetic algorithm fits.
PSO is not used in this thesis but we include a description here for completeness. PSO
[155] is a category of population based meta-heuristics which use random points flying
through the parameter space, each updating its velocity based on the performance history
of itself and its neighbours. An increased number of particles reduces the probability of
64
falling in a local minimum, however, the method can converge slowly for some problems
[156]. Hybrid methods which attempt to apply the best of both have been developed for
the optimisation of the BOCF model to the TNNP Model [157], however, this study is
limited in depth, and comparisons between the hybrid method and the existing methods
are not performed.
3.2.3 Objective Functions
RMS Error
Calculation of the RMS error is not trivial for a travelling wave, as we wish to avoid arte-
facts of the simulation protocol from incurring additional error. Factors such as response
to the stimulus and influence of boundary conditions are not relevant if we only require
a fit for how the AP propagates through tissue.
After simulation, we cut off the first 20 and the last 20 cells. The APs on all cells are
shifted in the time axis so that cell 21 (the first cell remaining in the simulation) begins
spiking at time t = 0. The objective function ERMS(p) was evaluated on the 80th cell.
To ensure a low error, the delay in the AP from the 21st cell to the 80th must match in
both models, which effectively constrains the wave speed. If the wave speed is incorrect,
then the RMS error will be high regardless of how well the morphology fits.
Cross-correlation
The alternative we propose to minimising the RMS error (an objective function that
implicitly requires an accurate CV to provide an accurate measure of goodness of fit) is
to fit the morphology separately to the CV, i.e. fitting D separately to the other pa-
rameters. The morphology must be fit first, as the influence of the morphology over the
wave speed is much greater than the influence of the wave speed over the morphology.
Specifically, the parameters responsible for the upstroke velocity have the most influence
over the wave speed. This is because a sharper upstroke results in the voltage differential
from one cell to the next to become larger at an increased rate, which proportionally
increases the conduction velocity (therefore requiring a lower diffusion term). During the
morphology fitting step, the wave speed should not have any influence over the error, and
so we require an objective function independent of the timing of the AP.
The cross-correlation is ideal for this purpose. The cross-correlation provides the
similarity between two discrete signals x and y of N sampling points, where y is lagged
by a value τ . This function (x ? y)(τ) is defined as
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(x ? y)(τ) =
N∑
m=1
x(m) y(m+ τ).
The cross-correlation function will be at its maximum for the value of τ , τmax which
maximises the correlation between x(t) and y(t − τ). The degree of similarity between
two signals is given by (x ? y)(τmax).
The autocorrelation is defined as the cross-correlation of a signal with itself, i.e. (x ?
x)(τ), which will have a maximum at τ = 0. Dividing the cross-correlation by the
maximum value of the autocorrelations (x?x) and (y?y) normalises the cross-correlation,
ensuring that if there is a lag such that there is a perfect fit (x(t) = y(t− τ)∀t < N), the
result will be 1. Our objective function Ecross(p) for the cross-correlation fit is then,
Ecross(p) = 1− max((x(p) ? y)(τ))√
(x(p) ? x(p))(0) · (y ? y)(0) , (3.2)
where as with ERMS(p), p is the set of parameters and x(p) is the simulated data
using the parameters p. Ecross(p) will give a result of 0 if there is a perfect fit, and 1 for a
worst possible case. Minimising this function gives us the parameter values for which the
AP morphology of the model most closely matches that of the data independent of the
wave speed. We note that minimising this function is the equivalent to maximising the
cross-correlation. The wave speed from cell 20 to 80 can then be fit independently using
a separate objective function varying only D as described previously when we estimated
D for the Courtemanche model.
3.2.4 Multi-Objective Optimisation
Multiple objective optimisation is performed using the Non-dominated Sorting Genetic
Algorithm II (NSGA-II) algorithm [158], as implemented by Matlab’s ‘gamultiobj’
function. The goal of this algorithm is to use an evolutionary process to obtain a Pareto
front. For any multi objective optimisation problem with pm inputs and En objectives
to minimise, a set of parameters p is defined as Pareto optimal or Non-dominated if it
is impossible to reduce the value of one objective function without increasing another.
The result of our fit is therefore not a single parameter set, but a front of Pareto optimal
solutions.
The NSGA-II Algorithm works much the same way as the GA described earlier, using
elite, mutation and crossover children. However, a much greater fraction of elite children
must be preserved or too much of the Pareto front will be lost during each generation.
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As such we follow the commonly accepted rule of thumb of taking best 35% of the popu-
lation as elite children. The termination criteria is based not on the best member of the
population, but on the relative change in the area behind the front across 100 generations.
Figure 3.2: A Sample Pareto Front. This front displays the Pareto optimal solutions
from the simple test problem f1(x) = (x − 2)2 + 20, f2(x) = (x + 2)2 − 10. The ends of
the Pareto front correspond to the optimal parameters for the single objective problems.
A line f2 = −f1 + c runs tangential to the front and the intersection denotes one possible
optimal for optimising both objectives.
Firstly, to demonstrate the method, we consider a simple problem with only one
parameter for which the global optimum for both objective functions is known. Consider
the two functions
f1(x) = (x− 2)2 + 20
f2(x) = (x+ 2)
2 − 10.
(3.3)
Trivially, f1(x) has a minimum value of 20 for x = 2 and f2(x) has a minimum value
of -10 for x = −2. In Figure 3.2 we show the Pareto Front obtained by application of the
NSGA-II algorithm with an initial parameter range from x = −10 to x = 10. The plotted
points at either end of the front are the result of optimising f1 and f2 independently, and
therefore correspond to values x = −2 and x = 2. In order to determine which value
on the front contains the best balance between the two objectives, a straight line can be
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drawn either of the forms f2 = −f1 +c, or connecting the two ends of the front, which can
then be translated to the minimum value of c for which the line is tangential to the front.
Alternative methods for determining a particular optimum are Euclidean distance to the
origin, or some problem-dependent weighting to prioritise more important objectives.
Due to the symmetry in this trivial problem, both ends of the front lie on a line
f2 = −f1 + c. Translating this line to the point where it is tangential to the front gives
f2 = −f1 + 18 which touches the front at (24,6) given by the parameter x = 0 (half way
between the two local minima). The high degree of symmetry in this problem comes from
both objective functions being identical translated quadratics, and cannot be assumed
true for the error of a mathematical model.
3.2.5 Pathways through Parameter Space from Health to Dis-
ease
We apply this optimisation technique to map a pathway though parameter space that
describes how the AP is deformed by AF-induced electrical remodelling. Again, we use
the Courtemanche model as a proxy for real AP data, this time using the original 1998
model to represent a healthy AP and the 1999 parameter set including relevant ionic
current reductions for a post-AF cell as before. To allow a greater focus on the intracel-
lular dynamics responsible for the change in AP morphology, the section of this chapter
concerned with multi-objective fits and pathways through parameter space is performed
on single cells.
As the change in the Courtemanche model comes from varying only 3 parameters, we
can also estimate intermediate states as required. We define the ‘degree of remodelling’
R to be 0 for a healthy AP and 1 for the remodelled parameter set. Only APs for R = 0
and R = 1 are known to the genetic algorithm, but it is worth noting at this time that
intermediate APs can be calibrated for validation purposes. We assume that this tran-
sition between Courtemanche parameter sets is a linear path from the R = 0 set to the
R = 1 set.
We perform a novel parameter fit in order to map this pathway. We use the NSGA-II
algorithm to simultaneously train parameters to fit both the healthy (R = 0) and the
electrically remodelled (R = 1) APs, such that f1(p) is quality of fit for R = 0 and f2(p)
is the quality of fit for R = 1. This will allow the calculation of the Pareto front, where
one end of the front corresponds to the optimal fit to the healthy cell, and the other end
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to the electrically remodelled cell. As one traverses along this front, the AP will deform
from the healthy state to the remodelled state.
If the front is sufficiently smooth, the morphology of the AP and the values of the
parameters should also smoothly vary along the front. If the Pareto front does describe
the transition, then the deformation of the morphology along the front in the BOCF
model should match the deformation of the morphology of the Courtemanche model as
we vary R from 0 to 1. We can identify key parameters underpinning this AP change by
analysing how parameters vary along the front.
3.3 Results
3.3.1 Cross-correlation Minimisation
Firstly, we demonstrate a potential advantage of using the Cross-correlation as a function
to fit the morphology of a travelling AP and how this can give an error function more
representative of what we are actually trying to fit. This is demonstrated by AP from a
parameter set pslow plotted in Figure 3.3. pslow has been deliberately chosen to reflect
well the AP morphology but with a diffusion constant much too small.
Figure 3.3: Action Potential with Good Morphology but Poor Conduction Ve-
locity. A target action potential (red) and a simulated action potential (blue) generated
from a parameter set designed to give a good action potential morphology but slow con-
duction velocity. As a result, the root mean squared error is high, and the parameter set
scores poorly, due to one bad parameter value out of 21 parameters.
It is clear to the eye that the morphology of the AP (blue) for pslow is very close
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Method Objective Function Evaluations Root MSE X-Correlation
None None 1 0.2495 0.1109
Nelder-Mead Cross-correlation 3546 0.0389 6.9216× 10−4
Nelder-Mead RMS error 2578 0.0157 6.3866× 10−4
Genetic Algorithm Cross-correlation 23600 0.0344 4.0263× 10−4
Genetic Algorithm RMS error 118400 0.0138 5.7596× 10−4
Table 3.1: Results from Single-Objective Optimisation. Table showing error in cal-
ibrating the BOCF model to the Courtemanche model with two different fitting methods
and two different objective functions. Function Evaluations is used to represent speed
of fit. The RMS error out-performs the Cross-correlation in every metric for the NMSS.
The Genetic Algorithm performed slower but better in every case. Simulations from the
Genetic Algorithm are shown in Figure 3.4.
to the target data (red), but shifted slightly to the right because of a slow diffusion
speed. As a result, at approximately y = 25, the Courtemanche model has reached its
peak, but the stimulus has yet to arrive at the 80th cell in the BOCF model, resulting
in an error of 1 (the highest error possible). This is a significant source of error when
using the RMS error as the objective function. This parameter set has a RMS error of
ERMS(pslow) = 0.1819, which is a marginal improvement over p0 (0.2494). Using the
Cross-correlation, this parameter set has an error of Ecross(pslow) = 5.8143× 10−4, which
is a massive improvement on the Cross-correlation for p0 (0.1119). These results show
that by using the cross-correlation as an error function, it is possible to isolate error
incurred from a poor morphology from the error incurred from a poor CV and that there
are regions of parameter space (near pslow) for which this is more representative of the
error.
Next, we test how well the two error functions actually perform when used in an
optimisation algorithm, using both a genetic algorithm and the NMSS. We present a
comparison of the two objective functions numerically in Table 3.1, evaluating the error
from both objective functions using both parameter sets, as well as the number of func-
tion evaluations used to perform the fit.
The results show that while maximising the cross-correlation does calibrate the model
parameters to fit the data, there is no clear benefit over minimising the RMS error. It
is a curious result that minimising the RMS error resulted in a lower value of Ecross(p)
than simply minimising Ecross(p) directly. As this only holds for the NMSS method, it is
reasonable to assume that there are many local minima for Ecross(p). For the NMSS, the
RMS error performed better in terms of number of function evaluations (2500 to 3500),
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(a) Root Mean Squared Error (b) Cross-correlation
Figure 3.4: Genetic Algorithm Optimisation of BOCF Model. Attempts to fit
the BOCF model to the target data using the RMS error and the cross-correlation as
objective functions. Both fits used a population bound by an order of magnitude above
and below the set in [119], and optimisation was performed using the Genetic Algorithm.
which is directly proportional to the evaluation time to perform the fit.
Using the GA, using Ecross(p) as an objective function worked much better than with
NMSS. However, there is still no clear advantage to use Ecross(p). The fit derived from
using ERMS(p) follows the remodelled atrial AP much better, as seen in Figure 3.4.
The superiority of the RMS error for performing the parameter fit indicates that the
region of parameter space for which the cross-correlation was a notable improvement
(the parameters with a good morphology but poor speed) was not visited by the genetic
algorithm or the NMSS. The best fit, from observation of the plots in Figure 3.4, is clearly
obtained from minimising RMS error, and the parameter set from this fit will be used in
future work in modelling the pulmonary vein electrophysiology.
3.3.2 Multi-Objective Optimisation
In this section, we present the results of using the NSGA-II algorithm to optimise si-
multaneously to the healthy and remodelled APs. Due to the poor performance of the
cross-correlation as an objective function, multi-objective optimisation was performed
using the RMS error, so f1(p) and f2(p) are the RMS error in the healthy and diseased
cells respectively.
126 generations were required after the initial population was evaluated, totalling
254000 runs of the objective functions. Evolution was terminated when the convergence
criterion was satisfied, that the average relative change in the area behind the Pareto
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front (calculated with respect to a reference point given by the maximum values of each
objective function on the previous generation’s front) across 100 consecutive generations
dropped below a tolerance. As 35% of the population are preserved as elite children, of
the 2000 members of the population, 700 were Pareto optimal when the algorithm and
these form the Pareto front. The remaining 1300 lie a short distance behind the front.
Figure 3.5: Pareto Front from Multi-Objective Optimisation of BOCF Model
to Healthy and Diseased States. This figure displays the Pareto Front of 700 points
obtained from simultaneously fitting the BOCF model to the healthy and the diseased
atrial action potentials. The smoothness of the curve indicates that parameter values
deform smoothly across the front.
We display the 700 individuals in the Pareto front in Figure 3.5. The top-left point in
the front (0.0430, 0.1346) marks the optimal fit for the healthy AP. As one travels across
the front, the AP is deformed towards the electrically remodelled state. The bottom right
point, situated at (0.1422, 0.0357) marks the optimal fit for the AP following electrical
remodelling. The line f1(p) = f2(p) is not drawn as we are computing the Pareto front
to find the pathway from one state to another, rather than to find a balanced optimal
solution.
A fragmented front with large discontinuities would indicate large jumps across pa-
rameter space, where the set of Pareto optimal solutions actually contains many different
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fronts. The smooth, continuous nature of our solution indicates that the whole front does
generally correspond to the same region of parameter space and that the AP does indeed
deform smoothly across the front.
Figure 3.6: Parameter Changes along the Pareto Front. Scatter plots showing how
all 20 parameters change along the front, with the degree of remodelling on the x axis
and parameter value on the y axis. Each point in the plot represents one of the 700
parameter sets on the front. p(17) stands out as a clearly important parameter change
due to the strong correlation between parameter value and position along the front.
In Figure 3.6 we include scatterplots of all 20 parameters in the model along the front.
The parameter set which optimises the fit to the healthy cell is composed of the first data
points in each of the 20 plots. This plot contains valuable information about how the
parameters affect the solution. As we know consecutive points in the front give a mini-
mal change in AP morphology, a high variance implies that the model is not sensitive to
parameter changes (a variety of parameter sets could potentially give the same solution).
We note that the vast majority of the parameters appear to have little correlation with
the position on the front, with the exception of the weak nonlinear response in p(13) (uso,
a phenomenological constant in the time constant of the slow outwards current) and the
strong correlation in p(17) (us, a phenomenological constant in s, the gating variable
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Parameter Correlation Relative Change Parameter Correlation Relative Change
1 -0.0107 -0.1226 % 11 0.4666 0.6239 %
2 0.6281 3.3249 % 12 -0.0673 0.0084 %
3 0.1110 0.2920 % 13 0.4136 2.4485 %
4 0.5820 1.4052 % 14 -0.5197 -1.1899 %
5 -0.4499 -3.3741 % 15 0.3899 0.8455 %
6 -0.3341 -0.7858 % 16 0.5691 6.4857 %
7 0.3093 0.8276 % 17 0.9835 13.3751 %
8 0.0676 -1.1345 % 18 0.4891 0.1360 %
9 0.4779 1.7900 % 19 0.0404 -0.4118 %
10 0.4242 0.2937 % 20 -0.4772 -0.4456 %
Table 3.2: Parameter Value Significance and Relative Change The Correlation
columns show correlation between parameter values and position along the front. Only
parameter 17 has a significant correlation at 0.9835, the next strongest correlation is 0.62
on parameter 2. Relative change gives the percentage change in the parameter from the
healthy to the diseased state. Again parameter 17 stands out, as its value at R = 1 was
13.37% higher than at R = 0. The next largest magnitude absolute change is parameter
16, at 6.48%
for the slow inwards current). The exact values of the Pearson correlation coefficients
are given in Table 3.2 and provide further evidence for the increase of p(17) as the key
parameter change in the transition between healthy and remodelled APs. The locations
of these parameters in the BOCF model is given in Equation (3.4) where show a subset
of the equations of the full model, with uso and us highlighted in bold.
u˙ = ∇ · (D˜∇u)− (Jfi + Jso + Jsi)
s˙ = ((1 + tanh[ks(u− us)])/2− s)/τs
Jsi = −H(u− θw)ws/τsi
Jso = (u− uo)(1−H(u− θw))/τo +H(u− θw)/τso
τso = τso1 + (τso2 − τso1)(1 + tanh[kso(u− uso)])/2;
(3.4)
p(17) is the phenomenological constant us inside the tanh function of the equation
for the gating variable s. An increase of us will shift the tanh[ks(u − us)] function to
the right (seen in Figure 3.7), lowering s˙. s is a phenomenological gating variable which
has a resting state at 0 and turns positive during an AP, so a decrease in s˙ will lower
the value of s throughout the AP. Any decrease in the value of s will also decrease the
absolute value of the phenomenological slow inwards current approximation Jsi.
The parameter change will have a stronger effect while tanh[ks(u − us)] is close to
74
Figure 3.7: Influence of Pareto Front on BOCF Model Equation. Plot showing
(1 + tanh[ks(u − us)])/2 in terms of u for the healthy action potential (blue) and the
remodelled action potential (red), showing the interval of u for which the parameter
change is important.
0 (while u ≈ us). Although all plots of the APs in this thesis are normalised to allow
better visual comparison across models, u ranges from 0.9 to 1.3868 for R = 0 and from
0 to 1.3916 for R = 1. We plot the values of (1 + tanh[ks(u − us)])/2 for values of u
from 0 to 1.4 in Figure 3.7, holding ks (p(16)) constant at the mean value on the front
(10.6337). This plot helps to visualise the interval of u for which our identified changes
in the parameter us has the biggest influence on the equations of the BOCF model (when
u is large).
As there are 3 ion channels in the BOCF model and 13 in the Courtemanchce model, us
and uso have no direct counterpart in the Courtemanche model. However, the ion channels
reduced to create the synthetic data, in accordance with experimental evidence, were the
slow outwards channels: Ito (transient outwards) and IKur (ultra-rapid delayed rectifier),
and the slow inwards channel ICa,L (Calcium leak). It is known that the reduction in ICa,L
alone can account for most of the morphological features associated with AF-induced
remodelling [11]. These morphological features mostly refer to the reduced APD and
size of the dome (the secondary spike in the AP following the initial peak), allowing
more wavefronts to coexist, and making spiral waves more likely to form. The parameter
change obtained from our parameter fit also functions to reduce the strength of the slow
inwards current, which reduces the APD and size of the dome, in accordance with the
findings above.
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3.3.3 Pathways Through Parameter Space
In this section, we provide a more sophisticated error analysis to investigate how well the
parameter change across the Pareto front, most importantly the change in us, approxi-
mates the actual transition in the biophysical model. We calculate error along the front
for 100 equally spaced values of R from 0 to 1. As only R = 1 and R = 0 were used in the
creation of the Pareto Front, if the intermediate parameter sets along the front do not
accurately represent the intermediate APs, we can expect to see a large error far from
the ends. Firstly, we present results simply from using 100 parameter sets equidistant
along the front. The result is shown in Figure 3.8.
Figure 3.8: Errors in Intermediate Action Potentials. Graph showing the change
in error through the pathway from health to disease. There is no additional source of
error in the intermediate values.
We note that the end points of this curve are constrained by the optimal fits for the
healthy and remodelled APs. The decrease is simply an artefact of the model fitting
better to the remodelled AP due to its simpler morphology. The important result is the
largely monotonic change from one state to the other. There is no clear additional source
of error incurred for the intermediate values of R, implying that APs were reproduced
well along the front. However, this is only one possible way we can evaluate error along
our parameter fit, and there are many alternative ways to traverse the front:
1. As before, use the raw values from the parameter sets on the Pareto front, including
every oscillation in all 20 parameters (original front).
2. Use values of us on the Pareto front and assume everything else is held constant at
the mean value (reduced front).
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3. Fit a linear function through the values of us and hold the others constant (linear
fit).
4. Fit a quadratic function through the values of us and hold the others constant
(quadratic fit).
5. Fit a quadratic function through the values of us and of uso and hold the others
constant (two parameter quadratic fit).
6. Ignore the intermediate front altogether and linearly interpolate all 20 parameters
from one end to the other (end to end interpolation).
The reduced front will tell us how important us is compared to the other parameters.
The polynomial fits give an equation for how parameters vary across the front, which can
tell us more about the underlying dynamics. The end to end interpolation would be the
intuitive way of estimating parameter change without using the multi-objective GA, and
comparing error along this path with the others tells us how important calculation of the
Pareto front is.
Figure 3.9 shows the error from all pathways previously described. The end to end
interpolation (in black) shows the error from simply linearly changing all parameters from
one end of the front to the other. The poor quality of fit for this approximation shows
that using only the ends of the front (as would be calculated if both objectives were
optimised independently) is an insufficient method to capture the smooth deformation of
the AP between states and highlights the importance of the multi-objective technique.
The red curve shows the error as only us is varied along the front and the others are
held at the mean value. This has a largely similar morphology to the original front (in
blue) which is evidence of a change in us being able to map the transition. However,
the reduced front contains numerous upwards spikes (notably on 0.69, and between 0.85
and 0.9). This is a result of certain points on the Pareto front lying in different regions
of parameter space, which can be verified by the points in the plot for p(17) in Figure
3.6 which do not lie on the linear trend. In the original front, this is accounted for by a
change in the 19 other parameters for the same point on the front, resulting in increased
error when the mean value is taken.
This sensitivity to location on the front can be smoothed by fitting polynomials (lin-
ear in yellow, quadratic in purple) through the change in us. As uso also has a notable
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Figure 3.9: Error Along Pareto Front for Multiple Paths. Graph showing the
change in error through the pathway from health to disease for multiple approximations
of the Pareto Front. All curves feature a similar morphology, with the exception of the
end to end interpolation, the only curve which does not use intermediate values along
the front. This is an important result, as it demonstrates the importance of considering
the entire front.
nonlinear trend, we also fit quadratics through uso (in green).
As these paths through parameter space are simply polynomials in one or two dimen-
sions, the error is much smoother than the numerical parameter sets on the Pareto front
and allow for calculation of an AP at any point on the pathway. As can be seen from the
linear fit (gold line) linear regression through the parameter space gives a good overall
shape but has the highest error on the end points. This is to be expected when using a
linear function to approximate a curve which is not perfectly linear.
It is difficult to infer any more details from the graph, so mean errors are given in
Table 3.3 for comparison. This table has been ordered in increasing error. The best fit
was from using all of the information from the original front. The next best fit was from
approximating two parameters with a quadratic function. Taking only one parameter
into account resulted in a higher error, with the quadratic fit performing batter than
the reduced front and the linear fit. The worst fit was from ignoring the front and
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Path Error
Original Front 3.7120× 10−2
Two Parameter Quadratic Fit 3.7218× 10−2
Quadratic Fit 3.7303× 10−2
Reduced Front 3.7310× 10−2
Linear Fit 3.7448× 10−2
End to End Interpolation 3.9666× 10−2
Table 3.3: Total Error Along Front Table showing the error along the entire front.
Results show the more of the front is taken into account, the lower the error.
interpolating end-to-end. Results essentially show us that the more of the front we take
into account, the better the fit is across the transition.
3.4 Discussion
This chapter aimed to explore the potential of parameter fitting methods to firstly adapt a
phenomenological model designed for the ventricles to model the atrial AP, and secondly,
use multi-objective optimisation techniques to characterise the pathway from healthy to
diseased states. Firstly, we investigated whether the cross-correlation was a better objec-
tive function than the RMS error for fitting the morphology and CV of a propagating AP.
The results show that the two are connected in that parameter values that scored
well on one objective function also performed well on the other. However, while the
results show that the cross-correlation is a good measure of fit in certain regions of pa-
rameter space, it is not efficient as an objective function. For the NMSS, minimising
RMS error resulted in a lower value for the cross-correlation than minimising the cross-
correlation did, and the cross-correlation offered no clear advantage when a GA was used.
Our results also allow us to also make comparisons between NMSS and the GA. We
see that for single objective optimisation, the genetic algorithm provided a minor increase
in quality of fit at the cost of a huge increase in number of function evaluations, although
different metaparameters (convergence criteria, population size, etc.) are likely to have
an effect on this. The choice of optimisation algorithm should, therefore, be chosen based
on the application, and whether optimising the AP model on a case specific basis is re-
quired. The parameter fit obtained from minimising the RMS error will be used in our
future work on modelling of the pulmonary vein electrophysiology.
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We are mostly limited by the lack of real human data to serve as a target AP for the
BOCF model. However, using the Courtemanche model as a proxy for real data, we were
able to ensure that the model and ‘data’ were both stimulated with an identical stimu-
lation protocol on identical cables of tissue. Further, there are many different methods
available for global optimisation which could have been used to provide further testing
of the objective functions, such as simulated annealing, statistical emulation and particle
swarm optimisation.
Our second main result in this chapter comes from investigating the potential of a
multi-objective genetic algorithm to determine pathways through parameter space, con-
necting states corresponding to health and disease. As a result, we could reduce the
transition from two disconnected points in 20-dimensional phase space to a simple poly-
nomial in one or two dimensions.
We identified the phenomenological constant us, was the most important parameter
in mapping the transition between healthy and diseased states. We also demonstrated
that identification of this parameter, responsible for changes to the slow inwards current,
is consistent with experimental evidence.
We found that using the Pareto front for this purpose provided a much better rep-
resentation of the AP deformation than assuming a linear connection between the two
points. The use of a Pareto front for this purpose is a novel idea, and one which we
feel is potentially applicable to mapping smooth transitions through parameter space in
other mathematical modelling applications, e.g. [159]. These results were obtained from
a single cell to focus on the intracellular dynamics.
As in the previous section, we are limited by a lack of real data, in this case along the
transition. We approximated the pathway in the Courtemanche model by a linear func-
tion and found a nonlinear change in the BOCF model parameters. In truth, of the three
currents affected by the remodelling process, some may be reduced quicker than others.
We cannot claim that the parameter path obtained for the BOCF model maps the true
physiological transition. We claim only that it maps the transformation obtained from a
linear path in the Courtemanche model much better than the more intuitive approach of
assuming a linear path in the BOCF model.
Further, we acknowledge that there is no well grounded theory to explain why the
Pareto front well approximates the intermediate values in the transition. Findings appear
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positive for the sample problem in this chapter, but it is unclear how well this method
would apply to other problems and would be an interesting topic for future work. At this
time, we can only speculate that this approach would work well in a range of problems
where a nonlinear change in parameters of one model is required to reproduce the response
to a linear input.
81
Chapter 4
Modelling of Pulmonary Vein
Recordings
4.1 Introduction
4.1.1 Background
This chapter introduces a new model capable of producing synthetic pulmonary vein
recordings of the type in Figure 4.1, recorded during the process of circumferential pul-
monary vein isolation (CPVI)1,2. We recall from the literature review that AF is often
initiated by an ectopic signal from the pulmonary veins and that the prevailing method
of treatment is to isolate the vein from the atrium by forming a continuous lesion around
the base, and that there are various strategies available to do this.
CPVI is a minimally invasive surgical technique for treatment of AF, in which a circu-
lar lesion is formed surrounding the pulmonary vein via the application of radiofrequency
energy, electrically isolating the left atrium from the pulmonary vein and so preventing
the propagation of an action potential (AP) in or out of the myocardial sleeve. Whilst
the initial success rate of pulmonary vein isolation is approximately 85% [67], recurrence
rates 5 months after ablation therapy can be as high as 30% in paroxysmal AF patients
1The work presented in this chapter has been reported in the following publication: Green HD,
Thomas G, Terry JR. (2017) Signal Reconstruction of Pulmonary Vein Recordings Using a Phenomeno-
logical Mathematical Model: Application to Pulmonary Vein Isolation Therapy, Frontiers in Physiology
volume 8 (496), DOI:10.3389/fphys.2017.00496. For this publication the contributions were as follows:
HG and JT provided concept; designed and executed the study; analyzed and interpreted the data. GT
provided data; performed analysis of clinical and reconstructed signals. All authors wrote and approved
the final manuscript.
2Further, the techniques have been published in the following patent application: Terry JR, Green
HD. (2017) Detection of conduction gaps in a pulmonary vein, WO Patent App. PCT/GB2016/053,421
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or 78% in permanent AF patients [53]. It is desirable to ensure that the ablation process
is completed as quickly as possible, as the duration of the procedure is known to strongly
correlate with the rate of recurrence [160]. Additionally, ablation of the pulmonary veins
carries a risk of pulmonary vein stenosis [71] and if complete electrical isolation is not
achieved, the lesions can become pro-arrhythmic through the creation of conduction ob-
stacles that facilitate the initiation of reentrant waves.
Figure 4.1: Clinical Pulmonary Vein Recording. The pulmonary vein recording of a
patient with atrial fibrillation during pulmonary vein isolation therapy. Spiking indicates
electrical activity as the action potential propagates through the recording catheter. Since
the pulmonary vein is not a perfect cylinder, not all electrodes make a good contact. For
example, Channels 3-4, 17-18, and 19-20 show no spiking activity for this reason. These
are referred to as missing channels throughout the thesis.
Often the initial circular lesion made during CPVI are incomplete and small conduc-
tion gaps can remain. These are most commonly due to poor depth penetration of the
lesion and the ablation catheter not maintaining a continuous contact with the heart tis-
sue. To provide a guide to the surgeon as to the location of the conduction gaps, bipolar
recordings of electrical activity around the pulmonary vein are taken using a lasso catheter
typically consisting of 10 or 20 electrodes (see Fig. 4.1 for an exemplary time-trace). The
conduction gap is assumed to correspond to the location of the electrode(s) where the first
spikes are observed and these sites are targeted for further ablation [40, 69]. However, as
the pulmonary vein is not a perfect cylinder it is common for some electrodes to make
poor contact with the tissue. Figure 4.1 is an example of this happening in clinic, and
in this case, it is difficult to infer the activation pattern across PV 17-18 and 19-20. If
these missing channels correspond to the region of first activation, this information loss
could potentially lead to ablating the wrong region, or concluding the process has been
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successful.
In this chapter, we focus on developing a mathematical representation of the phe-
nomenology of the electrical signal recorded from the lasso catheter and to use this to
reconstruct missing electrical signals. This is in contrast to typical approaches to mod-
elling the cardiac AP or the body surface ECG where physiologically detailed models are
typically used (see, for example, [15, 96] for comprehensive reviews). Developed appro-
priately, phenomenological models can be used to produce patient-specific simulations of
the electrophysiology during treatment and could, therefore, form a part of a therapeutic
decision support system to minimise the impact of information loss in clinic.
The use of physiologically detailed mathematical models has enabled personalised
3D modelling of the atria, largely involving detailed biophysical models to investigate
mechanisms behind the sustenance of AF [161, 162]. Additionally, fibrosis patterns have
attracted significant recent attention [163], and results obtained from the detailed mod-
els have elucidated the role of so called ‘islands of fibrosis’ in the atria [164]. Further,
techniques are in place for the simulation of ‘virtual ablation’ and bipolar electrograms
[165, 166, 167, 168]. In a 2014 study [10] a variety of ablation strategies were simulated
and compared in a computational study, finding that CPVI with two additional linear
lesions (along the roof and posterior wall) showed the highest AF termination rate.
However, such studies typically make the following assumptions:
1. the data collected and used to constrain the model is the ‘ground truth’;
2. ablated lesions made by the cardiologist are continuous.
Both assumptions are likely to be invalidated in the clinical setting, where significant
information loss due to poorly connected electrodes is commonplace and conduction gaps
create discontinuous lesions. These were highlighted in 2011 by Miyamoto et al. [70]
who proposed a method to infer a pulmonary vein activation map via gentle movement
of the catheter. In conclusion, they raised concerns that signals were unreliable due to
some electrodes touching the endocardium whilst others were not. A further issue is that
bipolar electrodes located symmetrically to a conduction gap will record a zero signal
despite a wavefront passing through.
To address these challenges, we develop an application of the BOCF model (intro-
duced in chapter 2 and discussed extensively in chapter 3) on a cylinder with regions
of zero conduction representing ablated tissue to build simulated representations of the
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bipolar signals recorded by the lasso catheter. Our focus on a simplified model of the
phenomenology of the electrical signal, rather than a detailed model of the underlying
electrophysiology, is twofold. First, a cardiologist uses information from the macroscopic
electrical recordings to identify appropriate site(s) to ablate, without recourse to any de-
tailed understanding of the underlying electrophysiology. Second, the time available for
the surgical procedure is of the order one-hour meaning that the model must efficiently
reproduce a signal to be of use as a decision support tool during the procedure. The
BOCF model provides a pragmatic balance between the quality of the simulated signal
and the computational time required to produce the output. For example, many detailed
biophysical cardiac models, such as [4, 123, 130, 149, 150] require significant time (of
order hours) to compute appropriate APs, rendering them inappropriate in the clinical
setting. In contrast, the BOCF model can be run multiple times for parameter estimation
and sensitivity analysis over much shorter timescales (of order seconds to minutes).
We demonstrate that this simple model can reproduce the activation pattern across
electrodes recorded in clinic. Furthermore, we test the potential of the model to recon-
struct recordings that have been lost to poor contact. We verify the accuracy of the
simulated recording using clinical data and minimising the root mean squared error be-
tween the activation patterns in the model and those in the data. To test the accuracy
of the reconstruction, we use recordings for which all channels are spiking cleanly and
remove a subset, so that the original signal can be used for error calculation.
Further, we present results showing cases in which the reconstruction of signals via
the model would lead to reducing the number of RFA pulses. Reducing the number of RF
pulses would both minimise unnecessary damage to the heart and shorten the duration
of the procedure. This is significant due to the correlation between the duration of the
procedure and the rate of recurrence [160].
4.2 Methods
In this section, we introduce the mathematical model used to generate the underlying
AP which is in turn used to generate a travelling wave of intracellular potential within
the pulmonary vein. We describe the methods used to simulate the models and how their
parameters may be calibrated (either from synthetic data or clinical recordings). We
further describe how the model can be used to reconstruct missing channels from data
collected clinically from a lasso catheter. A schematic of how the overall process might
be used to provide clinical decision support is illustrated in Figure 4.2.
85
Figure 4.2: Schematic and Application of Model. Figure showing the intended ap-
plication of the model. A) A cardiologist records Pulmonary Vein Recordings using a
lasso catheter. B) An example of a pulmonary vein recording with some channels not
correctly spiking (missing channels). C) A model simulation demonstrating the propa-
gation through a conduction gap, showing high intracellular potential in red and low in
blue. White stars are plotted on the electrode locations. D) The result of applying the
model to the signal in B to recover the lost channels.
4.2.1 Mathematical model of the underlying AP
To simulate the pulmonary vein AP we use the four variable BOCF model as discussed
in previous chapters. Given that the shape of the emergent electrical activity recorded
on the lasso catheter may be constrained by the underlying structure and function of the
AP, a propagating AP was simulated using the detailed biophysical Courtemanche model
for the human atrium [4, 79, 169] as a proxy for clinical AP data. A generic AP from the
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Courtemanche model was modified to account for the electrical remodelling associated
with AF [11] and used as the initial stimulus for the BOCF model with parameters as
defined in the sample fitting code in the appendix of [119].
These parameter choices were then evolved using the NMSS [154] (implemented by
MATLAB’s fminsearch), by minimising the root mean squared error between subse-
quent APs (see Figure 4.3). Alternatively, any of the methods discussed in chapter 3
for single-objective optimisation would be appropriate. In this chapter we present the
methods used in our published article for consistency. With a spatial resolution ∆x = 0.2
mm, a diffusion constant of DCourt = 2.615 was necessary for the simulated wave front
to match the conduction velocity of 48 cm/s observed clinically [153]. To eliminate any
effects from boundary conditions or transients from the stimulus, the fit was performed
at the point x = 10 mm on a tissue cable 20 mm long. A cycle length of 600 ms was
used to match the clinical data. This process resulted in the parameter choices defined
in Table 4.1.
Figure 4.3 shows the shape of the propagating APs under the above conditions us-
ing the BOCF model with parameters as in Table 4.1, alongside the Courtemanche AF
model as described in [11]. The important qualities reproduced were conduction velocity
(indicated by the simultaneous spike), upstroke velocity, and AP duration.
For the case of anisotropic diffusion an asymmetric finite difference method was used
to simulate the BOCF model (see [81] or Appendix 2 for full details). Since in general
the degree of anisotropy for an individual patient is unknown, we included the principal
axes and eigenvalues of the diffusion tensor as additional parameters to be optimised
by our fitting algorithm. Physiological studies place the anisotropy ratio between 2 and
10, [74, 170], which were used as bounds in our algorithms. The initial principal axes
were placed at 45 degrees to the x and y axes, maximising the effect on the propagation
pattern.
4.2.2 Simulating Pulmonary Vein Recordings
2D simulations of the pulmonary vein were performed by numerical integration of equa-
tion (2.16) by a finite difference method over a discretised cylindrical domain to represent
the excitable myocardial sleeve extending over the base of the pulmonary vein. Dimen-
sions vary from vein to vein, with the right inferior typically the largest and the left
inferior the smallest [171]. We assume dimensions within the range of observed measure-
ments: a length of 15 mm [172] and a diameter of 12.5 mm [173, 174]. A spatial resolution
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Parameter BOCF BOCF-AF Parameter BOCF BOCF-AF
τ+v 1.6650 1.6234 τso2 1.0261 0.9862
τ−w1 82.6769 69.1816 kso 2.0487 2.3769
τ−w2 9.0959 14.1985 uso 0.5149 0.9220
k−w 63.8099 65.4466 τs1 2.5879 2.5603
u−w 0.0331 0.0316 τs2 18.5596 12.5106
τ+w 213.1962 140.2385 ks 2.0468 1.5749
τfi 0.1256 0.0990 us 0.7033 1.1640
τo1 431.0734 452.4879 τsi 2.1260 2.1756
τso1 33.2039 25.6007 w
?
∞ 0.6520 0.9408
τso1 33.2039 25.6007 w
?
∞ 0.6520 0.9408
DBOCF N/A 0.8314
Table 4.1: Parameter Values of Bueno-Orovio Cherry Fenton Model. The origi-
nal parameters of the Bueno-Orovio Cherry Fenton model [119] alongside the parameters
obtained from our fitting algorithm. Diffusion coefficient DBOCF was not given in the
original model.
Figure 4.3: Propagating Action Potentials. Plots of Courtemanche [4] (blue), and
BOCF [119] (red) models using the parameters in Table 1, of an AP at a point 10 mm from
the stimulus with a spatial resolution of 0.2 mm and a time step of 0.01 ms. Model cali-
brated by minimising the root mean squared error using the NMSS. The Courtemanche
model is solved using the parameters in [11].
of ∆x = 0.2 mm was used to discretise this cylinder into a rectangular domain of 200 x 75
grid points. Periodic boundary conditions were used along the lines x = 1 and x = 200,
whilst Neumann boundary conditions were used along the lines y = 1 and y = 75 (where
x and y represent nodes on the grid). We set the conductivity to 0 to model the effect
of lesions due to ablated tissue at the relevant points, following the approach introduced
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in [165, 166, 167]. As we are only concerned with the effect on the AP propagation from
the ablation process, we do not require a model of the thermodynamic processes of the
catheter itself [175, 176].
A visual representation of this structure is shown in Figure 4.2, which shows the
propagating intracellular potential with the lines y = 1, y = ha and y = hr annotated
(panel C). An ectopic is initiated from a stimulus along the line y = 1; the edge of the
myocardial sleeve furthest from the atrial junction. Virtual ablation is performed by
introducing a line of lesions on the circle y = ha such that D(x, ha) = 0. Conduction
gaps are modelled such that D(x, ha) = DBOCF (for conductive tissue on small segments
of the circle y = ha). Consequently, semi-circular wavefront(s) will form on the other
side of the lesions. Although loosely based on the underlying mechanisms, the values of
the obtained parameters are phenomenological and fit to the available data to ensure an
accurate simulation on the lasso catheter electrodes, not to provide an estimation of the
real location of the conduction gap.
We simulate pulmonary vein recordings from the lasso catheter across n electrodes
(where n is typically 10 or 20), on y = hr, where hr > ha. The electrodes are assumed
to be equally spaced d = 200/n apart, such that for an n electrode catheter c = (a, hr)
where a = {d, 2d, ..., nd}). At each point c = (x′, y′), an approximation for the surface
potential Φ described originally in [177] is given by:
Φ(x′, y′) = aD(x′, y′)
∫ ∫
(−∇u) ·
[
∇1
r
]
dxdy, (4.1)
where
r =
√
(x′ − x)2 + (y′ − y)2. (4.2)
Bipolar recordings between electrodes i and j (denoted PV i-j clinically) are simulated
by
PV i− j = Φ(ai, hr)− Φ(aj, hr). (4.3)
Throughout this chapter, we divide the pulmonary vein into three equal sections, with
the ablation line positioned at ha = 25 and the recording catheter positioned at hr = 50.
This is a practical consideration, as quantifying these measurements during the procedure
would be difficult given information collected as standard in clinical practice.
89
4.2.3 Relative Activation Time Curves
The important characteristics of both the simulated and recorded data are the activation
times (from the maximal absolute value of dV/dt) of each signal compared to the others,
as this gives a representation of the wavefront shape termed the relative activation time
curve. It is necessary to use the absolute value as the recordings are bipolar. The relative
activation time curve can be visualised by plotting the catheter along the x axis and its
activation time on the y axis, giving a curve of the activation times of each signal relative
to the others.
To understand the relationship between the relative activation time curve and param-
eters of the overall pulmonary vein model, the quantity, size and locations of conduc-
tion gaps are used as input parameters since these have the most profound effect on the
emerging wavefront shape. The root mean squared error between relative activation times
obtained from simulated and clinical recordings are minimised, again using the NMSS
(implemented by MATLAB’s fminsearch) to establish the location of conduction gaps
which result in the most accurate activation time curve. Here it is important to note we
do not claim to have found the location of the conduction gap(s) via this fit, only that
we have calibrated model parameters that most closely recreate the phenomenology of
the waveforms from the recording catheter.
4.2.4 Reconstruction of Missing Channels
In the cases for which there is poor contact between recording catheter and tissue, the
signal is typically flat or white noise. This is evident, for example, in channels PV 3-4,
17-18 and 19-20 in Figure 4.1. To reconstruct missing electrode recordings, a partial
relative activation time curve was obtained from the active channels. Model parameters
of the overall pulmonary vein model were calibrated from the active channels, using the
NMSS (implemented by MATLAB’s fminsearch).
4.2.5 Clinical Data
Pulmonary vein recordings used in this chapter were obtained from adult male and female
subjects undergoing pulmonary vein isolation therapy at Bristol Heart Institute. Bipolar
recordings were obtained from a deflectable, circular, 20-pole Lasso catheter (Biosense
Webster Ltd). Patients with both paroxysmal and persistent atrial fibrillation were in-
cluded but all cases were paced into normal sinus rhythm by pacing at 600 ms intervals, as
per standard clinical practice. All data were appropriately anonymised prior to their use
in this study. Under United Kingdom law, patient data collected during normal clinical
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routine and anonymised before research use may be used for research without additional
consent.
4.3 Results
4.3.1 Model Simulations
Firstly, we explore dynamics of the model. The heat maps in Figure 4.4 show the intra-
cellular potential and an approximation of the surface potential from Equation (4.1) on
the pulmonary vein. The ablated lesion exists along the line y = ha, denoted on the y
axis label, with a small conduction gap which allows propagation of the action potential
towards the electrodes (illustrated by white circles). The boundaries on the top and bot-
tom of the grid are Neumann, while on the left and right periodic boundaries are used
such that the rectangular heat map represents a cylinder. This is more clearly shown
when the surface potential is used, as in panel b) of the figure, on which it is clear that
the left boundary matches up with the right boundary. The intracellular potential of this
simulation with the corresponding synthetic PV recordings is available as an animation
in https://www.youtube.com/watch?v=hoCOJ66BB0I.
As we are taking bipolar recordings, the spike on the simulated pulmonary vein record-
ing is influenced by but does not directly resemble the action potential morphology. In
Figure 4.5 we show one representative channel of the pulmonary vein recording. The
black signal is a channel simulated directly from the intracellular potential, i.e., simply
subtracting one action potential from another. The red line is the voltage trace resulting
from applying equation (4.2).
When the cell at the first node experiences an action potential, the second node is
still at the resting potential due to the high value of dV/dt following the stimulus. As the
action potential has a sharp upstroke and a slow recovery to the resting potential, when
the second cell fires and reaches its maximum, the first one is still in the plateau phase,
causing a return to the baseline when the difference is calculated from the intracellular
potentials. Any subsequent activity is small oscillations resulting from both cells return-
ing to the resting potential. As the surface approximation takes a greater area of the
domain into account, the difference in maximal dV/dt between activation and recovery
is much smaller, resulting in a biphasic spike pattern which more closely resembles the
morphology recorded in clinic (blue line).
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(a) Intracellular potential as wavefront passes through conduction gap
(b) Approximation of the surface potential
Figure 4.4: Simulation of Pulmonary Vein Electrophysiology. Heat maps of the
intracellular potential (a) and an approximation of the surface potential (b) as a cardiac
wavefront passes through a conduction gap on a cylinder at the same point in time with
the same parameters. The electrodes are illustrated by white circles, with ha and hr
noted on the y axes. Red corresponds to regions of high voltage, and blue corresponds to
regions of low voltage. The surface potential is more symmetrical about the wavefront.
4.3.2 Fitting Model to Data
Next, we consider how well the model can reproduce the phenomenology of the pulmonary
vein recordings when all 10 channels are active. To consider this, we use an exemplary set
of clinical pulmonary vein recordings collected during pulmonary vein isolation therapy
(as described in the methods). The goodness of fit between clinical recordings and model
simulations is determined by minimising the root mean squared error between the relative
activation times of the model and the data. This is achieved by varying the positions of
conduction gaps in the model. The average of ten recorded events in the data is used to
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Figure 4.5: Bipolar Intracardiac Signals. Voltage traces of bipolar recordings from the
data (in blue) from calculating differences between intracellular potentials (in black) and
from applying the surface potential approximation before calculating potential difference
(in red). Using the surface potential approximation gives a much better representation of
the biphasic spike seen in clinic. Time has been rescaled to easier compare morphologies.
form the target relative activation time curve. This ensures some robustness to variation
in the data and enables us to estimate the conduction gap location and width as param-
eters, which should be constant until ablated.
(a) Relative Activation Time Curves (b) Model and Clinical Pulmonary Vein Data
Figure 4.6: Parameter Fitting and Comparison with Clinical Recordings. a)
Presenting the relative activation time curves for the clinical data [presented in full in
panel 4b)] (black), the model assuming isotropic diffusion (blue) and the model assuming
anisotropic diffusion (red). Parameters of the model were calibrated by minimising the
root mean squared error between clinical recording and the model using the Nelder-Mead
method. b) Presenting an exemplar of clinical pulmonary vein recordings collected during
pulmonary vein isolation therapy at the Bristol Heart Institute (black). Overlaid are the
model simulations, with parameters calibrated as described in 4a), under the assumption
of isotropic diffusion (blue) and isotropic diffusion (red) respectively.
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For the chosen clinical data, and for parameter choices of the underlying BOCF model
as in Table 1, we find that the root mean squared error between the relative activation
time curve of the clinical data and that of the model (assuming isotropic diffusion) is
minimised by placing conduction gaps centred on points x = 65.5 and x = 167, with
widths 11 and 6 respectively. Both the number of minima and their locations are used
to optimise position and width of the conduction gaps. This is important since both the
number of minima and their locations within the relative activation time curve emerge
as a result of the conduction gaps generating the signal. In current clinical practice, the
earliest activation time(s) (e.g. the minima of the relative activation curve), are the most
important, as these are assumed to be closest to the conduction gap and therefore the
optimal ablation site. This is illustrated in Figure 4.6a, where we also present a model
fit under the assumption of anisotropic diffusion. In this case the conduction gaps are
centred on points x = 59.5 and x = 164.5, with width 11 and 13 respectively.
In Figure 4.6b, we present a comparison between the original choice of clinical pul-
monary vein recordings and simulations for the two classes of model. Time units of the
model are rescaled such that the relative activation time-scale of the model is equivalent
to that of the clinical recordings, which permits a clearer visual comparison. Note that
both classes of model result in visually similar simulated pulmonary vein recordings. We
perform a more rigorous analysis of differences between anisotropic and isotropic diffu-
sion later when considering the ability of the model to reconstruct missing channels in
the clinical data.
Next, we tested the capacity of the model to predict future ectopic events, given an
average over an initial ten events. For the identified choice of model parameters from the
initial ten events, we simulated a series of additional ectopic events and for each event we
calculated the root mean squared error between relative activation time curves obtained
from either simulated or clinical ectopic events. We define t0 as the time of the last event
in the training set, and tN as the time of the N
th subsequent ectopic event. Figure 4.7
shows how this error scales as the number N of the ectopic event moves further away
from the training set. The apparent periodicity in the error is most likely due to rhythmic
movements of the patient, such as breathing.
4.3.3 Reconstructing Missing Channels
We now focus on the capacity of the model to reconstruct missing channels, exemplars
of which were shown in Figure 4.1. This is a key result of this chapter and the one with
most relevance to a potential clinical decision support system. To test the accuracy of the
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Figure 4.7: Increase of Error with Prediction Horizon. Illustrating how the root
mean squared error in the activation time curve scales as the number of the ectopic event
N increases away from the initial ten ectopic events used to calibrate model parameters.
The line of best fit is displayed in blue. The periodicity in the error is likely due to
rhythmic movements of the patient, such as breathing.
model, we start with a clinical recording for which all channels are active. We then elimi-
nated a subset n (n = 0 to 5) of the channels replacing them with a zero time trace. Five
was chosen as the upper limit since clinically a recording with less than half the channels
active would not be relied on for determining the site of ablation. We then estimated
model parameters using the same approach as in the previous section, but only data from
those channels that were active. Using these parameters we then contrasted the error
between the relative activation time curves obtained from the simulated next ectopic
event and the subsequent ectopic event from the original clinical recording (including all
channels). This enables us to assess how well the model can reproduce clinically relevant
information (since the relative activation time curve is used for determining the site of
ablation).
Figure 4.8 shows a box plot for each value of n. Each box in the box plot represents
the root mean squared error between the relative activation time curves obtained from
the average across 20 model simulations (with anisotropic diffusion and without) and that
obtained from a clinically recorded ectopic event. The case n = 0 enables us to consider
the limit of the goodness of fit between the model and the clinical data. This is effectively
the intrinsic error attributable to the choice of model. For subsequent plots, n random
channels were removed from the training set (simulating the effect of lost information
due to poor contact). Different time intervals and different signals were used for each
calculation so that the error distribution presented is as close as possible to the errors
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Figure 4.8: Error vs Number of Reconstructed Channels. Box plot illustrating how
increasing the number of missing channels influences the minimised root mean squared
error between the relative activation time curves obtained from the model (assuming
both anisotropic diffusion (red) and isotropic diffusion (blue)) and the original clinical
recording. For each case, 20 simulations for up to 20 random choices of channels to
be reconstructed were performed. (+) symbols denote outliers in the 1% tail of the
error distributions. The case of 0 reconstructed channels enables a comparison of the
limit of the goodness of fit between models and the clinical data. We see that for 3 or
fewer channels being reconstructed, uncertainty is predominantly due to model choice
rather than the number of reconstructed channels, as we see no significant change in
the mean error between model and clinical data. We use an unequal variances t-test to
determine whether the errors came from a distribution with equal mean and find that
with the exception of 3 channels reconstructed there is no significant difference in the
errors between models.
that we might expect to observe in clinic. This is important as it minimises the likeli-
hood of observations simply being due to an artefact of the ectopic event chosen for the fit.
For up to 3 channels reconstructed, the median and maximum errors do not signif-
icantly increase over that of the control whether or not anisotropy is considered. This
is an important result as it demonstrates reconstructing up to three missing channels
is not a significant source of additional error and therefore the model as presented may
ultimately have clinical use under these conditions. Removing more than 3 channels leads
to information loss resulting in outliers with statistically significant errors (see the cases
for 4 and 5 channels removed). This demonstrates the limit of the number of missing
channels that the considered models can reliably reconstruct.
To consider the whether the assumption of anisotropic diffusion is significant, we
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performed an unequal variances t-test (so-called Welch’s t-test) to test whether the errors
from each model could have come from a distribution with the same mean. This test
consistently showed no significant difference (p > 0.05), except for the case of 3 signals
reconstructed (p = 0.0414). This suggests that whilst anisotropy is clearly important in
terms of the underlying physiology, it does not significantly affect the quality of model
fit to the phenomenology of the recorded signals. This is an important consideration
as calibration of model parameters is more efficient under the assumption of isotropic
diffusion.
4.3.4 Potential Clinical Application
To test the potential of this technique to aid the clinical procedure, we presented a
cardiologist specialising in pulmonary vein isolation therapy, with three variations of
clinical recordings collected from three patients:
1. the original clinical recordings with all channels active;
2. the original clinical recordings with key channels identifying the earliest activation
hidden;
3. a hybrid whereby we reconstruct channels (removed in scenario 2) using the math-
ematical model and present these alongside the remaining active channels.
These scenarios are illustrated in Figure 4.9. The cardiologist was unaware of the
origin of each recording, and to avoid bias, the recordings were supplied in a random
order. The following results were obtained (summarised in Table 4.2 for convenience).
For patient 1, given the original data, the first point of ablation would have been around
PV 5-6, with PV 15-16 noted as a second choice. With channels 15-16, 17-18, and 19-20
removed, only PV 5-6 was identified as the only appropriate ablation zone. When these
channels were reconstructed by the model, PV 17-18 was identified as the second choice
of ablation target. For this patient, the model has helped to identify a second relevant
ablation target that was not identified when channels were missing. If initial ablation is
not successful, the cardiologist will ablate in the area surrounding the target area, hence
an initial estimate closer to the optimal location will result in successful isolation using
fewer radiofrequency pulses. This will result in a smaller region of tissue being ablated
and a shorter procedure.
In the second patient presented, a clear earliest spike time was present on PV 5-6.
The removal of PV 5-6 and its neighbours led to PV 9-10 being identified as an ablation
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Patient Missing Reconstructed Original
1 PV 5-6 PV 5-6 / 17-18 PV 5-6 / 15-16
2 PV 9-10 PV 5-6 PV 5-6
3 PV 3-4 PV 9-10 PV 7-8
Table 4.2: Effect of Signal Reconstruction on Clinical Decision. The channel
corresponding to the area the cardiologist would ablate given the recording with channels
missing, the original data, and the data with the missing channels reconstructed via the
model. The decision made with the reconstructed signals is closer to the original than the
decision made using the missing recordings, demonstrating that the model reconstruction
has minimised the impact of the information loss on the clinical outcome. Recordings
from Patient 1 are given in Figure 4.9.
target. In this case, the reconstruction led to the same zone being targeted as the origi-
nal signal, while the estimation with the recordings missing was two channels away. For
this patient, reconstruction of the missing recordings led the cardiologist directly to the
optimal decision.
In the final patient, the earliest spike, on PV 7-8, was removed, along with PV 5-6
and 9-10. As previously, these missing channels shifted the chosen ablation target by 2
channels. The reconstructed signal led to a target selected which was closer to the target
chosen with all information present. As with patient 1, we infer this result as satisfactory,
as starting closer to the optimal target will lead to quicker isolation of the pulmonary vein.
In all three cases, the missing channels influenced the decision made by the cardiolo-
gist, demonstrating the potential impact of information loss in clinic. However, when the
cardiologist used the recordings combined with the signals reconstructed by the math-
ematical model to make a decision, the decision made was closer to the decision that
would have been made had all information been present. Whilst these results provide
only limited proof of concept at this stage, assuming the original data and clinical deci-
sion to represent the “ground truth”, then we believe there is significant potential for our
approach to minimise the effect of this lost information.
4.4 Discussion
In this chapter, we have demonstrated that key features of pulmonary vein recordings
can be generated by a phenomenological model, in this case, the BOCF model. Cali-
brating parameters of the BOCF model using the post fibrillation AP of atrial myocytes,
simulated using the biophysical Courtemanche model, provides a method for rapid simu-
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(a) Pulmonary Vein Recording with Channels
Removed
(b) Pulmonary Vein Recording with Original
Channels
(c) Pulmonary Vein Recording with Recon-
structed Channels
Figure 4.9: Illustrating the model reconstruction of pulmonary vein recordings.
In panel a) we present the original recording with three removed channels. In panel
b) the original recordings, and in panel c) the original recordings combined with the
reconstructed channels using the mathematical model. We presented these data to the
cardiologist who made a decision about the tissue underlying the channels they would
ablate in each case. This process was repeated for patients 2 and 3. In all three cases
reconstruction of the missing signals resulted in an improved clinical decision in contrast
to only using the recordings with missing signals.
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lation of atrial cells aﬄicted by AF-induced electrical remodelling. This is in contrast to
more detailed biophysical models [4, 123, 130, 149, 150] which may take several hours to
produce an output. Given that pulmonary vein isolation therapy typically lasts at most
two hours, having a mathematical model that can run in close to real time, is a critical
advantage when assessing suitability as a potential clinical decision support system.
Towards this aim, a primary result of this study was to model the phenomenology
of recordings from the lasso catheter used during the pulmonary vein isolation therapy
of AF. We found that the resulting model simulations accurately reproduce the relative
activation time curve seen in recordings from patients undergoing this procedure. The
pulmonary vein recordings made in this process are not always complete; there is often
the complete loss of some of the recording channels. This is most commonly due to poor
contact made between electrodes on the catheter and the pulmonary vein itself. This
loss of information can result in non-optimal clinical decision making during the isola-
tion therapy procedure. To address this issue we have demonstrated that a mathematical
model fitted to the available channels of the data can be used to reconstruct those missing
channels and we presented evidence in support of the accuracy of these reconstructions
through comparison to clinical data.
Of note, we find that up to three channels can be reconstructed without significantly
increases the inherent error due to the use of a model. The results show that, in principle,
these ideas could be adapted as part of a clinical decision support system, which could
be run in the operating theatre and provide information to the cardiologist during the
procedure.
A potential limitation of this study is the loss of biological detail arising from our use
of a phenomenological model over a biophysical one. However, it is important to note
that the appropriateness of any mathematical model is dependent on the challenge it is
designed to address. Here, we focus on the case of pulmonary vein isolation therapy,
where a cardiologist is using recordings of the emergent electrical signal from the heart
to make rapid decisions about regions of the heart to ablate. Consequently, a model that
can capture the phenomenology of these recordings (which ultimately are what the car-
diologist is using to guide their decision making) is a valid approach and does not require
a detailed analysis of the contribution of ionic channels and other physical quantities
involved in AP propagation.
In our current model, a number of assumptions have been made, most importantly
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regarding the conductance and the geometry. Whilst we account for anisotropic diffusion
by considering additional parameters, the diffusion tensor used is still homogeneous across
the conductive tissue, and the wave approaching the conduction gap is planar. This is
primarily since detailed fibre direction information would not be accessible to the cardi-
ologist during the clinical procedure. A further key assumption is the approximation of
the pulmonary vein sleeve as a cylinder. In the clinical procedure, the relevant region of
cardiac tissue is not only the pulmonary vein sleeve but also the atrial tissue surrounding
the ostium. However, while tissue expansion and asymmetry of an anatomically accurate
domain may affect the results for a given set of parameters, the signal reconstruction
technique incorporates the fitting of the parameters to the available signals, which will
account for the impact of these assumptions. Further geometrical assumptions, such as
the angles between the incoming wave, the ablation line and the recording catheter, can
not be quantified using standard clinical equipment and so we do not consider them in
the current study. We also assume that all cells are free atrial wall myocytes, rather than
pulmonary vein myocytes which have a shorter AP duration and amplitude in addition to
a lower upstroke velocity in comparison to the left atrium [178]. However, under current
clinical practice, it is not possible to identify which areas of the pulmonary vein ostium
is populated by pulmonary vein myocytes as opposed to those of the atrial wall.
While the model developed in this chapter has been developed with clinical appli-
cability in mind, future work will be necessary to establish the ultimate validity of and
optimise this approach in a clinical context. In particular, it is important to establish
the optimal level of detail of model required to reconstruct missing signals, and whether
additional detail can improve the accuracy of the methods, given the constraints of time
and recording protocols in standard clinical practice. Further, clinical metadata regard-
ing the locations and times at which ablation was performed on the patient is typically
not collected during the ablation procedure, so it is difficult to infer the optimal abla-
tion zone from patient data. The availability of such data would open up many new
lines of research, including the use of either phenomenological or biophysically detailed
patient-specific models to estimate the optimal ablation site directly.
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Chapter 5
A Data-Driven Approach to Signal
Reconstruction
5.1 Introduction
5.1.1 Background
Previous work in this thesis has been focused on the modelling of cardiac tissue by focus-
ing on the electrophysiology, specifically the AP, and how it propagates through tissue.
This process has facilitated the modelling of clinical signals recorded by the lasso catheter
during treatment of radiofrequency ablation. However, for this problem, the most impor-
tant quantity which we are trying to model is the activation times across the channels in
the recording. Clinically, the morphology of the emerging spike is of much lesser concern
than its activation time. In this chapter, we explore methods by which the activation
time across the recording catheter may be approximated without recourse to models of
cell dynamics.
The primary advantage of such a technique would be the significant reduction in
computation time. Even the simplest AP models require the solution of a reaction-
diffusion PDE, which can be computationally intensive on a large grid with a small time
step, especially so when parameters of the PDE must be calibrated. This would lead
to a decrease in computation time (especially so when parameters must be calibrated,
requiring multiple runs of the PDE). The trade off is the significant loss of biological
feasibility and detail. Without a realistic mechanism generating any synthetic data,
the scope of questions that can be interrogated using the model is much smaller. In this
section, we briefly review the existing model-free approaches, then develop extensions and
methodologies by which these could be applied to address the problem described in the
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previous chapter: the reconstruction of missing channels on pulmonary vein recordings.
5.1.2 Review of Existing Methods
Path-Finding Methods
One way to quantify AP propagation without modelling the AP itself is to use graph-
based path-finding methods. Path finding methods rely on the fact that the cardiac AP
is transferred only by gap junctions (short range connections), and therefore the time
taken for an AP to propagate from one point to another is closely related to the shortest
distance between the two points across the tissue surface.
The standard algorithm to find the shortest distance between two points on a weighted
graph is Dijkstra’s Algorithm, proposed by Dijkstra in 1959 [179]. Dijkstra’s algorithm
uses an iterative procedure, starting from the start node, ns, and working towards the
goal node, ng. We define a set ‘closed’ as the set of nodes that have been ‘visited’ by the
algorithm, and a set of tentative distances T , which are originally 0 for n = ns and ∞
for all other nodes. For each step in the algorithm:
1. The unvisited node n with the shortest tentative distance g(n) is visited
2. The tentative distance of all neighbouring nodes ni not in the visited set is updated
to min{g(ni), g(n) + e(n, ni)} where e(n, ni) is the weight of the edge from n to ni
3. n is added to the set ‘closed’ and the tentative distance is the shortest path from
ns to n. The algorithm terminates when ng ∈ closed
Such algorithms were investigated in the context of cardiology by Wallman in [180],
in which a development of Dijkstra’s algorithm, known as the A* (A Star) algorithm, was
used to estimate the arrival time of a propagating cardiac wavefront on a 3D mesh by
calculating the shortest path across the tissue. Dijkstra’s original algorithm will always
find the shortest path on any weighted network. The A* algorithm uses a heuristic h(n)
which provides an estimate of the distance of the optimal path from n to ng [181]. When
calculating a path through physical space, the heuristic is the Euclidean distance to ng.
Step 1 is modified so that the visited node is the one with the minimum g(n) + h(n).
This modification reduces the number of nodes visited on the way to ng, although it is
possible for the A* Algorithm to fail to find the optimal path if the Euclidean distance
from node n to ng is not a good estimation of the path length. This can happen if, for
example, there is a region of very costly paths between node n and ng, such that a longer
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Figure 5.1: Pathfinding on the Pulmonary Vein. Shortest paths are shown from
Dijkstra’s Algorithm (green) and the A* Algorithm (blue) across a pulmonary vein. The
blue path is mostly hidden behind the green path. The small discrepancy occurs when
both algorithms take a different route around a parallelogram in the mesh and have
identical path lengths.
path around this region is actually quicker.
We performed this method using the PV mesh recorded by the University Hospital of
Bordeaux to find the shortest distance from one point to another (Figure 5.1). The cost
along each path was assumed to be the Euclidean distance between the two points. As
such, the Euclidean distance is a good heuristic and the A* Algorithm will find the short-
est path. A line around the join between the PV and the atrium was drawn to represent
an ablated lesion. All edges on the faces touching the vertices on this line were set to be
of infinite length so that the path cannot pass through it. A gap was left to represent a
partially complete lesion. The paths taken from both algorithms were identical lengths,
with the only difference being that the A* Algorithm chose a different path around a
parallelogram in the mesh.
Figure 5.2 compares the computational efficiency of the two algorithms by calculating
the shortest path across a straight but long section of the PV. Both algorithms computed
identical shortest paths. However, 3512 vertices were visited by the A* Algorithm, while
Dijkstra’s Algorithm visited 20833 vertices, representing a significant decrease in compu-
tation time by using A*.
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A limitation of this technique is the requirement of high-resolution heart scans, cou-
pled with the locations of the electrodes in the catheter. In the model previously de-
scribed, it was simple to place electrodes at equal points at a certain distance from the
lesion. Any estimation of activation time patterns across a catheter using path-finding
methods would be critically dependant on where we choose to draw the lesion, which num-
ber electrodes are on which side of the PV, and how we choose to orient the recording
catheter.
(a) Nodes visited by the A* Algorithm (b) Nodes visited by Dijkstra’s Algorithm
Figure 5.2: Visited Nodes from A* and Dijkstra’s Algorithm. The optimal path
(green) is identical for both the A* Algorithm (a) and Dijkstra’s (b). However, the
number of nodes visited by the A* Algorithm is signficantly smaller. The points marked
in blue are the points visited by the algorithm, and is representative of the computation
time reduction.
Weber’s Sine Wave Model
An alternate ‘model’ proposed to represent the recording pattern across a circular catheter
is a simple sine wave. [77, 182]. Although these studies were performed not with the
recording catheter around the PV ostium (as it is in CPVI therapy) but on a flat wall
of the atrium, the activation pattern across the catheter was modelled by fitting a sine
wave to the activation times using the equation
t(n) = tc − A · cos [φ(n)− φ0] (5.1)
where t(n) are the activation times and φ(n) is the angle of the electrode on the
catheter.
These studies were performed with clinical applications in mind. In [182], using the
orientation of the catheter and the shape of the sine function, CV (calculated by sine
wave amplitude) and direction of the wavefront (calculated by where the minima and
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maxima are) were calculated accurately. The latter is especially relevant to our goals, as
this was tested in clinic by pacing the atrium from the pulmonary veins. Fitting a sine
wave facilitated the estimation of which PV was initiating the ectopic bursts, which would
help a clinician know which vein to focus on. In [77], the technique was extended to esti-
mate CV restitution, by pacing the atrium at different frequencies and measuring the CV.
Using a sine wave is a convenient and extremely efficient way of quantifying the activa-
tion pattern on the lasso catheter. However, as presented, the technique is too simple to
model some of the issues faced in clinic during CPVI. For instance, the sine wave has been
chosen with a period equal to the distance around the vein, meaning that each wavefront
is modelled by one and only one full revolution. This is true for large wavefronts across
the atrial surface, but not true if the recording catheter is placed around the pulmonary
vein ostium, as two conduction gaps.
In this chapter, we investigate ways in which Weber’s approach can be developed in
a manner that can be applied to guiding a clinician during CPVI, which can be com-
pared against the model previously described. We describe developments of the method
to more accurately model the complexities occurring from recording around the PV os-
tium, and present results obtained from fitting to clinical data. From there, we describe
methods by which synthetic pulmonary vein recordings could be developed to replace
missing signals as previously described. As the techniques described in this chapter do
not rely on a differential equation, parameter calibration and computation time are faster.
To put the time scales in context, computation one time step of one node of the BOCF
model is approximately equal to 3 of the sine wave. With a spatial resolution ∆x = 0.2
mm, we have 15,000 nodes to perform this computation, and at a temporal resolution
of 0.01 ms, 60,000 time steps to simulate 600 ms of data. The ratio in computation
times for the PV model to the Extended Sine Model is 2.7× 109 : 1. The PV model has
4 parameters to calibrate to data compared to 5 from the Extended Sine Model. This
reduction in dimensionality reduces the ratio in effective computation time in clinic to
approximately 3.5× 108 : 1, although this is of course dependent on the efficiency of the
code.
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5.2 Methods
5.2.1 Extended Sine Model
As in the previously discussed work, we use a sine function to model the activation across
electrodes. However, we can exert a greater control of this function than has previously
been explored by Equation (5.1). We introduce two new parameters:
1. ω - a parameter to control the frequency of the sine wave.
2. m - a parameter that permits a linear trend in the sine wave.
ω is an important consideration for the application, as this removes the assumption
that the catheter contains only one cycle of the sine wave. This is important as there
may be multiple conduction gaps in the ablated lesion, or a coiling of the lasso catheter,
causing multiple minima to appear in the activation time curve. The linear term allows
greater control of the curve. Without this term, both minima would occur at the same
point in time, which is not usually the case, as the wavefront can pass through both
conduction gaps at different times, or at different speeds (a smaller gap slowing propa-
gation down greater than a larger one). We define x to be on the half-integers between
the electrode numbers, for example, the channel PV 3-4, corresponding to the difference
between electrodes 3 and 4, is represented on the x axis by x = 3.5. Our model, the
Extended Sine Model, for the activation pattern is then:
y = A sin (ω(x− τ)) +mx+ c. (5.2)
This equation can be used in the same way as Equation (5.1) for estimating the CV
from the parameter A. As the x axis is representative of the electrode number and not
physical space, the value of ω will depend on the number of electrodes on the catheter.
x = 0.5 and x = n + 0.5 both correspond to the midpoint of the first and last channel.
Therefore the model is defined on the interval x ∈ [0.5, n+ 0.5].
5.2.2 Reconstruction of Missing Signals
Equation (5.2) provides a quick and simple way of modelling the activation pattern across
the catheter. It does not, however, contain a model for the morphology of the spike, and
so simply calibrating the parameters to match the data does not immediately give us a
method of producing a synthetic pulmonary vein recording in a situation where signals
are missing. In this chapter, realistic synthetic spikes are generated by using the spikes
of the channels on the catheter which are functioning correctly. This ensures a spike
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morphology consistent with the other spikes on the catheter.
If some channel n is inactive, we can estimate the activation time by calibrating the
Extended Sine Model to the others. Synthetic spikes can be generated by calculating a
superposition of the neighbours of the series of inactive channels. As we are only con-
cerned with generating one activation spike, copies of these signals are made, shifted so
that they have the same activation time. The superposition of these two waves can be
used to generate a synthetic spike. This can then be shifted such that the activation time
is the same as the model predicts it should be.
If multiple consecutive channels are inactive, as is often the case in clinic, we use a
weighted amplitude superposition of the neighbours of the inactive signals. For example,
if PV 11-12 and PV 13-14 are both inactive, PV 11-12 is calculated by (2× PV9− 10 +
PV15− 16)/3. This assumes that the wave morphology varies uniformly across the active
channels.
5.2.3 Signal Processing
As in the previous section in which a reaction-diffusion equation was used to model PV
recordings, clinical data from Bristol Heart Institute was used to validate model results.
This data was collected according to the methods described in chapter 4.
In this chapter, we quantify the activation time using an adaptation of the methods
described in [182]. Firstly, as cardiac electrograms are extremely noisy, each signal in
the electrogram is denoised. We implement a wavelet-based denoising algorithm [183]
as implemented by MATLAB’s ‘wden’ function. Wavelet denoising is preferred over
Fourier Transform-based methods as they preserve sharp features in the data and can
maintain a fine resolution in both frequency and in time.
A wavelet is an oscillation with a well defined amplitude which starts and returns
to zero at the end of the oscillation. The Wavelet Transform of a signal x(t) is defined
as a function of a scale parameter s corresponding to the frequency and a translation
parameter τ describing the translation of the wavelet through the signal by
X(s, τ) =
1√
s
∫ ∞
−∞
x(t)ϕ
(
t− τ
s
)
dt. (5.3)
The function ϕ(t) is the mother wavelet a basis function used to generate wavelets by
translation by τ and scaling by s. While a Fourier Transform uses a basis function eiωt,
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Figure 5.3: A plot of the Symlet 4 Wavelet Scaling Function. A plot of the
function ϕ(t) used in the Wavelet Transform in Equation (5.3). The scale on the t axis
is irrelevant as the function is always scaled by a factor of s and translated by τ .
there are many different options for ϕ(t), a comprehensive review can be found in [184].
Most common for denoising are the Daubechies Wavelets, introduced in [185], which have
no closed-form solution but are calculated from the cascade algorithm [186]. The Symlet
Wavelets are a modification on Daubechies with greater symmetry [187], and have been
applied in a number of different fields for the purposes of denoising [188, 189]. A plot of
the sym4 wavelet is given in Figure 5.3. The Wavelet Transform X(s, τ) is then thresh-
olded and inverted to provide a denoised signal.
We then apply a Nonlinear Energy Operator (NLEO) to the filtered signal. The NLEO
was originally designed for speech recognition applications [190],[191], and attempts to
quantify the ‘energy’ E of a discrete signal x by the transformation
En = x
2
n − xn−1 · xn+1. (5.4)
The algorithm has more recently been used to quantify the level of activity in a noisy
cardiac signal [192, 193]. The energy function E produces a sharp positive spike for
epochs with a high positive second derivative and negative values of x, and epochs with
a high negative second derivative and positive values of x. This indifference to sign is
important for bipolar recordings, as both peaks of a biphasic spike will have positive
energy.
As bipolar electrograms typically produce a biphasic spike, the resulting energy from
the NLEO will often have two positive spikes (one for the up spike and one for the down
spike). We apply a Gaussian Filter with a window width of 30 time points to the energy
to find the maximum across multiple spikes [194]. The Gaussian Filter is a smoothing
transformation with a number of applications, most notably used by the blur function of
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(a) Raw Signal (b) Denoised Signal
(c) Signal Energy (d) Filtered Energy
Figure 5.4: Signal processing of a noisy PV recording. The raw signal (a) is
denoised using a Wavelet Transform of the type in Equation (5.3) to produce (b). Using
the nonlinear energy operator (5.4) the ‘energy’ of the signal is computed (c). This is
passed through a Gaussian Filter (5.5) to produce a smoothed energy function (d).
(a) Original Signals (b) Activation Time Curve
Figure 5.5: PV Signals and Activation Time Curve. (a) A PV recording with all
channels correctly spiking. PV 5-6 in this signal is the example signal used in Figure 5.4
to describe the signal processing algorithms. (b) The activation time curve calculated
from applying the described algorithms on all 10 channels.
Photoshop. A window of a discrete size (in our case 30) is generated by the function
w(n) = e(−n
2/2σ2) (5.5)
where σ is the standard deviation of the Gaussian Function (0.4 for a standard Gaus-
sian Filter). The function w(n) then acts as coefficients of a moving average filter which
passes through the signal. After the resulting filtered energy is shifted backwards by half
the width of the window, the maximum of the smoothed energy function is inferred to
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be the activation time of the signal. The whole process is given in Figure 5.4, and the
application (the computation of an activation time curve) is given in Figure 5.5.
5.3 Results
5.3.1 Quality of Fit
Firstly, as in chapter 4, we investigate the capacity of the model to reproduce the phe-
nomenology of the activation pattern across the recording catheter in an ideal setting.
We quantify the goodness of fit by evaluating Equation (5.2) on values of x corresponding
to the electrode numbers in the catheter, as defined in the methods. As all data used in
this thesis is recorded on a 20 electrode catheter, x is defined on 1.5+2n where n = 0 to 9.
Figure 5.6 shows the result of fitting Equation (5.2) to the activation time curve of
the exemplary pulmonary vein recording in Figure 5.5. We plot only the activation time
curves as this model does not produce a time trace of the electrical signal to compare
with the data. However, as the model is simply a continuous sine function, we can plot
the relative activation time curve as an actual continuous curve. There is no need to
normalise the activation time curve in this case, as Equation (5.2) has a parameter A
to control the amplitude and c to control the y-intercept. For the data presented in
Figure 5.6, optimised parameters were as follows: A = −11.93, ω = 0.5763, τ = 3.712,
m = −0.0341, and c = 145.
While Weber’s original paper used the parameter A to infer CV, this was performed
with recordings on the atrial wall. In our case, in the pulmonary vein, the excitation
wave does not pass across the middle of catheter (as this corresponds to the middle of
the PV, where there is no tissue). Either a high CV or a low curvature would result
in all electrodes activating closer together and lower the parameter A. As a result, due
to tissue topology, we cannot infer conduction velocity. ω = 0.5763 implies a sinusoidal
period of 10.90, which corresponds to 1.83 complete cycles around the catheter, caused by
the presence of 2 distinct conduction gaps. m = −0.0341 adds a slight negative gradient
to the sine wave, causing one minimum to occur at an earlier time than the other, repro-
ducing the known effect of cardiac wavefronts passing through a wide gap faster than a
narrow one. The parameters τ and c simply change the initial phase of the sine term and
the time since the recording began, neither of which have any relevance to the physiology.
Secondly, we demonstrate the importance of the additional terms introduced in Equa-
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Figure 5.6: Comparison of Extended Sine Model and Data. Presenting a compar-
ison of the Extended Sine Model for the activation times on a lasso catheter (blue curve)
with recorded data from a patient collected during pulmonary vein isolation therapy at
Bristol Heart Institute (red stars).
Figure 5.7: Comparison of Errors in Sine Model and Extended Sine Model.
Boxplots presenting a comparison of the simple model for the activation times on a
lasso catheter (blue curve) with recorded data from a patient collected during pulmonary
vein isolation therapy at Bristol Heart Institute (red stars). Extended Sine Model was
significantly better (p = 3× 10−11).
tion (5.2) by comparing the quality of fit with that of Weber’s original model (Equation
(5.1)) described in [182]. We used 10 different ectopic events across the same 3 patients
in the previous chapter and optimised both equations using the same genetic algorithm.
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The results are demonstrated in Figure 5.7. The Extended Sine Model obviously has a
significantly lower error (p = 3× 10−11 from a Mann-Whitney Test).
The large error in the original model is due to the parameter ω, which is not fixed in
our extended model. As the period in Weber’s model is constrained to the circumference
of the catheter, when applied to signals taken from within the PV, the frequency is often
wrong. Minimising the RMS error naturally weights the optimiser towards eliminating
the largest errors first. As a result, any parameter optimising scheme will avoid such
regions of parameter space, and return a curve with an extremely small amplitude. As
the model was designed to be used when the catheter is on the atrial wall, this evidence
is not criticism of the model itself, but merely shows that the extended model is needed
to model the catheter activation time when placed around the PV.
5.3.2 Reconstruction of Missing Channels
In this section, we present results from using the Extended Sine Model to reconstruct
channels lost in the operating theatre. Firstly, we present an example case of using the
Extended Sine Model to reconstruct recordings lost in clinic.
Figure 5.8: Example of Signal Reconstruction using Extended Sine Model. An
example of reconstructing missing signals on PV 5-6, 7-8 and 9-10. The original data
is shown in blue. The signals generated by the reconstruction algorithm driven by the
Extended Sine Model is overlaid in red.
Figure 5.8 shows an exemplary case. Signals PV 5-6, 7-8 and 9-10 were removed from
the recording prior to the optimisation of the Extended Sine Model. The activation times
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on the missing channels, important for clinical decision making, are well reproduced by
this technique. As the spikes on the reconstructed channels are formed by a weighted
average of the time traces on PV 3-4 and PV 11-12, the result is a realistic spike which
reflects the complexity of the spike on the recording. A realistic looking spike is poten-
tially important if the technique is to be used by a clinician to make decisions.
We numerically quantify the error in this procedure in the same way as in the previous
chapter: by taking a recording in which all channels are spiking cleanly and eliminating
a random subset during the fitting procedure. The results of this are displayed in Figure
5.9, in which each box plot corresponds to a different number of channels being removed
and reconstructed, and the y axis shows the RMS error in activation times across the
recording. As both are RMS Errors across all 10 channels, boxplot 0 is essentially the
same as shown for the Extended Model in Figure 5.7. This shows the error inherent in
the model, which is used as a control to test how much of the error is incurred from the
missing information.
Figure 5.9: Error vs Number of Reconstructed Channels. Box plot illustrating how
increasing the number of missing channels influences the minimised root mean squared
error between the relative activation time curves obtained from the Extended Sine Model
and the original clinical recording. For each case, 20 simulations for up to 20 random
choices of channels to be reconstructed were performed. (+) symbols denote outliers
in the 1% tail of the error distributions. The case of 0 reconstructed channels enables
a comparison of the limit of the goodness of fit between models and the clinical data.
For 2 or fewer channels, there is no statistically significant error incurred during the
reconstruction. For 3, the error increase is significant but of a small magnitude.
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Errors were compared using the Mann-Whitney Test. Reconstructing either 1 or 2
channels resulted in no statistically significant increase in error (p = 0.3632 and 0.2116
respectively). For 3 reconstructed channels, the upper quartiles of the errors are notably
higher, and the distribution is significantly higher than that of 0 reconstructed channels
to the 5% confidence interval (p = 0.0281). For 4 and 5 reconstructed channels, the errors
are significantly higher than that of 0 (p = 0.0014 and 1.2493× 10−5 respectively).
These results suggest that we can reconstruct up to two missing signals using the
proposed technique without introducing additional error. In this results section, we do
not perform the test on how this influences the clinical decision, instead this is explained
in the following chapter on a much larger dataset, allowing for statistical comparisons to
be made between the Extended Sine Model and the PV Model.
5.4 Discussion
In this chapter we have developed an extended version of an existing model for the ac-
tivation times on the lasso catheter used during AF ablation. The original model was
proposed to infer propagation direction and conduction velocity in the atrium by placing
the catheter against the atrial wall. Such a model provides an advantage of several orders
of magnitude in terms of computation time over the reaction-diffusion model presented
in the previous chapter.
However, the model does not reproduce the activation times on the catheter when it
is placed around the ostium of the pulmonary vein. Our extension of the model added
two extra parameters that allow for the model to reproduce the activation patterns seen
on the catheter on this topologically different surface with more complex wavefront cur-
vature due to propagation through the conduction gap.
We demonstrated an algorithm that can use this model to reconstruct a missing signal
by using the superposition of its neighbours. Up to 2 channels can be reconstructed with
no significant increase in error. 3 channels results in a significantly significant but small
in magnitude increase in error. It is unclear if this increase in error will compromise the
ability of the model to guide clinical decision making in situations where more than 3
channels are missing. For more than 3 channels, the error increases quite rapidly, espe-
cially at the higher tail of the distribution.
There are a number of limitations in the techniques proposed in this chapter, most
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notably from the extremely simplified model of the activation front. Unlike the PV Model
described in chapter 4, the Extended Sine Model is not based on any underlying biological
principles at all. While this approximation provides an improvement of several orders
of magnitude in terms of computation time by avoiding the need for solving a PDE nu-
merically, many assumptions are present. By the use of a sine wave, all minima will be
equally spaced apart, which may not be the case in all clinical recordings. While extra
parameters could help address this assumption, if too many parameters are introduced,
the model could become over-defined for the number of data points remaining, resulting
in an unreliable fitting process. Furthermore, the model is less adaptable to advances in
technology. With the PV Model, various factors such as fibre orientation, local inhomo-
geneities in CV and shape of the PV were not included because they are not recorded in
the standard clinical procedure, however, they could be in future work if this situation
changes. This is not possible with the simplicity of the Extended Sine Model in this
chapter, however, in its present form it may still be a viable alternative to reconstructing
inactive channels in clinic.
The viability of this model in the operating theatre as part of a therapeutic decision
support system during radiofrequency ablation will be investigated in the next chapter
alongside the PV Model by testing both techniques using a dataset of 27 patients. This
test will provide a level of statistical power which allows a rigorous comparison of the
PV Model and the Extended Sine Model for the purposes of minimising the impact
of information loss on clinical decision making. This will help ascertain whether the
computational efficiency of the Extended Sine Model justifies the extreme simplifications
of the physiology.
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Chapter 6
Trialling Prototype Decision
Support Tools
6.1 Introduction
In the previous chapters, we have presented two different methods for reconstructing
missing pulmonary vein recordings in clinic. In chapter 4 we presented a model driven
approach based on the underlying electrophysiology. In contrast, chapter 5 presented
a more data-driven approach that used an extended sine wave to model the activation
times and then generated an electrical signal using the average of the neighbours. These
methods were calibrated using pulmonary vein recordings from Bristol Heart Institute.
We demonstrated that it is possible to reconstruct pulmonary vein recordings that
have been lost to poor contact. In this chapter, using a much larger dataset from a
greater number of patients, we perform a more sophisticated statistical analysis of the
reconstruction methods.
Firstly, we compare how well the methods fit to clean data for which all spikes are
visible, simply to compare the accuracy of which the phenomenology on the lasso catheter
(specifically the activation times) is reproduced. The remainder of the chapter focuses
on the reconstruction problem.
Secondly, we perform statistical analysis on the error on the active channels com-
pared to the missing ones. If we find a strong correlation between the error on the active
channels and the missing ones, we can accurately predict to what level of accuracy our
reconstruction is valid, which is potentially valuable information if the reconstruction is
to be used to inform clinical decision making.
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Finally, explore both methods on this larger dataset. Where previously with n = 3
patients we could only look at the results case by case, with a larger dataset we can
employ more sophisticated statistical analysis to compare the decision making with the
removed and reconstructed data.
6.2 Methods
6.2.1 Mathematical Models
The mathematical models used to represent the phenomenology of the PV recordings are
the same as those discussed in the previous chapters. From here on ‘PV Model’ refers
to the work in chapter 4, in which a reaction diffusion equation solved on a cylindrical
domain was used to represent the wavefront propagating through an ablated lesion during
ablation. ‘Extended Sine Model’ refers to the extension of Weber’s Sine Model presented
in chapter 5, which reproduces the activation time pattern on the recording catheter
without modelling the underlying electrophysiology.
6.2.2 Data Collection
For comparison between the two models 27 PV recordings were collected from adult male
and female subjects with both paroxysmal and persistent atrial fibrillation undergoing
pulmonary vein isolation therapy at Bristol Heart Institute. Bipolar recordings were ob-
tained from a deflectable, circular, 20-pole Lasso catheter (Biosense Webster Ltd). These
signals were collected under the supervision of an experienced cardiac technician who
helped to identify the epochs of interest.
As in previous chapters, all data were appropriately anonymised prior to their use
in this study. Under United Kingdom law, patient data collected during normal clinical
routine and anonymised before research use may be used for research without additional
consent.
6.2.3 Assessing Influence on Decision Making
As previously, we tested the influence of the presented techniques on clinical decision-
making by presenting modified recordings for each of the 27 patients to a cardiologist
experienced in the procedure of CPVI and recording their choice of ablation target. Sig-
nals were presented as follows: A) the original signal, B) the signal with channels removed
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to simulate information loss, C) the removed channels reconstructed using the PV model
and D) the removed channels reconstructed using the extended sine model. The origi-
nal signals were presented to the cardiologist twice to examine inherent variation in the
decision-making process.
For case B, as some recordings contained a high level of noise during periods of inac-
tivity, replacing them with a zero time trace as in chapter 4 led to recordings that looked
very artificial, with the active channels keeping their residual noise and the inactive ones
modelled by perfectly flat line. We improved this aspect of the test by using a wavelet
denoising algorithm to ‘designal’ the time trace, such that the removed recording is left
with the same amplitude of noise that was in the original recording. This better simulates
the effect of lost information than a zero time trace.
The 135 recordings (5 cases from 27 patients) were presented to the cardiologist in a
random order. For some recordings, signals were inferred to be ‘far field’ signals by the
cardiologist, meaning the electrodes were picking up distant activity from elsewhere in
the heart. If the signal is truly far field, this would have been determined by the body
surface ECG spiking simultaneously with the PV recording. To avoid such technicalities
affecting results, we perform all statistical analyses on N = 23 patients.
Clinical decision making in each case was compared with the decision made with the
complete information. We quantify ‘error’ in terms of the number of channels the decision
made was away from the original decision. e.g. if channel PV 3-4 was identified as a target
on the original recording, and the neighbouring channel PV 5-6 was targeted with the
model, that corresponds to an error of 1. In rare instances the cardiologist identified two
neighbouring channels when the earliest activation time was unclear. In these cases, an
average point was used. If the modified signal was identified as far field, an error of 5
was recorded.
6.3 Results
6.3.1 Complete Data Fits
Firstly we investigate the capacity of both the PV Model and the Extended Sine Model
to reproduce the activity on the recording catheter in the ideal setting in which all 10
channels are active. Relative activation time curves in both models were normalised so
that the errors can be easily compared. We find a very similar error in both models. The
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mean error across all 23 patients were 0.1247 (SD = 0.0626) in the PV model and 0.1238
(SD = 0.0573) in the Extended Sine Model. Boxplots showing the distributions of the
errors in both models are displayed in Figure 6.1.
Figure 6.1: Boxplots of Error Distributions in PV Model and Extended Sine
Model. Boxplots showing the distribution of the root mean squared error in activation
times of pulmonary vein recordings from complete PV recordings from 23 different pa-
tients. There was no statistically significant difference in the error distributions of the
two models (p = 0.9515).
From the boxplots displayed it is clear that both models have a similar median in error.
To further explore the relationship between errors, Figure 6.2 displays each data displays
error in both models for a particular patient as a single data point. There was a strong
positive correlation between the errors in both models (r = 0.8314, p = 8.89 × 10−7).
Upper and lower bounds for r for a 95% confidence interval are [0.6378, 0.9262]. This
correlation implies that both models either fit or don’t fit equally well to the same patients.
As data is clearly paired (from the strong correlation) we use the Wilcoxon signed rank
test to determine if there is any statistically significant difference in the distributions. The
test returned a significance value of p = 0.9515, giving very strong evidence that there
is no statistically significant difference in the medians of the errors in both models. In
summary, there is very little difference in the quality of fit of either model to the relative
activation time curve of a complete PV recording.
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Figure 6.2: Scatterplot of Errors in PV Model against Extended Sine Model.
This scatteplot shows the error in both models for each patient in the study, with line of
best fit in blue. The strong positive correlation (r = 0.8314) shows that the errors are
similar in each model for each individual, not just across the entire group.
6.3.2 Signal Reconstruction
The previous section indicated that there was no statistically significant difference in the
quality of fit of either model when trained to complete signals. In this section we inves-
tigate the relative errors in the model when applied to reconstruct signals missing in the
operating theatre. For each of the 23 patients, 3 channels (those inferred to be the most
likely a clinician would first attempt to ablate) were removed from the recording. Both
models were trained using only the remaining 7 channels. Error was calculated across all
10 channels, giving the results displayed in the box plots in Figure 6.3.
The mean error in the PV model was 0.2158 (SD = 0.1133) and in the Extended Sine
Model was 0.1912 (SD = 0.1182). As previously, we used the Wilcoxon signed rank test
to test for any significant differences in the medians of both distributions. The Wilcoxon
signed rank test returned a significance value of p = 0.3615, implying no statistically
significant conclusions one way or the other. We repeated the computation using the
Mann-Whitney test (which does not rely on the data being paired) and arrived at a sim-
ilar conclusion (p = 0.2625).
We also calculate the correlation between the errors on the 7 visible channels and
the 10 in the complete recording. The relationship between these errors has the clinical
relevance of being able to predict how accurate the reconstruction will be. A strong cor-
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Figure 6.3: Boxplots of Error Distributions in PV Model and Extended Sine
Model. Boxplots showing the distribution of the root mean squared error in activation
times across PV recordings from 23 patients, with 3 channels reconstructed PV Model
and by the Extended Sine Model. There was no statistically significant difference in the
error distributions of the two models (p = 0.3615).
relation would imply that the quality of fit on the 7 active channels is a good predictor
of the quality of fit across the entire recording.
In Figure 6.4 we present scatterplots of the error on the visible channels against the
error across the whole recording for both the PV model and the Extended Sine Model.
A weak positive correlation is present in both plots, with r = 0.5115 (p = 0.0126) for
the PV model and r = 0.4768 (p = 0.0214) for the Extended Sine Model. The 95%
confidence intervals for r were [0.1258, 0.7628] and [0.0805, 0.7430]. While the PV model
had a stronger and more significant correlation than the Extended Sine Model, there is
significant overlap in the 95% confidence intervals.
6.3.3 Influence on Clinical Decision Making
This subsection analyses the influence that the described techniques have on the decision
of a clinician. Decisions were recorded with reconstructed data from the PV Model, the
Extended Sine Model, and with channels removed. Further, decisions were recorded twice
on the original recording. To avoid sensitivity to which of the two ‘original’ decisions we
use as our ground truth, we compare decision made with the mean of the decisions made
when faced with the original recording.
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(a) PV Model (b) Extended Sine Model
Figure 6.4: Scatterplots showing Correlation between Error on Active Channels
and Error across Whole Recording. These scatterplots show the connection between
how well the models fit to the active channels and how well the resulting fit is to the
whole signal. a) results from the PV model (r = 0.5115). b) results from the Extended
Sine Model (r = 0.4768). Correlation is not strong enough for the error across the whole
recording to be reliably predicted from the error on the active channels for either model.
Figure 6.5 shows the error in clinical decision making using the signals with removed
channels, channels reconstructed by the PV Model and channels reconstructed by the
Extended Sine Model. Full results are provided in a table in Appendix C.
From the histograms it is clear that both models reduced the error in clinical decision
making. The mean error with removed channels was 2.2065 channels (SD = 1.4512),
compared to an error of 1.4239 (SD = 1.0804) with the PV model and an error of 1.5543
(SD = 1.3734) with the extended sine model. Using the extended sine model resulted
in the highest frequency of perfect decisions, but also a large number of severe errors,
resulting in the high SD reported. Error in decision-making is shown in the histograms
in Figure 6.5. For 15/23 (65%) of patients, the clinician’s decision was consistent when
presented with the same recording twice, giving a mean error of 0.9348 (SD = 1.4640). As
this is the variation from testing the clinician against himself, this mean error represents
the best that could be reasonably expected from our reconstruction efforts.
As each sample is performed on the same ectopic event with the same signals removed,
and the data is clearly not normally distributed, the Wilcoxon signed-rank test was used
to compare the medians. The assumption that the PV Model and Extended Sine Model
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(a) Error in Decision Making with Channels
Removed to simulate lost information
(b) Error in Decision Making with Channels
Reconstructed by the PV Model
(c) Error in Decision Making with Channels
Reconstructed by the Extended Sine Model
(d) Variability in Decision Making on the
same clinical signal
Figure 6.5: Histograms Showing Error in Clinical Decision Making. Histograms
presented show the error in clinical decision making with a) channels removed, b) re-
constructed by a mathematical model of the elecrophysiology and c) by a data driven
approach using an extended sine wave. d) shows the variability present in the decision
process. The decisions made with the PV Model and with Extended Sine Model were
both significantly better than the decisions made with the channels removed (p = 0.0083
and 0.0255 respectively).
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reconstructions are paired is further justified by the correlation shown in Figure 6.2. The
Mann-Whitney test was used to find whether the decision change from the reconstruction
was significantly larger than the error inherent in the decision making process.
The PV model provided a significant improvement in decision making over the re-
moved channels (p = 0.0083). The Extended Sine Model also provided a statistically
significant improvement over having no information (p = 0.0255). The errors made when
using the PV Model were indistinguishable from the errors made using the Extended Sine
Model (p = 0.7520).
6.4 Discussion
This chapter used a larger dataset of 27 patients to compare the PV Model and the Ex-
tended Sine Model. Following extensive testing considering a variety of factors, we found
both models to be equally effective.
When performing fits on complete recordings, a statistically significant result to the
5% confidence level indicated that the models fit to the same degree of accuracy. When
using the same test to compare how errors increase when using the models to recon-
struct data, the Extended Sine Model had a lower mean, but this was not significant.
Interestingly, we found a strong correlation between quality of fit between PV Model and
Extended Sine Model when comparing individual patients.
This implies that the models struggle to fit to the same patients, and it is not possible
to predict which model will perform better for a given patient before the fit. The error
in the active channels on the PV Model provided a slightly better correlation coefficient
with which the error on reconstructed signals could be predicted, but this was not signif-
icantly different from that of the Extended Sine Model, and too weak to make a reliable
prediction anyway.
The similarity between the two models persists when investigating influence on clinical
decision making. We find that both models offer a significant improvement over leaving
the recording with missing channels, as is presently done in clinic. This is a very positive
result, as it shows that over 23 patients, both of the models that we have presented in
this thesis improve clinical decision making to the 5% confidence level.
From the point of view of implementation more concrete comparisons can be made
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between the two methods with the knowledge that they are are effectively the same in
providing decision support. The Extended Sine Model is much quicker to compute due
to the avoidance of a reaction diffusion equation that needs to be time-stepped on a high-
resolution domain. This speed-up in computation time, which as established in chapter
5 is between 8 and 9 orders of magnitude, is especially important when calibrating the
model to fit a patient in real time. Using present technology and without the use of any
high performance computing facilities, the information collected indicates reconstruction
of missing signals by the Extended Sine Model may be the most appropriate in clinic.
However, the Extended Sine Model contains no biological detail and as a result is
difficult to extend to adapt to new technology. There are many factors which we the-
oretically could account for in the PV model, but did not as they were not routinely
collected in clinic, and unavailable to us. These include fibre orientation in the heart,
areas of inhomogeneous conduction velocity, and the geometrical mesh of the heart. The
PV model could potentially adapt to this information if it was recorded in clinic.
126
Chapter 7
Discussion
From diagnosis, to drug discovery, to signal processing, mathematical modelling is a
valuable tool in the research of cardiac disease. Exploration of the parameter space of
detailed biophysical models, such as the Courtemanche model, has helped to identify
ionic current channel targets for drug development. Investigation of a mathematical
model rather than a real cell allows for a greater amount of cell properties down to the
individual ion channels to be investigated simply by changing parameters. Mathematical
models have also been developed to diagnose diseases across the cardiac system from
sinoatrial node dysfunction to ventricular fibrillation, often producing a simulation of the
body-surface ECG taking into account the conductivity of the torso. In radiofrequency
ablation of atrial fibrillation, various ablation strategies have been compared for their
efficiency in eliminating spiral waves through mathematical simulations of the underlying
dynamics.
7.1 Discussion of Results
In this thesis we have focused on developing phenomenological mathematical models
which could potentially be computed in real time in the operating theatre to aid a car-
diologist’s decision-making process. In chapter 3 we demonstrated new techniques to
investigate the parameter space of a cardiac model, and calculated the pathway through
parameter space connecting healthy and diseased states as a front of Pareto optimal so-
lutions used the NSGA-II method. Having characterised this, then the main focus of
the remainder of the thesis was to explore translational potential. We developed a novel
mathematical model the PV electrophysiology, focusing on recordings of the electrical
signal recorded around the PV ostium used to guide ablation, for which no model pre-
viously existed. We then used the model to address information loss issues arising from
poor electrode contact.
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7.1.1 Parameter Optimisation
Chapter 3 explored parameter optimisation strategies applied to cardiac models with two
main aims. The first was to investigate a novel, alternative cost function to increase the
efficiency of fitting a travelling action potential to data. The second was to find a path
through parameter space linking healthy and disease states, in order to identify the key
parameters involved.
Our proposed alternate cost function was to maximise the cross-correlation rather
than minimise the mean squared error between the two action potentials. However, while
we demonstrated that there are regions of parameter space for which this cost function is
more representative of the actual error, the cost function performed poorly when perform-
ing actual parameter fits, as the region of parameter space with a notable improvement
was simply not explored by either the NMSS or the GA.
We then explored paths through parameter space from a healthy cell to a diseased
cell using a Pareto Front. We found that using a Pareto Front allowed for a significant
increase in accuracy across the transition, compared to fitting to the two states and in-
terpolating. In addition, parameter change across the front can help us to identify which
parameters are of most importance based on how much they change across the front.
The parameter change identified caused a reduction in the slow inwards channel, re-
ducing the APD and size of the dome morphology. This change is consistent with what
we know about the physiological changes underpinning electrical remodelling in AF, as
the morphological changes are largely caused by a reduction in the slow inwards Calcium
leak current.
Simplifying the front by reducing it down to the line of best fit through the most
important parameter still provided an improvement on linear interpolation across all
20. This simultaneous reduction of dimensionality and increase in accuracy allows for a
much simpler representation of the transition which could potentially be useful for further
mathematical analysis, such as bifurcation theory, on the key parameter identified.
7.1.2 Pulmonary Vein Model
Chapter 4 presented the key result of the thesis: the development of a novel phenomeno-
logical model of the pulmonary veins during radiofrequency ablation therapy capable of
reproducing key features of the clinical PV recordings. To my knowledge, these record-
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ings, despite being commonly used across the world during pulmonary vein ablation, had
never been studied using a mathematical model before. Using a simple geometrical do-
main and a phenomenological reaction diffusion equation, we were able to reproduce the
phenomenology of the recording catheter.
Due to the translational nature of this thesis, we investigated the use of the model
in clinic by focusing on a common problem seen in the operating theatre: that some
channels do not spike properly due to poor contact between electrode and tissue. We
demonstrated that we could train the model to those channels that are spiking correctly,
and simulate the model to reproduce those that are not. The RMS error in activation
times was not significantly increased for up to three signals reconstructed, indicating that
in clinic, we would be able to reconstruct up to three signals lost to poor contact.
We further investigated the potential applicability of the model in clinic by running a
study using historic data, in which original signals were modified to reproduce the effect
of information loss due to poor contact, and asking a cardiologist trained in the ablation
procedure to identify where he would ablate. The study showed two key results: firstly
that the loss of information does change the clinical cardiologist’s decision on where to
ablate, and secondly, that using the model reduces the impact of the information loss on
the decision.
7.1.3 Data-Driven Method
In chapter 5 we introduced an alternative method for reconstructing clinical signals, by
directly modelling the activation pattern without recourse to modelling the electrophys-
iology of the pulmonary vein. We build on existing work which fit a simple sine wave
to the activation pattern of the lasso catheter for the purpose of estimating conduction
velocity and fibre orientation in the atrium. We adapted this model to make it suitable
to reproduce the activation time pattern when the lasso catheter is positioned around the
pulmonary vein ostium by adding two extra parameters and demonstrated the improve-
ment this development offers over the existing model.
Using a sine wave to model the activation pattern offers significant speed-up over us-
ing a reaction diffusion equation, however, this increase in computational efficiency comes
with a decrease in realism, by only modelling the activation times we do not generate a
synthetic signal. We show that using the simplified sine wave model, we can still recon-
struct missing channels by taking averages of the channels of those which are spiking, and
shifting the signals such that the activation time is in accordance with model predictions.
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The methods presented in this chapter are much simpler than in chapter 4 but are
not built on any electrophysiological principles. If such a method would be sufficient for
providing an improvement in the operating theatre, it would be simpler and quicker to
implement.
7.1.4 Clinical Testing
In chapter 6 we compare the methods introduced in chapters 4 and 5 using a larger dataset
from Bristol Heart Institute with 27 patients. We compared the models numerically and
in terms of the efficacy of a decision support system by repeating the clinical trial.
In terms of the effectiveness of the model to both fit to complete PV recordings, recon-
struct data, and direct clinical decision making, there was very little difference between
the PV Model and the Extended Sine Model. All statistical tests either returned an
insignificant p value or returned a strongly significant result suggesting the models were
identical. We also found that both the PV Model and the Extended Sine Model were
strongly correlated in terms of which patients they gave the best fits for.
As both models were indistinguishable statistically, the most appropriate tool for the
guidance of clinical decision is the one that can be computed the quickest: the Extended
Sine Model, for which parameters can be calibrated in under a second. In the future,
should an improvement in clinical data collection enable factors such as fibre orientation to
be recorded, these can be easily included in the PV Model by adaptation of the numerical
methods. In short, we conclude that the Extended Sine Model is more appropriate under
the current state of the art, but the PV Model is adaptable to future advances in clinical
monitoring.
7.2 Future Research
7.2.1 Paths Through Parameter Space
The result that following a Pareto Front through parameter space provides an improve-
ment over interpolating is an interesting result and has broader implications outside of
the scope of cardiac modelling. The result that a Pareto Front can pick up the nonlinear
parameter changes in the BOCF model necessary to replicate the linear change in the
Courtemanche model parameters could potentially be explored in future work.
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More validation, using different combinations of models and even experimental valida-
tion, would be necessary before we can conclusively say that the technique is applicable to
other problems. Subsequently, this technique could potentially be useful in any scientific
problem where two states are known, but a simulation is required of the intermediate
states.
The most significant potential application of our use of the Pareto Front comes from
the ability to identify key parameters across the transition between states. Applied
to other problems where parameters have a more well defined physical meaning (such
as a biophysical cardiac model) it could potentially be possible to learn more about
physiological changes at the subcellular level by observing how biophysical parameters
change across the front.
7.2.2 Conduction Gap Detection
This thesis has focused primarily on building a mathematical model reconstruct of missing
signals in the operating theatre, providing the cardiologist with more reliable information
to make the decision on where to ablate. However, such an implementation still relies on
the intuition of the clinician once the reconstructed signal is simulated. The most obvious
development on this would be to extend the model to the degree of realism to which the
optimal ablation location could be directly inferred. Such a technique could revolutionise
the way the optimal ablation zone is determined by allowing a mathematical model built
on the underlying biophysics to determine the most likely conduction gap location, rather
than relying on intuition.
A number of additional steps would need to be taken to realise this idea. The as-
sumption of isotropy, while sufficient for reconstructing signals, would alter the optimised
location of the conduction gap, and as such, the accuracy of which the conduction gap
could be estimated would be dependent on the accuracy of the diffusion tensor. The
geometry of the heart and regions of tissue expansion between the ablation line and the
recording catheter would also become more relevant when we are trying to work from the
catheter back to the conduction gap location.
In order for such a technique to be implemented, we would ideally require the fibre
orientation to infer the eigenvectors of the diffusion tensor, coupled with a 3D mesh model
of the patient’s pulmonary vein ostium to perform finite element simulations. While the
3D mesh is recorded within the Carto software commonplace in the operating theatre,
dominant conduction direction is not recorded in standard clinical practice. As a result,
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any integration of a model requiring these properties into a therapeutic decision support
system would require the introduction of additional recording technology, which is outside
the scope of this thesis.
7.2.3 Integration into Clinical Practice
The model presented is sufficient to reconstruct missing recordings. However, the proce-
dure requires parameter optimisation (the location and size of conduction gaps) to train
the model to the signals that aren’t spiking, in order to simulate the others. The vast
majority of the computation time is spent training the model so that the missing signals
can be simulated. The computation time is exacerbated by the inefficiency of general
purpose optimisers such as the GA or NMSS. As the parameters being optimised are
integers within a certain range, there are only a finite number of parameter choices, and
current implementations of general purpose optimisation techniques tend to repeat the
same calculations.
It is likely the most efficient optimisation technique will come from a bespoke algo-
rithm developed specifically for the purpose, rather than a general method such as the
GA or the NMSS. If such an optimisation scheme is developed, the model would be ready
for clinical use, and future work should be directed towards this aim to make the system
as easy and intuitive as possible for the clinical cardiologist to integrate into existing
practice.
This would involve the further pursuit of our patent application which outlines and
protects the IP on clinically relevant techniques [195]. While the clinical cardiologists
involved in the work at Bristol Heart Institute and the University Hospital of Bordeaux
expressed interest in the tools developed in the thesis, further investigation would need
to be undertaken to assess the global interest in our proposed decision support system
among the clinical community. From there, the system would need to be developed on
the technical side, either integrated as a feature in existing software (such as Boston-
Scientific’s LabSystem Pro currently used to analyse signals) or as a standalone software
package. Next, a large scale, formal clinical trial would be necessary to test the system
during the live procedure, rather than retrospectively on past cases, before it is ready for
widespread adoption by the clinical community.
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Appendix A
Courtemanche Model Equations
V˙ = −(iNa + iK1 + ito + iKur + iKr + iKs + iBNa + iBCa + iNaK + iCaP + iNaCa + iCaL + ist)/Cm
iNa = Cm · gNa ·m3 · h · j(V − ENa)
ENa = (R · T/F ) ln(Nao/Nai)
αm =
V = −47.13 3.2else 0.32(V + 47.13)/(1− exp(−0.1(V + 47.13)))
βm = 0.08 exp(−V/11)
m∞ = αm/(αm + βm)
τm = 1/(αm + βm)
m˙ = (m∞ −m)/τm
αh =
V < −40 0.135 exp(−(V + 80)/6.8)else 0
βh =
V < −40 3.56 exp(0.079V ) + 3.1× 105 exp(0.35 ∗ V )else 1/(0.13(1 + exp(−(V + 10.66)/11.1)))
h∞ = αh/(αh + βh)
τh = 1/(αh + βh)
h˙ = (h∞ − h)/τh
αj =
V < −40
(−1.2714×105 exp(0.2444V )−3.474×10−5 exp(−0.04391V ))(V+37.78)
(1+exp(0.311(V+79.23)))
else 0
βj =
V < −40
0.1212∗exp(−0.01052V )
(1+exp(−0.1378(V+40.14)))
else 0.3∗exp(−2.535×10
−7∗V )
(1+exp(−0.1(V+32)))
(A.1)
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j∞ = αj/(αj + βj)
τj = 1/(αj + βj)
j˙ = (j∞ − j)/τj
EK = (R · T/F ) ln(Ko/Ki)
iK1 =
Cm · gK1(V − EK)
(1 + exp(0.07 ∗ (V + 80)))
ito = Cm · gto · oa3 · oi(V − EK)
αoi = (18.53 + exp((V + 113.7)/10.95))
−1
βoi = (35.56 + exp(−(V + 1.26)/7.44))−1
τoi = (αoi + βoi)
−1/KQ10
oi∞ = (1 + exp((V + 43.1)/5.3))−1
o˙i = (oi∞ − oi)/τoi
gKur = 0.005 + 0.05/(1 + exp((15− V )/13))
iKur = Cm · gKur · ua3 · ui · (V − EK)
αua = 0.65(exp(−(V + 10)/8.5) + exp((30− V )/59))−1
βua = 0.65(2.5 + exp((V + 82)/17))
−1
τua = (αua + βua)
−1/KQ10
ua∞ = (1 + exp(−(V + 30.3)/9.6))−1
u˙a = (ua∞ − ua)/τua
αui = (21 + exp((185− V )/28))−1
βui = 1/ exp((158− V )/16)
τui = (αui + βui)
−1/KQ10
ui∞ = (1 + exp((V − 99.45)/27.48))−1
u˙i = (ui∞ − ui)/τui
iKr =
Cm · gKr · xr(V − EK)
1 + exp((V + 15)/22.4)
αxr =
abs(V + 14.1) < 10−10 0.0015else 0.0003(V+14.1)
1−exp(−(V+14.1)/5)
βxr =
abs(V − 3.3328) < 10−10 3.7836118× 10−4else 7.3898×10−5(V−3.3328)
exp((V−3.3328)/5.1237)−1
τxr = (αxr + βxr)
−1
xr∞ = (1 + exp(−(V + 14.1)/6.5))−1
x˙r = (xr∞ − xr)/τxr
(A.2)
134
iKs = Cm · gKs · xs2(V − EK)
αxs =
abs(V − 19.9) < 1× 10−10 6.8× 10−4else 4×10−5(V−19.9)
(1−exp((19.9−V )/17))
βxs =
abs(V − 19.9) < 1× 10−10 3.15× 10−4else 3.5×10−4(V−19.9)
(exp((V−19.9)/9)−1)
τxs = 0.5(αxs + βxs)
−1
xs∞ =
(
1 + exp((19.9− V )
12.7
)−0.5
x˙s = (xs∞ − xs)/τxs
iCaL = Cm · gCaL · d · f · fCa(V − 65)
d∞ = (1 + exp(−(V + 10)/8))−1
τd =
abs(V + 10) < 1× 10−10 4.5791+exp(−(V+10)/6.24)else 1−exp((V+10)/−(6.24))
0.035∗(V+10)∗(1+exp(−(V+10)/6.24))
d˙ = (d∞ − d)/τd
f∞ =
exp(−((V + 28))/6.9)
1 + exp(−(V + 28)/6.9)
τf = 9(0.0197 exp(−((0.0337)2)(V + 10)2) + 0.02)−1
f˙ = (f∞ − f)/τf
fCa∞ = (1 + Cai/0.00035)
−1
˙fCa = (fCa∞ − fCa)/τfCa
σ = (exp(Nao/67.3)− 1)/7
fNaK =
(
1 + 0.1245 exp
(−0.1 · F · V
R · T
)
+ 0.0365σ · exp
(−F · V
R · T
))−1
iNaK =
Cm · iNaKmax · fNaK
(1 + (KmNai/Nai)
1.5)
Ko/(Ko +KmKo)
ECa = R · T/2F ln(Cao/Cai)
iBNa = Cm · gBNa(V − ENa)
iBCa = Cm · gBCa(V − ECa)
iBK = Cm · gBK (V − EK)
iNaCa = Cm · INaCamax
(
exp
(
γ·F ·V
R·T
) ∗Nai3 · Cao − exp( (γ−1)F ·VR·T )Na3o · Cai)
(KmNa
3 +Na3o)(KmCa+ Cao)
(
1 +Ksat ∗ exp
(
(γ−1)V ·F
R·T
))
(A.3)
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iCaP = Cm · iCa · Pmax · Cai/(0.0005 + Cai)
Fn = 103
(
10−15Vrel · irel − 10
−15
2F
(0.5iCaL − 0.2iNaCa)
)
irel = Krel · u2 · v · w(Carel − Cai)
u∞ =
(
1 + exp
(−(Fn− 3.4175× 10−13)
13.67× 10−16
))−1
u˙ = (u∞ − u)/τu
τv = 1.91 + 2.09
(
1 + exp
(−(Fn− 3.4175× 10−13)
13.67× 10−16
))−1
v∞ = 1−
(
1 + exp
(−(Fn− 6.835× 10−14)
13.67× 10−16
))−1
v˙ = (v∞ − v)/τv
τw =
abs(V − 7.9) < 10−10 6× 0.2/1.3else 6 1−exp(−(V−7.9)/5)
(1+0.3 exp(−(V−7.9)/5))(V−7.9)
w∞ = 1− (1 + exp(−(V − 40)/17))−1
w˙ = (w∞ − w)/τw
itr = (Caup − Carel)/τtr
iup = Iupmax/(1 +Kup/Cai)
iupleak = Iupmax ∗ Caup/Caupmax
CaCMDN = CMDNmax · Cai/(Cai +KmCMDN)
CaTRPN = TRPNmax · Cai/(Cai +KmTRPN)
CaCSQN = CSQNmax · Carel/(Carel +KmCSQN)
Vi = Vcell · 0.68
Vrel = 0.0048Vcell
Vup = 0.0552Vcell
˙Nai = (−3iNaK − (3iNaCa + iBNa + iNa))/(Vi · F )
K˙i = (2iNaK − (iK1 + ito + iKur + iKr + iKs + iBK ))/(Vi · F )
˙Cai = B1/B2
B1 =
2iNaCa − (iCaP + iCaL + iBCa)
2Vi · F +
Vup(iupleak − iup) + irel · Vrel
Vi
B2 = 1 +
TRPNmax ∗KmTRPN
(Cai +KmTRPN)2
+
CMDNmax ∗KmCMDN
(Cai +KmCMDN)2
˙Caup = iup − (iupleak + itr · Vrel/Vup)
˙Carel = (itr − irel)
(
1 +
CSQNmax ·KmCSQN
(Carel +KmCSQN)2
)−1
(A.4)
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Where any undefined symbols are constant parameters given in [4] or [11].
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Appendix B
Derivation and Programming of the
Asymmetric Finite Difference Stencil
This appendix describes the derivation of the 9 point finite difference stencil used in the
calculation of anisotropic diffusion. The calculations are performed in 2 dimensions on a
rectangular grid with spatial resolutions ∆x and ∆y, but could be scaled to any integer
dimension ≥ 2. The stencil calculates an approximation for the diffusion term ∇· (D˜∇u)
in a generic reaction-diffusion equation where
∑
Jion is the sum of all currents in the
reaction part of the model (phenomenological or biophysical).
∂u
∂t
= ∇ · (D∇u) +
∑
Jion, (B.1)
where D is the diffusion tensor, which for isotropic diffusion can be treated as a
constant. For anisotropic diffusion, we consider a unit direction vector b = (cosα, sinα)T
to be pointing in the dominant direction of diffusion. Diffusion coefficients parallel and
perpendicular to b are defined as D‖ and D⊥. The diffusion matrix D = (D‖−D⊥)bbT +
D⊥I, such that
D =
(
D‖b21 +D⊥b
2
2 (D‖ −D⊥)b1b2
(D‖ −D⊥)b1b2 D⊥b21 +D‖b22
)
. (B.2)
To ensure no loss of generality, unless specifically mentioned, we assume that D‖, D⊥
and α are not constant. In theory, these quantities could be a function of time, of any
of the state variables, of space, or even stochastic, so long as they can be numerically
evaluated at any point on the domain for every time step.
As the finite difference stencil is independent of the reaction, it is sufficient to consider
the heat equation
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∂u
∂t
= ∇ · (D · ∇u), (B.3)
which we express as
q = −D · ∇u, ∂u
∂t
= −∇ · q, (B.4)
by expressing the bracketed term in (B.3) as −q. From here, we use asymmetric finite
differences to calculate the stencil used in our numerical methods. For these methods,
the diffusion tensor is defined on the half indicies, i.e. for a generic point in the grid
(i, j), the diffusion tensor D is defined on (i± 1
2
, j) and (i, j ± 1
2
). At any point (i, j), we
calculate
qi,j = −Di,j ·
(
∂u
∂x
∣∣∣∣
i,j
,
∂u
∂y
∣∣∣∣
i,j
)
. (B.5)
However, as we define D on the half indices, we require qi± 1
2
,j and qi,j± 1
2
, allowing us
to use the central difference formula to calculate diffusion.
∇ · q =
(q1)i+ 1
2
,j − (q1)i− 1
2
,j
∆x
+
(q1)i,j+ 1
2
− (q1)i,j− 1
2
∆y
(B.6)
Defining D on the half indicies is where the asymmetry comes from, as we must
handle the x and y differentials differently on each point in the stencil. For qi+ 1
2
,j, the x
differential can be handled through the standard central difference formula:
∂u
∂x
∣∣∣∣
i+ 1
2
,j
=
ui+1,j − ui,j
∆x
. (B.7)
This, howver, does not apply to the y derivative as there is no change in y across
these two grid points. To calculate ∂u
∂y
∣∣∣∣
i+ 1
2
,j
we use a somewhat longer central difference
formula, which calculates the average of the y derivative from (i, j − 1) to (i, j + 1) and
(i+ 1, j − 1) to (i+ 1, j + 1) (a rectangle centred on (i+ 1
2
, j)):
∂u
∂y
∣∣∣∣
i+ 1
2
,j
=
ui+1,j+1 + ui,j+1 − ui+1,j−1 − ui,j−1
4∆y
. (B.8)
Applying equation (B.5) with spatial derivatives as in (B.7) and (B.8) at (i + 1
2
, j)
gives
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qi+ 1
2
,j = −
(
D‖b21 +D⊥b
2
2 (D‖ −D⊥)b1b2
(D‖ −D⊥)b1b2 D⊥b21 +D‖b22
)
i+ 1
2
,j
·
(
ui+1,j−ui,j
∆x
ui+1,j+1+ui,j+1−ui+1,j−1−ui,j−1
4∆y
)
(B.9)
which, defining the elements of Di+ 1
2
,j asD(1, 1)i+ 1
2
,j, D(1, 2)i+ 1
2
,j, D(2, 1)i+ 1
2
,j, D(2, 2)i+ 1
2
,j,
evaluates to
qi+ 1
2
,j = −
(
D(1, 1)i+ 1
2
,j
(ui+1,j−ui,j)
∆x
+D(1, 2)i+ 1
2
,j
(ui+1,j+1+ui,j+1−ui+1,j−1−ui,j−1)
4∆y
D(2, 1)i+ 1
2
,j
(ui+1,j−ui,j)
∆x
+D(2, 2)i+ 1
2
,j
(ui+1,j+1+ui,j+1−ui+1,j−1−ui,j−1)
4∆y
)
. (B.10)
Similar calculations can be performed on half-indices on the y axes to obtain
qi,j+ 1
2
= −
(
D(1, 1)i,j+ 1
2
(ui+1,j+1+ui+1,j−ui−1,j+1−ui−1,j
4∆x
+D(1, 2)i,j+ 1
2
(ui+1,j−ui,j)
∆y
D(2, 1)i,j+ 1
2
(ui+1,j+1+ui+1,j−ui−1,j+1−ui−1,j
4∆x
+D(2, 2)i,j+ 1
2
(ui+1,j−ui,j)
∆y
)
. (B.11)
Diffusion can then be calculated by substituting equations (B.10) and (B.11) into
(B.6). A number of simplifications can be made to simplify this large numerical scheme.
Firstly, if the diffusion matrix D is constant across the domain, evaluation of (B.6)
becomes much simpler. After some calculation we find
∇ · q =
−
(
D(1, 1)(ui+1,j + ui−1,j − 2ui,j)
∆x
+
D(1, 2)(ui+1,j+1 + ui−1,j−1 − (ui−1,j+1 + ui+1,j−1))
4∆y
)
/∆x
−
(
D(2, 1)(ui+1,j+1 + ui−1,j−1 − (ui−1,j+1 + ui+1,j−1))
4∆x
+
D(2, 2)(ui,j+1 + ui,j−1 − 2ui,j))
∆y
)
/∆y
(B.12)
The terms with the leading diagonal of D as a coefficient are calculated through basic
finite differences in the relevant direction. The backwards diagonal terms are given by
the sum of the terms on opposite corners of the 9 points subtracted from the sum of the
terms on the other corners. If ∆x = ∆y = h,
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∇ · q =
−
(
4D(1, 1)(ui+1,j + ui−1,j − 2ui,j) +D(1, 2)(ui+1,j+1 + ui−1,j−1 − (ui−1,j+1 + ui+1,j−1))
4∆h2
)
−
(
D(2, 1)(ui+1,j+1 + ui−1,j−1 − (ui−1,j+1 + ui+1,j−1)) + 4D(2, 2)(ui,j+1 + ui,j−1 − 2ui,j))
∆4h2
)
.
(B.13)
Further, if D = DI, equation (B.13) simplifies to the familiar formula for finite
differences:
∇ · q = −D
(
ui+1,j + ui−1,j + ui,j+1 + ui,j−1 − 4ui,j
h2
)
. (B.14)
We calculate an efficient procedure for programming the computation of Equation
(B.12) using an extended version of the technique given in the sample MATLAB scripts
of [196], for which diffusion is isotropic, and the only boundary conditions considered are
Neumann. We define vectors N and S which have the same length as Y , the number of
nodes in the y axis. The elements of the vector N are defined as N(i) = i+ 1, such that
the elements of N point to the element above. S is defined similarly for points below.
Boundary conditions are handled on N(Y ) and S(1). Considering only diffusion in the y
axis, using N(Y ) = Y as in [196] will give a scheme on the boundary of
∇ · q = −D
(
ui,j−1 − ui,j
h2
)
. (B.15)
on the upper boundary. Setting N(Y ) = 1 will cause a periodic boundary condition.
N and S stand for North and South. Similar vectors E and W can be defined for East
and West. For isotropic diffusion we use the code from [196]:
E=[1 1:(size1 -1)];
W=[2: size1 size1];
N=[1 1:(size2 -1)];
S=[2: size2 size2];
spat=D.*(u(N,:)+u(S,:)+u(:,E)+u(:,W)-4*u)/(dx*dx).
For anisotropic diffusion with a tensor as defined in (B.2), we use the following:
spat=(D(1 ,1)*(u(N,:)+u(S,:)-2*u)+...
D(2 ,2)*(u(:,E)+u(:,W)-2*u)+...
D(1 ,2)*(u(N,E)+u(S,W)-u(S,E)-u(N,W))/4+...
D(2 ,1)*(u(N,E)+u(S,W)-u(S,E)-u(N,W))/4);
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Appendix C
Results of Large Clinical Test
This appendix chapter contains the full results of the clinical test used in chapter 6 to
compare the ability of both the PV model and the data-driven sine model to reconstruct
pulmonary vein recordings with missing signals for the purposes of aiding clinical decision
making. Recordings for all 27 patients were collected at Bristol Heart Institute from
routine clinical procedure and analysed by a cardiologist trained in the ablation procedure
(who would have treated some of the patients in the first place). Signals were presented to
the clinician in a random order to avoid any associations being made and subconsciously
influencing the decision.
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Patient Original Original 2 Removed PV Model Sine Model
1 PV 15-16 PV 9-10 PV 9-10 PV 13-14 PV 11-12
2 PV 15-16 FF PV 15-16 FF FF
3 PV 3-4 PV 15-16 PV 17-18 PV 17-18 PV 15-16
4 PV 5-6 PV 17-18 PV 17-18 PV 5-6 PV 17-18
5 PV 1-2 PV 1-2 PV 15-16 PV 17-18 PV 17-18
6 PV 11-12 PV 11-12 PV 13-14 PV 11-12 PV 11-12
7 PV 9-10 PV 10-11 PV 7-8 PV 9-10 PV 11-12
8 PV 15-16 PV 15-16 PV 7-8 PV 3-4 PV 19-20
9 PV 13-14 PV 13-14 PV 11-12 PV 13-14 PV 3-4
10 PV 3-4 PV 3-4 PV 1-2 PV 5-6 PV 5-6
11 PV 9-10 PV 13-14 PV 1-2 PV 11-12 PV 11-12
12 PV 7-8 PV 11-12 FF PV 7-8 PV 3-4
13 PV 1-2 PV 15-16 PV 3-4 PV 15-16 PV 1-2
14 PV 11-12 PV 11-12 PV 1-2 PV 15-16 PV 1-2
15 PV 9-10 PV 9-10 PV 15-16 PV 11-12 PV 11-12
16 PV 15-16 PV 15-16 PV 15-16 PV 13-14 PV 13-14
17 PV 9-10 PV 9-10 PV 15-16 PV 11-12 / 13-14 PV 13-14
18 PV 3-4 PV 17-18 PV 19-20 PV 5-6 PV 17-18
19 PV 11-12 PV 11-12 PV 13-14 PV 15-16 PV 11-12
20 PV 7-8 PV 7-8 PV 19-20 PV 19-20 PV 7-8
21 PV 9-10 PV 9-10 PV 5-6 PV 11-12 PV 5-6
22 FF FF FF FF FF
23 PV 3-4 PV 3-4 PV 3-4 PV 3-4 PV 3-4
24 PV 11-12 FF FF FF FF
25 FF PV 15-16 FF FF FF
26 PV 11-12 PV 11-12 PV 13-14 PV 13-14 PV 13-14
27 PV 9-10 PV 9-10 PV 5-6 PV 7-8/9-10 PV 9-10
Table C.1: Clinical Decision making with Doctored PV Recordings. This table
shows the full results of the clinical trial using past cases and recording a trained cardiolo-
gist’s decision on optimal ablation location. ‘Missing’ shows the choice of ablation target
when some channels were removed, simulating the effect of poor contact. ‘EP Model’
and ‘Sine Model’ are the choice of ablation target chosen when the removed channels are
reconstructed by the methods described in chapters 4 and 5 respectively. ‘Original’ is
the unedited signal with all channels spiking, showing the decision which would be made
with all information present.
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